BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 50213671 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:58.71,74.80,8.20,87.93,69.75,wD:48.59,22.31,4.4,33.48,95.101,(27.14,-11.6,;25.81,-10.83,;25.81,-9.29,;24.47,-8.52,;24.47,-6.97,;23.14,-6.2,;21.8,-6.97,;21.8,-8.5,;20.47,-6.2,;20.47,-4.66,;21.89,-4.07,;23.12,-5,;24.38,-4.1,;23.93,-2.63,;24.71,-1.31,;23.96,.04,;22.43,.05,;21.64,-1.26,;22.38,-2.61,;19.13,-6.97,;17.8,-6.2,;17.8,-4.66,;16.46,-6.97,;16.46,-8.51,;17.8,-9.28,;17.8,-10.82,;19.14,-11.58,;19.13,-13.12,;17.8,-13.89,;20.46,-13.9,;15.12,-6.21,;13.78,-6.97,;13.78,-8.51,;12.45,-6.2,;12.42,-4.66,;13.74,-3.87,;15.09,-4.61,;16.4,-3.81,;16.37,-2.28,;17.69,-1.49,;17.67,.05,;16.32,.8,;15,.01,;15.03,-1.52,;13.71,-2.32,;11.12,-6.97,;9.78,-6.21,;9.78,-4.66,;8.44,-6.98,;8.44,-8.51,;9.78,-9.29,;11.18,-8.65,;12.21,-9.8,;11.45,-11.14,;9.94,-10.82,;7.1,-6.21,;5.76,-6.97,;5.76,-8.5,;4.43,-6.2,;4.43,-4.66,;5.76,-3.89,;7.1,-4.65,;8.42,-3.88,;8.42,-2.34,;7.09,-1.57,;5.75,-2.34,;3.1,-6.99,;1.76,-6.22,;1.76,-4.68,;.42,-6.99,;.42,-8.53,;-.9,-6.21,;-2.25,-6.97,;-2.25,-8.51,;-3.58,-6.2,;-4.91,-6.98,;-3.58,-4.66,;-2.25,-3.89,;-.92,-4.66,;.41,-3.89,;.4,-2.35,;1.77,-1.59,;-.92,-1.58,;-2.25,-2.35,;25.81,-6.21,;25.81,-4.67,;27.15,-6.98,;28.48,-6.21,;28.48,-4.66,;29.82,-3.89,;31.15,-4.66,;29.82,-2.35,;29.82,-6.97,;29.82,-8.51,;31.15,-6.2,;32.49,-6.97,;32.49,-8.5,;33.83,-9.28,;35.16,-8.5,;36.5,-9.28,;36.5,-10.82,;35.16,-11.58,;33.83,-10.81,;33.83,-6.2,;35.15,-6.96,;33.83,-4.65,)| InChI=1S/C76H91N17O13/c1-3-4-23-57(69(100)93-64(40-65(95)96)75(106)88-59(66(78)97)35-45-16-7-5-8-17-45)86-73(104)62(38-51-41-83-56-24-14-13-22-54(51)56)91-70(101)58(25-15-32-82-76(79)80)87-71(102)61(37-48-26-29-49-20-11-12-21-50(49)33-48)90-74(105)63(39-52-42-81-43-84-52)92-72(103)60(36-46-18-9-6-10-19-46)89-67(98)44(2)85-68(99)55(77)34-47-27-30-53(94)31-28-47/h5-14,16-22,24,26-31,33,41-44,55,57-64,83,94H,3-4,15,23,25,32,34-40,77H2,1-2H3,(H2,78,97)(H,81,84)(H,85,99)(H,86,104)(H,87,102)(H,88,106)(H,89,98)(H,90,105)(H,91,101)(H,92,103)(H,93,100)(H,95,96)(H4,79,80,82) NENKRICCIWXRGU-UHFFFAOYSA-N 50321604 (3S,6S,9S,12S,15R,18S,21S,24R,27S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-27-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-28-(4-hydroxyphenyl)-24-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26-octaoxo-4,7,10,13,16,19,22,25-octaazaoctacosan-1-oic acid::CHEMBL1172429 Cholecystokinin receptor type A Homo sapiens 1.6 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321604 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2125&target=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321604&enzyme=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search 91933504 104143133 CHEMBL1172429 1 MDVVDSLLVNGSNITPPCELGLENETLFCLDQPRPSKEWQPAVQILLYSLIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLLKDFIFGSAVCKTTTYFMGTSVSVSTFNLVAISLERYGAICKPLQSRVWQTKSHALKVIAATWCLSFTIMTPYPIYSNLVPFTKNNNQTANMCRFLLPNDVMQQSWHTFLLLILFLIPGIVMMVAYGLISLELYQGIKFEASQKKSAKERKPSTTSSGKYEDSDGCYLQKTRPPRKLELRQLSTGSSSRANRIRSNSSAANLMAKKRVIRMLIVIVVLFFLCWMPIFSANAWRAYDTASAERRLSGTPISFILLLSYTSSCVNPIIYCFMNKRFRLGFMATFPCCPNPGPPGARGEVGEEEEGGTTGASLSRFSYSHMSASVPPQ 7XOV,7XOU,7EZM,7EZK,7EZH,7MBX,7MBY Cholecystokinin receptor type A CCKAR_HUMAN P32238 B2R9Z5 50213672 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:58.71,74.80,8.20,87.93,69.75,wD:48.59,22.31,4.4,33.48,95.101,(27.14,-11.6,;25.81,-10.83,;25.81,-9.29,;24.47,-8.52,;24.47,-6.97,;23.14,-6.2,;21.8,-6.97,;21.8,-8.5,;20.47,-6.2,;20.47,-4.66,;21.89,-4.07,;23.12,-5,;24.38,-4.1,;23.93,-2.63,;24.71,-1.31,;23.96,.04,;22.43,.05,;21.64,-1.26,;22.38,-2.61,;19.13,-6.97,;17.8,-6.2,;17.8,-4.66,;16.46,-6.97,;16.46,-8.51,;17.8,-9.28,;17.8,-10.82,;19.14,-11.58,;19.13,-13.12,;17.8,-13.89,;20.46,-13.9,;15.12,-6.21,;13.78,-6.97,;13.78,-8.51,;12.45,-6.2,;12.42,-4.66,;13.74,-3.87,;15.09,-4.61,;16.4,-3.81,;16.37,-2.28,;17.69,-1.49,;17.67,.05,;16.32,.8,;15,.01,;15.03,-1.52,;13.71,-2.32,;11.12,-6.97,;9.78,-6.21,;9.78,-4.66,;8.44,-6.98,;8.44,-8.51,;9.78,-9.29,;11.18,-8.65,;12.21,-9.8,;11.45,-11.14,;9.94,-10.82,;7.1,-6.21,;5.76,-6.97,;5.76,-8.5,;4.43,-6.2,;4.43,-4.66,;5.76,-3.89,;7.1,-4.65,;8.42,-3.88,;8.42,-2.34,;7.09,-1.57,;5.75,-2.34,;3.1,-6.99,;1.76,-6.22,;1.76,-4.68,;.42,-6.99,;.42,-8.53,;-.9,-6.21,;-2.25,-6.97,;-2.25,-8.51,;-3.58,-6.2,;-4.91,-6.98,;-3.58,-4.66,;-2.25,-3.89,;-.92,-4.66,;.41,-3.89,;.4,-2.35,;1.77,-1.59,;-.92,-1.58,;-2.25,-2.35,;25.81,-6.21,;25.81,-4.67,;27.15,-6.98,;28.48,-6.21,;28.48,-4.66,;29.82,-3.89,;31.15,-4.66,;29.82,-2.35,;29.82,-6.97,;29.82,-8.51,;31.15,-6.2,;32.49,-6.97,;32.49,-8.5,;33.83,-9.28,;35.16,-8.5,;36.5,-9.28,;36.5,-10.82,;35.16,-11.58,;33.83,-10.81,;33.83,-6.2,;35.15,-6.96,;33.83,-4.65,)| InChI=1S/C76H91N17O13/c1-3-4-23-57(69(100)93-64(40-65(95)96)75(106)88-59(66(78)97)35-45-16-7-5-8-17-45)86-73(104)62(38-51-41-83-56-24-14-13-22-54(51)56)91-70(101)58(25-15-32-82-76(79)80)87-71(102)61(37-48-26-29-49-20-11-12-21-50(49)33-48)90-74(105)63(39-52-42-81-43-84-52)92-72(103)60(36-46-18-9-6-10-19-46)89-67(98)44(2)85-68(99)55(77)34-47-27-30-53(94)31-28-47/h5-14,16-22,24,26-31,33,41-44,55,57-64,83,94H,3-4,15,23,25,32,34-40,77H2,1-2H3,(H2,78,97)(H,81,84)(H,85,99)(H,86,104)(H,87,102)(H,88,106)(H,89,98)(H,90,105)(H,91,101)(H,92,103)(H,93,100)(H,95,96)(H4,79,80,82) NENKRICCIWXRGU-UHFFFAOYSA-N 50321604 (3S,6S,9S,12S,15R,18S,21S,24R,27S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-27-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-28-(4-hydroxyphenyl)-24-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26-octaoxo-4,7,10,13,16,19,22,25-octaazaoctacosan-1-oic acid::CHEMBL1172429 Gastrin/cholecystokinin type B receptor Homo sapiens 190 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321604 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2126&target=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321604&enzyme=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933504 104143133 CHEMBL1172429 1 MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG 8IA7,7XOW Gastrin/cholecystokinin type B receptor GASR_HUMAN P32239 A8K7P9 O75824 Q16144 Q92492 Q96LC6 Q9NYK7 Q9UBV1 50213673 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C76H90N16O12/c1-4-5-23-58(68(97)90-64(38-66(94)95)73(102)87-60(67(78)96)32-45-16-7-6-8-17-45)85-71(100)62(34-51-39-83-57-24-14-13-22-54(51)57)89-69(98)59(25-15-28-82-76(79)80)86-70(99)61(33-46-26-27-47-18-9-10-19-48(47)31-46)88-72(101)63(36-52-40-81-42-84-52)91-74(103)65-35-49-20-11-12-21-50(49)41-92(65)75(104)56(77)37-55-43(2)29-53(93)30-44(55)3/h6-14,16-22,24,26-27,29-31,39-40,42,56,58-65,83,93H,4-5,15,23,25,28,32-38,41,77H2,1-3H3,(H2,78,96)(H,81,84)(H,85,100)(H,86,99)(H,87,102)(H,88,101)(H,89,98)(H,90,97)(H,91,103)(H,94,95)(H4,79,80,82) TVINVHGLLFLSBP-UHFFFAOYSA-N 50321596 (3S,6R,9S,12S,15S,18S)-3-((1H-imidazol-5-yl)methyl)-12-((1H-indol-3-yl)methyl)-18-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-1-(2-((R)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-15-butyl-9-(3-guanidinopropyl)-6-(naphthalen-2-ylmethyl)-1,4,7,10,13,16-hexaoxo-2,5,8,11,14,17-hexaazaicosan-20-oic acid::CHEMBL2372623 Mu-type opioid receptor Rattus norvegicus 100 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321596 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321596&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 73354785 104143125 CHEMBL2372623 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50213674 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:58.71,74.80,8.20,87.93,69.75,wD:48.59,22.31,4.4,33.48,95.101,(27.14,-11.6,;25.81,-10.83,;25.81,-9.29,;24.47,-8.52,;24.47,-6.97,;23.14,-6.2,;21.8,-6.97,;21.8,-8.5,;20.47,-6.2,;20.47,-4.66,;21.89,-4.07,;23.12,-5,;24.38,-4.1,;23.93,-2.63,;24.71,-1.31,;23.96,.04,;22.43,.05,;21.64,-1.26,;22.38,-2.61,;19.13,-6.97,;17.8,-6.2,;17.8,-4.66,;16.46,-6.97,;16.46,-8.51,;17.8,-9.28,;17.8,-10.82,;19.14,-11.58,;19.13,-13.12,;17.8,-13.89,;20.46,-13.9,;15.12,-6.21,;13.78,-6.97,;13.78,-8.51,;12.45,-6.2,;12.42,-4.66,;13.74,-3.87,;15.09,-4.61,;16.4,-3.81,;16.37,-2.28,;17.69,-1.49,;17.67,.05,;16.32,.8,;15,.01,;15.03,-1.52,;13.71,-2.32,;11.12,-6.97,;9.78,-6.21,;9.78,-4.66,;8.44,-6.98,;8.44,-8.51,;9.78,-9.29,;11.18,-8.65,;12.21,-9.8,;11.45,-11.14,;9.94,-10.82,;7.1,-6.21,;5.76,-6.97,;5.76,-8.5,;4.43,-6.2,;4.43,-4.66,;5.76,-3.89,;7.1,-4.65,;8.42,-3.88,;8.42,-2.34,;7.09,-1.57,;5.75,-2.34,;3.1,-6.99,;1.76,-6.22,;1.76,-4.68,;.42,-6.99,;.42,-8.53,;-.9,-6.21,;-2.25,-6.97,;-2.25,-8.51,;-3.58,-6.2,;-4.91,-6.98,;-3.58,-4.66,;-2.25,-3.89,;-.92,-4.66,;.41,-3.89,;.4,-2.35,;1.77,-1.59,;-.92,-1.58,;-2.25,-2.35,;25.81,-6.21,;25.81,-4.67,;27.15,-6.98,;28.48,-6.21,;28.48,-4.66,;29.82,-3.89,;31.15,-4.66,;29.82,-2.35,;29.82,-6.97,;29.82,-8.51,;31.15,-6.2,;32.49,-6.97,;32.49,-8.5,;33.83,-9.28,;35.16,-8.5,;36.5,-9.28,;36.5,-10.82,;35.16,-11.58,;33.83,-10.81,;33.83,-6.2,;35.15,-6.96,;33.83,-4.65,)| InChI=1S/C76H91N17O13/c1-3-4-23-57(69(100)93-64(40-65(95)96)75(106)88-59(66(78)97)35-45-16-7-5-8-17-45)86-73(104)62(38-51-41-83-56-24-14-13-22-54(51)56)91-70(101)58(25-15-32-82-76(79)80)87-71(102)61(37-48-26-29-49-20-11-12-21-50(49)33-48)90-74(105)63(39-52-42-81-43-84-52)92-72(103)60(36-46-18-9-6-10-19-46)89-67(98)44(2)85-68(99)55(77)34-47-27-30-53(94)31-28-47/h5-14,16-22,24,26-31,33,41-44,55,57-64,83,94H,3-4,15,23,25,32,34-40,77H2,1-2H3,(H2,78,97)(H,81,84)(H,85,99)(H,86,104)(H,87,102)(H,88,106)(H,89,98)(H,90,105)(H,91,101)(H,92,103)(H,93,100)(H,95,96)(H4,79,80,82) NENKRICCIWXRGU-UHFFFAOYSA-N 50321604 (3S,6S,9S,12S,15R,18S,21S,24R,27S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-27-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-28-(4-hydroxyphenyl)-24-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26-octaoxo-4,7,10,13,16,19,22,25-octaazaoctacosan-1-oic acid::CHEMBL1172429 Delta-type opioid receptor Homo sapiens 42 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321604 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321604&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933504 104143133 CHEMBL1172429 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 50213675 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:58.71,74.80,8.20,87.93,69.75,wD:48.59,22.31,4.4,33.48,95.101,(27.14,-11.6,;25.81,-10.83,;25.81,-9.29,;24.47,-8.52,;24.47,-6.97,;23.14,-6.2,;21.8,-6.97,;21.8,-8.5,;20.47,-6.2,;20.47,-4.66,;21.89,-4.07,;23.12,-5,;24.38,-4.1,;23.93,-2.63,;24.71,-1.31,;23.96,.04,;22.43,.05,;21.64,-1.26,;22.38,-2.61,;19.13,-6.97,;17.8,-6.2,;17.8,-4.66,;16.46,-6.97,;16.46,-8.51,;17.8,-9.28,;17.8,-10.82,;19.14,-11.58,;19.13,-13.12,;17.8,-13.89,;20.46,-13.9,;15.12,-6.21,;13.78,-6.97,;13.78,-8.51,;12.45,-6.2,;12.42,-4.66,;13.74,-3.87,;15.09,-4.61,;16.4,-3.81,;16.37,-2.28,;17.69,-1.49,;17.67,.05,;16.32,.8,;15,.01,;15.03,-1.52,;13.71,-2.32,;11.12,-6.97,;9.78,-6.21,;9.78,-4.66,;8.44,-6.98,;8.44,-8.51,;9.78,-9.29,;11.18,-8.65,;12.21,-9.8,;11.45,-11.14,;9.94,-10.82,;7.1,-6.21,;5.76,-6.97,;5.76,-8.5,;4.43,-6.2,;4.43,-4.66,;5.76,-3.89,;7.1,-4.65,;8.42,-3.88,;8.42,-2.34,;7.09,-1.57,;5.75,-2.34,;3.1,-6.99,;1.76,-6.22,;1.76,-4.68,;.42,-6.99,;.42,-8.53,;-.9,-6.21,;-2.25,-6.97,;-2.25,-8.51,;-3.58,-6.2,;-4.91,-6.98,;-3.58,-4.66,;-2.25,-3.89,;-.92,-4.66,;.41,-3.89,;.4,-2.35,;1.77,-1.59,;-.92,-1.58,;-2.25,-2.35,;25.81,-6.21,;25.81,-4.67,;27.15,-6.98,;28.48,-6.21,;28.48,-4.66,;29.82,-3.89,;31.15,-4.66,;29.82,-2.35,;29.82,-6.97,;29.82,-8.51,;31.15,-6.2,;32.49,-6.97,;32.49,-8.5,;33.83,-9.28,;35.16,-8.5,;36.5,-9.28,;36.5,-10.82,;35.16,-11.58,;33.83,-10.81,;33.83,-6.2,;35.15,-6.96,;33.83,-4.65,)| InChI=1S/C76H91N17O13/c1-3-4-23-57(69(100)93-64(40-65(95)96)75(106)88-59(66(78)97)35-45-16-7-5-8-17-45)86-73(104)62(38-51-41-83-56-24-14-13-22-54(51)56)91-70(101)58(25-15-32-82-76(79)80)87-71(102)61(37-48-26-29-49-20-11-12-21-50(49)33-48)90-74(105)63(39-52-42-81-43-84-52)92-72(103)60(36-46-18-9-6-10-19-46)89-67(98)44(2)85-68(99)55(77)34-47-27-30-53(94)31-28-47/h5-14,16-22,24,26-31,33,41-44,55,57-64,83,94H,3-4,15,23,25,32,34-40,77H2,1-2H3,(H2,78,97)(H,81,84)(H,85,99)(H,86,104)(H,87,102)(H,88,106)(H,89,98)(H,90,105)(H,91,101)(H,92,103)(H,93,100)(H,95,96)(H4,79,80,82) NENKRICCIWXRGU-UHFFFAOYSA-N 50321604 (3S,6S,9S,12S,15R,18S,21S,24R,27S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-27-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-28-(4-hydroxyphenyl)-24-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26-octaoxo-4,7,10,13,16,19,22,25-octaazaoctacosan-1-oic acid::CHEMBL1172429 Mu-type opioid receptor Rattus norvegicus 250 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321604 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321604&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933504 104143133 CHEMBL1172429 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50213676 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CCC(=O)N(C1CCN(CCc2ccccc2)CC1)c1ccccc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C74H92N16O11/c1-2-3-28-57(68(96)88-63(44-66(93)94)73(101)85-59(67(75)95)40-49-21-10-5-11-22-49)83-71(99)61(42-51-45-80-56-29-17-16-27-55(51)56)87-69(97)58(30-18-36-79-74(76)77)84-70(98)60(41-50-23-12-6-13-24-50)86-72(100)62(43-52-46-78-47-81-52)82-64(91)31-32-65(92)90(53-25-14-7-15-26-53)54-34-38-89(39-35-54)37-33-48-19-8-4-9-20-48/h4-17,19-27,29,45-47,54,57-63,80H,2-3,18,28,30-44H2,1H3,(H2,75,95)(H,78,81)(H,82,91)(H,83,99)(H,84,98)(H,85,101)(H,86,100)(H,87,97)(H,88,96)(H,93,94)(H4,76,77,79) WVNNVFIQARDNCG-UHFFFAOYSA-N 50321602 (3S,6S,9S,12S,15R,18S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-15-benzyl-6-butyl-12-(3-guanidinopropyl)-5,8,11,14,17,20,23-heptaoxo-23-((1-phenethylpiperidin-4-yl)(phenyl)amino)-4,7,10,13,16,19-hexaazatricosan-1-oic acid::CHEMBL1172244 Melanocortin receptor 4 Homo sapiens 398 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321602 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6546&target=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321602&enzyme=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 49798104 104143131 CHEMBL1172244 1 MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY 8QJ2,9K3K,7F58,7F55,7F54,7F53,7PIV,7PIU,7AUE Melanocortin receptor 4 MC4R_HUMAN P32245 B2RAC3 Q16317 Q3MIJ6 50213677 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:8.20,58.71,93.99,78.84,wD:73.79,48.59,22.31,33.48,4.4,101.107,(24.59,-5.48,;25.93,-4.72,;25.93,-3.18,;24.59,-2.4,;24.59,-.86,;23.26,-.1,;21.93,-.87,;21.93,-2.41,;20.59,-.11,;20.59,1.44,;22,2.07,;23.25,1.19,;24.48,2.12,;23.98,3.58,;24.73,4.92,;23.94,6.24,;22.4,6.22,;21.65,4.87,;22.44,3.55,;19.25,-.87,;17.91,-.12,;17.91,1.43,;16.57,-.89,;16.57,-2.43,;17.91,-3.2,;17.91,-4.73,;19.24,-5.51,;19.24,-7.05,;17.93,-7.8,;20.61,-7.81,;15.25,-.1,;13.92,-.87,;13.92,-2.41,;12.59,-.1,;12.6,1.44,;13.92,2.21,;15.26,1.44,;16.59,2.21,;16.6,3.75,;17.93,4.53,;17.92,6.07,;16.58,6.84,;15.25,6.06,;15.26,4.52,;13.92,3.75,;11.26,-.86,;9.92,-.1,;9.92,1.45,;8.58,-.87,;8.58,-2.41,;9.92,-3.18,;11.32,-2.55,;12.36,-3.69,;11.59,-5.03,;10.08,-4.71,;7.25,-.09,;5.91,-.85,;5.91,-2.39,;4.58,-.08,;4.58,1.46,;5.91,2.23,;7.25,1.47,;8.58,2.24,;8.58,3.78,;7.24,4.55,;5.91,3.78,;3.25,-.85,;1.92,-.07,;1.92,1.47,;.58,-.85,;-.75,-.07,;-2.08,-.85,;-2.08,-2.38,;-3.41,-.07,;-3.41,1.47,;-4.75,-.84,;-6.09,-.08,;-6.09,1.47,;-7.42,-.86,;-7.4,-2.4,;-8.75,-.1,;-10.08,-.88,;-10.06,-2.42,;-8.72,-3.17,;-11.4,-3.2,;-12.73,-2.44,;-14.07,-3.22,;-12.76,-.9,;-11.41,-.13,;-11.43,1.41,;25.93,-.09,;25.93,1.45,;27.26,-.87,;28.59,-.09,;28.59,1.45,;29.93,2.21,;31.25,1.45,;29.93,3.76,;29.93,-.87,;29.93,-2.4,;31.26,-.1,;32.6,-.87,;32.6,-2.4,;33.93,-3.17,;35.28,-2.4,;36.61,-3.17,;36.61,-4.71,;35.27,-5.48,;33.94,-4.71,;33.93,-.1,;35.27,-.86,;33.93,1.45,)| InChI=1S/C80H98N18O14/c1-5-6-25-60(73(106)98-67(40-69(101)102)79(112)94-62(70(82)103)34-48-18-9-7-10-19-48)92-77(110)65(37-53-41-87-59-26-16-15-24-56(53)59)96-74(107)61(27-17-30-86-80(83)84)93-76(109)64(36-50-28-29-51-22-13-14-23-52(51)33-50)95-78(111)66(38-54-42-85-44-89-54)97-75(108)63(35-49-20-11-8-12-21-49)91-68(100)43-88-71(104)47(4)90-72(105)58(81)39-57-45(2)31-55(99)32-46(57)3/h7-16,18-24,26,28-29,31-33,41-42,44,47,58,60-67,87,99H,5-6,17,25,27,30,34-40,43,81H2,1-4H3,(H2,82,103)(H,85,89)(H,88,104)(H,90,105)(H,91,100)(H,92,110)(H,93,109)(H,94,112)(H,95,111)(H,96,107)(H,97,108)(H,98,106)(H,101,102)(H4,83,84,86) AHRZYQWKXXBNHK-UHFFFAOYSA-N 50321606 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxy-2,6-dimethylphenyl)-27-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172253 Mu-type opioid receptor Rattus norvegicus 0.130000 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321606 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321606&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933506 104143135 CHEMBL1172253 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50213678 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C78H94N18O14/c1-3-4-23-58(71(104)96-65(40-67(99)100)77(110)92-60(68(80)101)35-46-16-7-5-8-17-46)90-75(108)63(38-52-41-85-57-24-14-13-22-55(52)57)94-72(105)59(25-15-32-84-78(81)82)91-74(107)62(37-49-26-29-50-20-11-12-21-51(50)33-49)93-76(109)64(39-53-42-83-44-87-53)95-73(106)61(36-47-18-9-6-10-19-47)89-66(98)43-86-69(102)45(2)88-70(103)56(79)34-48-27-30-54(97)31-28-48/h5-14,16-22,24,26-31,33,41-42,44-45,56,58-65,85,97H,3-4,15,23,25,32,34-40,43,79H2,1-2H3,(H2,80,101)(H,83,87)(H,86,102)(H,88,103)(H,89,98)(H,90,108)(H,91,107)(H,92,110)(H,93,109)(H,94,105)(H,95,106)(H,96,104)(H,99,100)(H4,81,82,84) ZZVLKHHSRQKCEV-UHFFFAOYSA-N 50321607 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxyphenyl)-27-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172252 Mu-type opioid receptor Rattus norvegicus 1.3 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321607 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321607&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798112 104143136 CHEMBL1172252 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50213679 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:69.75,8.20,58.71,89.95,wD:48.59,22.31,33.48,4.4,97.103,74.80,(28.82,-7.95,;30.15,-7.19,;30.15,-5.65,;28.82,-4.88,;28.82,-3.34,;27.48,-2.57,;26.15,-3.35,;26.15,-4.89,;24.82,-2.58,;24.82,-1.03,;26.22,-.4,;27.48,-1.28,;28.71,-.35,;28.21,1.11,;28.95,2.45,;28.16,3.77,;26.62,3.74,;25.87,2.4,;26.66,1.08,;23.48,-3.34,;22.13,-2.59,;22.13,-1.04,;20.8,-3.36,;20.8,-4.9,;22.13,-5.67,;22.13,-7.21,;23.47,-7.98,;23.47,-9.52,;22.16,-10.27,;24.84,-10.28,;19.47,-2.57,;18.15,-3.35,;18.15,-4.88,;16.82,-2.57,;16.82,-1.03,;18.15,-.26,;19.48,-1.03,;20.81,-.26,;20.82,1.28,;22.15,2.06,;22.15,3.6,;20.8,4.36,;19.47,3.58,;19.48,2.05,;18.14,1.28,;15.48,-3.33,;14.14,-2.57,;14.14,-1.02,;12.8,-3.34,;12.8,-4.88,;14.14,-5.65,;15.55,-5.02,;16.59,-6.17,;15.81,-7.5,;14.31,-7.18,;11.47,-2.57,;10.13,-3.32,;10.13,-4.86,;8.81,-2.55,;8.81,-1.01,;10.13,-.25,;11.47,-1.01,;12.81,-.24,;12.8,1.31,;11.47,2.07,;10.14,1.3,;7.47,-3.33,;6.13,-2.55,;6.13,-1.01,;4.8,-3.33,;4.8,-4.87,;3.47,-2.56,;2.12,-3.32,;2.13,-4.86,;.8,-2.54,;.81,-1,;-.54,-3.3,;-1.86,-2.52,;-1.85,-.98,;-.51,-.23,;-3.18,-.2,;-4.52,-.96,;-5.84,-.18,;-4.53,-2.49,;-3.2,-3.27,;-3.21,-4.81,;30.15,-2.57,;30.15,-1.03,;31.49,-3.34,;32.82,-2.57,;32.82,-1.02,;34.15,-.26,;35.48,-1.03,;34.15,1.29,;34.15,-3.34,;34.15,-4.88,;35.49,-2.57,;36.82,-3.34,;36.82,-4.88,;38.16,-5.65,;39.5,-4.87,;40.83,-5.65,;40.84,-7.18,;39.5,-7.95,;38.16,-7.19,;38.16,-2.57,;39.49,-3.33,;38.16,-1.02,)| InChI=1S/C78H95N17O13/c1-5-6-25-59(71(102)95-66(40-67(97)98)77(108)90-61(68(80)99)34-47-18-9-7-10-19-47)88-75(106)64(37-52-41-85-58-26-16-15-24-55(52)58)93-72(103)60(27-17-30-84-78(81)82)89-73(104)63(36-49-28-29-50-22-13-14-23-51(50)33-49)92-76(107)65(38-53-42-83-43-86-53)94-74(105)62(35-48-20-11-8-12-21-48)91-69(100)46(4)87-70(101)57(79)39-56-44(2)31-54(96)32-45(56)3/h7-16,18-24,26,28-29,31-33,41-43,46,57,59-66,85,96H,5-6,17,25,27,30,34-40,79H2,1-4H3,(H2,80,99)(H,83,86)(H,87,101)(H,88,106)(H,89,104)(H,90,108)(H,91,100)(H,92,107)(H,93,103)(H,94,105)(H,95,102)(H,97,98)(H4,81,82,84) JMDKMESJXNSGPX-UHFFFAOYSA-N 50321605 (6R,9S,12S,15R,18S,21S,24S,27S)-12-((1H-imidazol-5-yl)methyl)-21-((1H-indol-3-yl)methyl)-27-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-9-benzyl-24-butyl-18-(3-guanidinopropyl)-1-(4-hydroxy-2,6-dimethylphenyl)-6-methyl-15-(naphthalen-2-ylmethyl)-4,7,10,13,16,19,22,25-octaoxo-3,5,8,11,14,17,20,23,26-nonaazanonacosan-29-oic acid::CHEMBL1172428 Gastrin/cholecystokinin type B receptor Homo sapiens 180 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321605 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2126&target=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321605&enzyme=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933505 104143134 CHEMBL1172428 1 MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG 8IA7,7XOW Gastrin/cholecystokinin type B receptor GASR_HUMAN P32239 A8K7P9 O75824 Q16144 Q92492 Q96LC6 Q9NYK7 Q9UBV1 50213680 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:69.75,8.20,58.71,89.95,wD:48.59,22.31,33.48,4.4,97.103,74.80,(28.82,-7.95,;30.15,-7.19,;30.15,-5.65,;28.82,-4.88,;28.82,-3.34,;27.48,-2.57,;26.15,-3.35,;26.15,-4.89,;24.82,-2.58,;24.82,-1.03,;26.22,-.4,;27.48,-1.28,;28.71,-.35,;28.21,1.11,;28.95,2.45,;28.16,3.77,;26.62,3.74,;25.87,2.4,;26.66,1.08,;23.48,-3.34,;22.13,-2.59,;22.13,-1.04,;20.8,-3.36,;20.8,-4.9,;22.13,-5.67,;22.13,-7.21,;23.47,-7.98,;23.47,-9.52,;22.16,-10.27,;24.84,-10.28,;19.47,-2.57,;18.15,-3.35,;18.15,-4.88,;16.82,-2.57,;16.82,-1.03,;18.15,-.26,;19.48,-1.03,;20.81,-.26,;20.82,1.28,;22.15,2.06,;22.15,3.6,;20.8,4.36,;19.47,3.58,;19.48,2.05,;18.14,1.28,;15.48,-3.33,;14.14,-2.57,;14.14,-1.02,;12.8,-3.34,;12.8,-4.88,;14.14,-5.65,;15.55,-5.02,;16.59,-6.17,;15.81,-7.5,;14.31,-7.18,;11.47,-2.57,;10.13,-3.32,;10.13,-4.86,;8.81,-2.55,;8.81,-1.01,;10.13,-.25,;11.47,-1.01,;12.81,-.24,;12.8,1.31,;11.47,2.07,;10.14,1.3,;7.47,-3.33,;6.13,-2.55,;6.13,-1.01,;4.8,-3.33,;4.8,-4.87,;3.47,-2.56,;2.12,-3.32,;2.13,-4.86,;.8,-2.54,;.81,-1,;-.54,-3.3,;-1.86,-2.52,;-1.85,-.98,;-.51,-.23,;-3.18,-.2,;-4.52,-.96,;-5.84,-.18,;-4.53,-2.49,;-3.2,-3.27,;-3.21,-4.81,;30.15,-2.57,;30.15,-1.03,;31.49,-3.34,;32.82,-2.57,;32.82,-1.02,;34.15,-.26,;35.48,-1.03,;34.15,1.29,;34.15,-3.34,;34.15,-4.88,;35.49,-2.57,;36.82,-3.34,;36.82,-4.88,;38.16,-5.65,;39.5,-4.87,;40.83,-5.65,;40.84,-7.18,;39.5,-7.95,;38.16,-7.19,;38.16,-2.57,;39.49,-3.33,;38.16,-1.02,)| InChI=1S/C78H95N17O13/c1-5-6-25-59(71(102)95-66(40-67(97)98)77(108)90-61(68(80)99)34-47-18-9-7-10-19-47)88-75(106)64(37-52-41-85-58-26-16-15-24-55(52)58)93-72(103)60(27-17-30-84-78(81)82)89-73(104)63(36-49-28-29-50-22-13-14-23-51(50)33-49)92-76(107)65(38-53-42-83-43-86-53)94-74(105)62(35-48-20-11-8-12-21-48)91-69(100)46(4)87-70(101)57(79)39-56-44(2)31-54(96)32-45(56)3/h7-16,18-24,26,28-29,31-33,41-43,46,57,59-66,85,96H,5-6,17,25,27,30,34-40,79H2,1-4H3,(H2,80,99)(H,83,86)(H,87,101)(H,88,106)(H,89,104)(H,90,108)(H,91,100)(H,92,107)(H,93,103)(H,94,105)(H,95,102)(H,97,98)(H4,81,82,84) JMDKMESJXNSGPX-UHFFFAOYSA-N 50321605 (6R,9S,12S,15R,18S,21S,24S,27S)-12-((1H-imidazol-5-yl)methyl)-21-((1H-indol-3-yl)methyl)-27-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-9-benzyl-24-butyl-18-(3-guanidinopropyl)-1-(4-hydroxy-2,6-dimethylphenyl)-6-methyl-15-(naphthalen-2-ylmethyl)-4,7,10,13,16,19,22,25-octaoxo-3,5,8,11,14,17,20,23,26-nonaazanonacosan-29-oic acid::CHEMBL1172428 Mu-type opioid receptor Rattus norvegicus 10.0 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321605 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321605&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933505 104143134 CHEMBL1172428 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50213681 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:33.48,22.31,4.4,48.59,93.100,wD:70.77,58.62,8.20,85.92,(16.65,-3.98,;15.32,-4.75,;15.32,-6.29,;13.98,-7.06,;13.98,-8.6,;12.65,-9.36,;11.32,-8.59,;11.32,-7.05,;9.99,-9.35,;9.99,-10.9,;11.32,-11.67,;12.72,-11.05,;13.76,-12.19,;12.98,-13.52,;13.46,-14.99,;12.42,-16.14,;10.92,-15.81,;10.44,-14.35,;11.48,-13.21,;8.66,-8.59,;7.33,-9.38,;7.33,-10.92,;6,-8.61,;6,-7.07,;7.33,-6.3,;7.33,-4.76,;8.66,-3.97,;8.68,-2.43,;7.33,-1.66,;10,-1.66,;4.65,-9.35,;3.32,-8.59,;3.32,-7.05,;1.99,-9.36,;1.76,-10.89,;2.96,-11.84,;2.73,-13.37,;3.92,-14.33,;5.36,-13.77,;6.57,-14.74,;8.01,-14.17,;8.23,-12.64,;7.03,-11.68,;5.59,-12.24,;4.39,-11.29,;.66,-8.58,;-.66,-9.38,;-.66,-10.92,;-2,-8.61,;-2,-7.07,;-.66,-6.29,;.75,-6.93,;1.79,-5.78,;1.01,-4.45,;-.5,-4.76,;-3.33,-9.38,;-4.67,-8.61,;-4.67,-7.07,;-6,-9.38,;-7.33,-8.62,;-8.66,-9.39,;-9.99,-8.62,;-11.33,-9.39,;-11.33,-10.93,;-9.99,-11.69,;-8.66,-10.92,;-7.33,-11.7,;-6,-10.91,;-4.66,-11.68,;-3.33,-10.91,;-4.66,-13.22,;-5.99,-13.99,;-3.32,-13.99,;-3.32,-15.53,;-4.65,-16.3,;-5.98,-15.53,;-4.65,-17.84,;-3.31,-18.61,;-3.31,-20.15,;-1.98,-17.84,;-1.98,-16.29,;-.65,-15.52,;15.32,-9.37,;15.32,-10.91,;16.65,-8.59,;17.98,-9.36,;17.98,-10.91,;19.32,-11.67,;20.64,-10.9,;19.32,-13.21,;19.32,-8.59,;19.32,-7.05,;20.65,-9.36,;21.98,-8.59,;21.98,-7.05,;23.31,-6.28,;24.65,-7.06,;25.98,-6.29,;25.99,-4.75,;24.65,-3.98,;23.32,-4.75,;23.31,-9.36,;24.65,-8.59,;23.31,-10.91,)| InChI=1S/C76H90N16O12/c1-4-5-23-58(68(97)90-64(38-66(94)95)73(102)87-60(67(78)96)32-45-16-7-6-8-17-45)85-71(100)62(34-51-39-83-57-24-14-13-22-54(51)57)89-69(98)59(25-15-28-82-76(79)80)86-70(99)61(33-46-26-27-47-18-9-10-19-48(47)31-46)88-72(101)63(36-52-40-81-42-84-52)91-74(103)65-35-49-20-11-12-21-50(49)41-92(65)75(104)56(77)37-55-43(2)29-53(93)30-44(55)3/h6-14,16-22,24,26-27,29-31,39-40,42,56,58-65,83,93H,4-5,15,23,25,28,32-38,41,77H2,1-3H3,(H2,78,96)(H,81,84)(H,85,100)(H,86,99)(H,87,102)(H,88,101)(H,89,98)(H,90,97)(H,91,103)(H,94,95)(H4,79,80,82) TVINVHGLLFLSBP-UHFFFAOYSA-N 50321597 (3S,6R,9S,12S,15S,18S)-3-((1H-imidazol-5-yl)methyl)-12-((1H-indol-3-yl)methyl)-18-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-1-((R)-2-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-15-butyl-9-(3-guanidinopropyl)-6-(naphthalen-2-ylmethyl)-1,4,7,10,13,16-hexaoxo-2,5,8,11,14,17-hexaazaicosan-20-oic acid::CHEMBL1172249 Gastrin/cholecystokinin type B receptor Homo sapiens 126 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321597 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2126&target=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321597&enzyme=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933500 104143126 CHEMBL1172249 1 MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG 8IA7,7XOW Gastrin/cholecystokinin type B receptor GASR_HUMAN P32239 A8K7P9 O75824 Q16144 Q92492 Q96LC6 Q9NYK7 Q9UBV1 50213682 C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:5.5,1.0,78.83,66.79,55.66,37.39,97.102,wD:22.22,41.55,89.94,(17.54,.39,;18.85,-.37,;20.18,.39,;20.18,1.92,;18.85,2.7,;21.5,2.69,;21.5,4.24,;22.81,1.93,;22.81,.41,;21.51,-.37,;21.53,-1.91,;22.87,-2.67,;22.87,-4.2,;24.18,-1.88,;24.18,-.35,;18.85,-1.92,;20.2,-2.69,;17.54,-2.68,;17.54,-4.23,;16.23,-4.98,;14.91,-4.23,;16.23,-6.53,;14.91,-7.3,;13.6,-6.53,;12.26,-7.31,;12.29,-8.88,;10.96,-9.65,;9.62,-8.89,;9.61,-7.35,;10.94,-6.57,;14.91,-8.85,;16.26,-9.62,;13.6,-9.6,;13.6,-11.15,;12.3,-11.91,;12.3,-13.47,;10.99,-14.22,;10.99,-15.77,;9.67,-16.53,;8.36,-15.77,;8.36,-14.26,;7.02,-16.55,;7.02,-18.1,;8.36,-18.88,;9.61,-17.94,;10.87,-18.83,;10.39,-20.31,;11.18,-21.63,;10.42,-22.98,;8.88,-22.99,;8.1,-21.66,;8.85,-20.32,;5.7,-15.79,;4.36,-16.57,;4.36,-18.12,;3.05,-15.81,;3.05,-14.3,;4.36,-13.54,;4.36,-11.99,;5.67,-11.23,;5.67,-9.68,;4.33,-8.91,;6.98,-8.93,;1.71,-16.59,;.4,-15.83,;.4,-14.32,;-.95,-16.61,;-.95,-18.16,;.4,-18.93,;1.74,-18.14,;3.07,-18.9,;3.08,-20.45,;4.42,-21.21,;1.76,-21.23,;.42,-20.46,;-2.26,-15.85,;-3.61,-16.63,;-3.61,-18.18,;-4.92,-15.87,;-6.26,-16.65,;-4.92,-14.35,;-3.61,-13.6,;-2.21,-14.2,;-1.18,-13.04,;-1.97,-11.71,;-3.47,-12.05,;12.33,-16.55,;12.33,-18.07,;13.67,-15.77,;14.98,-16.53,;14.98,-18.05,;16.33,-18.82,;17.67,-18.05,;16.33,-20.33,;16.33,-15.75,;16.33,-14.2,;17.64,-16.51,;18.98,-15.73,;18.98,-14.18,;20.3,-13.43,;21.63,-14.17,;22.95,-13.39,;22.94,-11.85,;21.61,-11.09,;20.27,-11.87,;20.3,-16.49,;21.64,-15.71,;20.3,-18.01,)| InChI=1S/C74H92ClN19O14/c1-42(87-66(101)52(76)31-45-23-27-50(95)28-24-45)65(100)85-40-62(96)88-58(33-44-15-6-3-7-16-44)68(103)82-29-11-10-19-55(69(104)94-61(37-63(97)98)73(108)91-57(64(78)99)32-43-13-4-2-5-14-43)89-72(107)60(35-47-38-84-54-18-9-8-17-51(47)54)93-70(105)56(20-12-30-83-74(79)80)90-71(106)59(34-46-21-25-48(75)26-22-46)92-67(102)53(77)36-49-39-81-41-86-49/h2-9,13-18,21-28,38-39,41-42,52-53,55-61,84,95H,10-12,19-20,29-37,40,76-77H2,1H3,(H2,78,99)(H,81,86)(H,82,103)(H,85,100)(H,87,101)(H,88,96)(H,89,107)(H,90,106)(H,91,108)(H,92,102)(H,93,105)(H,94,104)(H,97,98)(H4,79,80,83) VEMKPSHWNYIGPG-UHFFFAOYSA-N 50321601 (2S,5R,11S,18S,21S)-2-amino-21-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-18-((S)-2-((S)-2-((R)-2-((S)-2-amino-3-(1H-imidazol-5-yl)propanamido)-3-(4-chlorophenyl)propanamido)-5-guanidinopentanamido)-3-(1H-indol-3-yl)propanamido)-11-benzyl-1-(4-hydroxyphenyl)-5-methyl-3,6,9,12,19-pentaoxo-4,7,10,13,20-pentaazatricosan-23-oic acid::CHEMBL1172245 Mu-type opioid receptor Rattus norvegicus 32 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321601 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321601&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933503 104143130 CHEMBL1172245 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50213683 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:33.48,22.31,4.4,48.59,93.100,wD:70.77,58.62,8.20,85.92,(16.65,-3.98,;15.32,-4.75,;15.32,-6.29,;13.98,-7.06,;13.98,-8.6,;12.65,-9.36,;11.32,-8.59,;11.32,-7.05,;9.99,-9.35,;9.99,-10.9,;11.32,-11.67,;12.72,-11.05,;13.76,-12.19,;12.98,-13.52,;13.46,-14.99,;12.42,-16.14,;10.92,-15.81,;10.44,-14.35,;11.48,-13.21,;8.66,-8.59,;7.33,-9.38,;7.33,-10.92,;6,-8.61,;6,-7.07,;7.33,-6.3,;7.33,-4.76,;8.66,-3.97,;8.68,-2.43,;7.33,-1.66,;10,-1.66,;4.65,-9.35,;3.32,-8.59,;3.32,-7.05,;1.99,-9.36,;1.76,-10.89,;2.96,-11.84,;2.73,-13.37,;3.92,-14.33,;5.36,-13.77,;6.57,-14.74,;8.01,-14.17,;8.23,-12.64,;7.03,-11.68,;5.59,-12.24,;4.39,-11.29,;.66,-8.58,;-.66,-9.38,;-.66,-10.92,;-2,-8.61,;-2,-7.07,;-.66,-6.29,;.75,-6.93,;1.79,-5.78,;1.01,-4.45,;-.5,-4.76,;-3.33,-9.38,;-4.67,-8.61,;-4.67,-7.07,;-6,-9.38,;-7.33,-8.62,;-8.66,-9.39,;-9.99,-8.62,;-11.33,-9.39,;-11.33,-10.93,;-9.99,-11.69,;-8.66,-10.92,;-7.33,-11.7,;-6,-10.91,;-4.66,-11.68,;-3.33,-10.91,;-4.66,-13.22,;-5.99,-13.99,;-3.32,-13.99,;-3.32,-15.53,;-4.65,-16.3,;-5.98,-15.53,;-4.65,-17.84,;-3.31,-18.61,;-3.31,-20.15,;-1.98,-17.84,;-1.98,-16.29,;-.65,-15.52,;15.32,-9.37,;15.32,-10.91,;16.65,-8.59,;17.98,-9.36,;17.98,-10.91,;19.32,-11.67,;20.64,-10.9,;19.32,-13.21,;19.32,-8.59,;19.32,-7.05,;20.65,-9.36,;21.98,-8.59,;21.98,-7.05,;23.31,-6.28,;24.65,-7.06,;25.98,-6.29,;25.99,-4.75,;24.65,-3.98,;23.32,-4.75,;23.31,-9.36,;24.65,-8.59,;23.31,-10.91,)| InChI=1S/C76H90N16O12/c1-4-5-23-58(68(97)90-64(38-66(94)95)73(102)87-60(67(78)96)32-45-16-7-6-8-17-45)85-71(100)62(34-51-39-83-57-24-14-13-22-54(51)57)89-69(98)59(25-15-28-82-76(79)80)86-70(99)61(33-46-26-27-47-18-9-10-19-48(47)31-46)88-72(101)63(36-52-40-81-42-84-52)91-74(103)65-35-49-20-11-12-21-50(49)41-92(65)75(104)56(77)37-55-43(2)29-53(93)30-44(55)3/h6-14,16-22,24,26-27,29-31,39-40,42,56,58-65,83,93H,4-5,15,23,25,28,32-38,41,77H2,1-3H3,(H2,78,96)(H,81,84)(H,85,100)(H,86,99)(H,87,102)(H,88,101)(H,89,98)(H,90,97)(H,91,103)(H,94,95)(H4,79,80,82) TVINVHGLLFLSBP-UHFFFAOYSA-N 50321597 (3S,6R,9S,12S,15S,18S)-3-((1H-imidazol-5-yl)methyl)-12-((1H-indol-3-yl)methyl)-18-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-1-((R)-2-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-15-butyl-9-(3-guanidinopropyl)-6-(naphthalen-2-ylmethyl)-1,4,7,10,13,16-hexaoxo-2,5,8,11,14,17-hexaazaicosan-20-oic acid::CHEMBL1172249 Melanocortin receptor 4 Homo sapiens 160 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321597 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6546&target=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321597&enzyme=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 91933500 104143126 CHEMBL1172249 1 MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY 8QJ2,9K3K,7F58,7F55,7F54,7F53,7PIV,7PIU,7AUE Melanocortin receptor 4 MC4R_HUMAN P32245 B2RAC3 Q16317 Q3MIJ6 50213684 Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N1CC(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@H](Cc2ccc3ccccc3c2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CSSC[C@@H](N)C1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:69.84,89.95,29.31,10.11,wD:44.48,74.80,19.20,81.87,55.59,(1.42,-5.48,;.09,-4.71,;-1.25,-5.49,;-2.59,-4.72,;-3.92,-5.48,;-2.59,-3.17,;-1.25,-2.41,;-1.25,-.87,;.08,-3.17,;1.41,-2.4,;2.75,-3.17,;2.75,-4.71,;4.08,-2.39,;4.08,-.85,;5.42,-3.16,;6.02,-4.57,;5.09,-5.8,;3.56,-5.61,;5.68,-7.22,;4.75,-8.45,;3.42,-7.68,;2.08,-8.45,;.68,-7.83,;-.35,-8.98,;.42,-10.31,;1.93,-9.98,;4.75,-9.99,;3.42,-10.76,;6.09,-10.76,;6.09,-12.3,;4.75,-13.07,;4.75,-14.61,;6.08,-15.37,;6.09,-16.91,;4.75,-17.69,;4.75,-19.22,;3.42,-19.99,;2.08,-19.22,;2.09,-17.68,;3.42,-16.92,;3.42,-15.39,;7.42,-13.07,;7.42,-14.61,;8.75,-12.3,;10.09,-13.07,;10.09,-14.61,;8.75,-15.38,;8.75,-16.92,;7.42,-17.69,;7.42,-19.23,;6.09,-20,;8.75,-20,;11.42,-12.3,;12.75,-13.07,;11.42,-10.76,;12.75,-9.99,;14.09,-10.76,;15.42,-9.99,;15.57,-8.48,;17.08,-8.15,;17.86,-9.48,;19.37,-9.79,;19.85,-11.26,;18.82,-12.42,;17.3,-12.1,;16.82,-10.63,;12.75,-8.45,;11.42,-7.68,;14.09,-7.68,;14.09,-6.14,;12.75,-5.37,;12.75,-3.83,;10,-3.73,;8.47,-3.54,;7.88,-2.12,;8.81,-.89,;6.35,-1.93,;5.75,-.51,;15.42,-5.37,;16.75,-6.14,;15.42,-3.83,;16.75,-3.06,;18.09,-3.83,;19.42,-3.06,;19.42,-1.52,;20.76,-3.83,;16.75,-1.52,;15.42,-.75,;18.09,-.75,;18.09,.78,;16.75,1.55,;16.75,3.09,;18.09,3.85,;18.09,5.39,;16.76,6.16,;15.42,5.39,;15.43,3.86,;19.42,1.55,;19.42,3.09,;20.76,.78,)| InChI=1S/C68H81N17O13S2/c1-36-21-44(86)22-37(2)46(36)28-47(69)66(97)85-32-57(87)78-54(27-43-31-74-35-77-43)63(94)81-52(25-39-18-19-40-13-6-7-14-41(40)23-39)61(92)79-50(17-10-20-75-68(72)73)60(91)82-53(26-42-30-76-49-16-9-8-15-45(42)49)62(93)84-56(34-100-99-33-48(70)67(85)98)65(96)83-55(29-58(88)89)64(95)80-51(59(71)90)24-38-11-4-3-5-12-38/h3-9,11-16,18-19,21-23,30-31,35,47-48,50-56,76,86H,10,17,20,24-29,32-34,69-70H2,1-2H3,(H2,71,90)(H,74,77)(H,78,87)(H,79,92)(H,80,95)(H,81,94)(H,82,91)(H,83,96)(H,84,93)(H,88,89)(H4,72,73,75) YDLLMSIGAKQIBS-UHFFFAOYSA-N 50321598 (S)-3-((4R,7S,10S,13R,16S,22S)-16-((1H-imidazol-5-yl)methyl)-7-((1H-indol-3-yl)methyl)-22-amino-20-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-10-(3-guanidinopropyl)-13-(naphthalen-2-ylmethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexaazacyclotricosane-4-carboxamido)-4-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid::CHEMBL1172248 Melanocortin receptor 4 Homo sapiens 398 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321598 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6546&target=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321598&enzyme=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 91933501 104143127 CHEMBL1172248 1 MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY 8QJ2,9K3K,7F58,7F55,7F54,7F53,7PIV,7PIU,7AUE Melanocortin receptor 4 MC4R_HUMAN P32245 B2RAC3 Q16317 Q3MIJ6 50213685 Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N1CC(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@H](Cc2ccccc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CSSC[C@@H](N)C1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:10.11,65.79,85.90,29.31,wD:19.20,70.75,40.43,77.82,51.54,(-6.99,1.44,;-8.33,2.2,;-9.67,1.43,;-11.01,2.2,;-12.34,1.43,;-11,3.74,;-9.66,4.51,;-9.66,6.05,;-8.33,3.74,;-7,4.51,;-5.67,3.75,;-5.66,2.21,;-4.33,4.52,;-4.34,6.06,;-3,3.75,;-2.4,2.34,;-3.33,1.11,;-4.86,1.3,;-2.73,-.31,;-3.66,-1.53,;-5,-.77,;-6.33,-1.54,;-7.73,-.92,;-8.76,-2.06,;-7.99,-3.4,;-6.48,-3.07,;-3.66,-3.08,;-5,-3.85,;-2.33,-3.85,;-2.33,-5.39,;-3.66,-6.16,;-3.66,-7.7,;-5,-8.46,;-5,-10,;-3.67,-10.77,;-2.33,-10,;-2.34,-8.46,;-1,-6.16,;-1,-7.7,;.34,-5.39,;1.67,-6.16,;1.67,-7.7,;.34,-8.47,;.34,-10.01,;-1,-10.78,;-1,-12.32,;-2.33,-13.09,;.34,-13.09,;3,-5.39,;4.34,-6.16,;3,-3.85,;4.34,-3.08,;5.67,-3.85,;7.01,-3.08,;7.16,-1.56,;8.67,-1.24,;9.44,-2.57,;10.95,-2.88,;11.43,-4.34,;10.4,-5.5,;8.89,-5.18,;8.41,-3.71,;4.34,-1.54,;3,-.77,;5.67,-.77,;5.67,.77,;4.34,1.54,;4.34,3.08,;1.59,3.18,;.06,3.38,;-.54,4.79,;.39,6.02,;-2.07,4.99,;-2.66,6.41,;7.01,1.54,;8.34,.77,;7.01,3.08,;8.34,3.85,;9.67,3.08,;11.01,3.85,;11.01,5.39,;12.34,3.08,;8.34,5.39,;7.01,6.16,;9.67,6.16,;9.67,7.7,;8.34,8.47,;8.34,10.01,;9.68,10.78,;9.68,12.32,;8.34,13.09,;7.01,12.31,;7.01,10.77,;11.01,8.47,;11.01,10.01,;12.34,7.7,)| InChI=1S/C64H79N17O13S2/c1-34-20-40(82)21-35(2)42(34)26-43(65)62(93)81-30-53(83)74-50(25-39-29-70-33-73-39)59(90)77-48(23-37-14-7-4-8-15-37)57(88)75-46(18-11-19-71-64(68)69)56(87)78-49(24-38-28-72-45-17-10-9-16-41(38)45)58(89)80-52(32-96-95-31-44(66)63(81)94)61(92)79-51(27-54(84)85)60(91)76-47(55(67)86)22-36-12-5-3-6-13-36/h3-10,12-17,20-21,28-29,33,43-44,46-52,72,82H,11,18-19,22-27,30-32,65-66H2,1-2H3,(H2,67,86)(H,70,73)(H,74,83)(H,75,88)(H,76,91)(H,77,90)(H,78,87)(H,79,92)(H,80,89)(H,84,85)(H4,68,69,71) OYHTUAKSBPLZSH-UHFFFAOYSA-N 50321599 (S)-3-((4R,7S,10S,13R,16S,22S)-16-((1H-imidazol-5-yl)methyl)-7-((1H-indol-3-yl)methyl)-22-amino-20-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-13-benzyl-10-(3-guanidinopropyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexaazacyclotricosane-4-carboxamido)-4-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid::CHEMBL1172247 Mu-type opioid receptor Rattus norvegicus 20 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321599 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321599&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933502 104143128 CHEMBL1172247 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50213686 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C74H92N18O14/c1-3-4-24-54(67(100)92-61(38-63(95)96)73(106)88-56(64(76)97)33-44-17-8-5-9-18-44)86-71(104)59(36-48-39-81-53-25-15-14-23-51(48)53)90-68(101)55(26-16-31-80-74(77)78)87-70(103)58(35-46-21-12-7-13-22-46)89-72(105)60(37-49-40-79-42-83-49)91-69(102)57(34-45-19-10-6-11-20-45)85-62(94)41-82-65(98)43(2)84-66(99)52(75)32-47-27-29-50(93)30-28-47/h5-15,17-23,25,27-30,39-40,42-43,52,54-61,81,93H,3-4,16,24,26,31-38,41,75H2,1-2H3,(H2,76,97)(H,79,83)(H,82,98)(H,84,99)(H,85,94)(H,86,104)(H,87,103)(H,88,106)(H,89,105)(H,90,101)(H,91,102)(H,92,100)(H,95,96)(H4,77,78,80) ZUUGDHAKGUQZKD-UHFFFAOYSA-N 50321608 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-15,21-dibenzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxyphenyl)-27-methyl-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172251 Melanocortin receptor 4 Homo sapiens 1259 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321608 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6546&target=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321608&enzyme=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 49798111 104143137 CHEMBL1172251 1 MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY 8QJ2,9K3K,7F58,7F55,7F54,7F53,7PIV,7PIU,7AUE Melanocortin receptor 4 MC4R_HUMAN P32245 B2RAC3 Q16317 Q3MIJ6 50213687 N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C66H81ClN18O14/c67-40-19-15-38(16-20-40)27-49-62(96)80-47(14-8-24-74-66(70)71)61(95)84-51(29-41-28-39-11-4-5-12-45(39)77-41)64(98)79-46(60(94)85-53(32-56(89)90)65(99)81-48(57(69)91)26-36-9-2-1-3-10-36)13-6-7-23-73-54(87)31-52(82-58(92)44(68)25-37-17-21-43(86)22-18-37)59(93)75-34-55(88)78-50(63(97)83-49)30-42-33-72-35-76-42/h1-5,9-12,15-22,28,33,35,44,46-53,77,86H,6-8,13-14,23-27,29-32,34,68H2,(H2,69,91)(H,72,76)(H,73,87)(H,75,93)(H,78,88)(H,79,98)(H,80,96)(H,81,99)(H,82,92)(H,83,97)(H,84,95)(H,85,94)(H,89,90)(H4,70,71,74) YCEIOOXEUSAMIZ-UHFFFAOYSA-N 50321600 (S)-3-((3S,6S,9S,12S,18R,26S)-12-((1H-imidazol-5-yl)methyl)-3-((1H-indol-2-yl)methyl)-18-((S)-2-amino-3-(4-hydroxyphenyl)propanamido)-9-(4-chlorobenzyl)-6-(3-guanidinopropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,21-heptaazacyclohexacosane-26-carboxamido)-4-((R)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid::CHEMBL1172246 Gastrin/cholecystokinin type B receptor Homo sapiens 1000 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321600 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2126&target=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321600&enzyme=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798106 104143129 CHEMBL1172246 1 MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG 8IA7,7XOW Gastrin/cholecystokinin type B receptor GASR_HUMAN P32239 A8K7P9 O75824 Q16144 Q92492 Q96LC6 Q9NYK7 Q9UBV1 50213688 N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C66H81ClN18O14/c67-40-19-15-38(16-20-40)27-49-62(96)80-47(14-8-24-74-66(70)71)61(95)84-51(29-41-28-39-11-4-5-12-45(39)77-41)64(98)79-46(60(94)85-53(32-56(89)90)65(99)81-48(57(69)91)26-36-9-2-1-3-10-36)13-6-7-23-73-54(87)31-52(82-58(92)44(68)25-37-17-21-43(86)22-18-37)59(93)75-34-55(88)78-50(63(97)83-49)30-42-33-72-35-76-42/h1-5,9-12,15-22,28,33,35,44,46-53,77,86H,6-8,13-14,23-27,29-32,34,68H2,(H2,69,91)(H,72,76)(H,73,87)(H,75,93)(H,78,88)(H,79,98)(H,80,96)(H,81,99)(H,82,92)(H,83,97)(H,84,95)(H,85,94)(H,89,90)(H4,70,71,74) YCEIOOXEUSAMIZ-UHFFFAOYSA-N 50321600 (S)-3-((3S,6S,9S,12S,18R,26S)-12-((1H-imidazol-5-yl)methyl)-3-((1H-indol-2-yl)methyl)-18-((S)-2-amino-3-(4-hydroxyphenyl)propanamido)-9-(4-chlorobenzyl)-6-(3-guanidinopropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,21-heptaazacyclohexacosane-26-carboxamido)-4-((R)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid::CHEMBL1172246 Mu-type opioid receptor Rattus norvegicus 3981 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321600 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321600&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798106 104143129 CHEMBL1172246 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50213689 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:33.48,22.31,4.4,48.59,93.100,wD:70.77,58.62,8.20,85.92,(16.65,-3.98,;15.32,-4.75,;15.32,-6.29,;13.98,-7.06,;13.98,-8.6,;12.65,-9.36,;11.32,-8.59,;11.32,-7.05,;9.99,-9.35,;9.99,-10.9,;11.32,-11.67,;12.72,-11.05,;13.76,-12.19,;12.98,-13.52,;13.46,-14.99,;12.42,-16.14,;10.92,-15.81,;10.44,-14.35,;11.48,-13.21,;8.66,-8.59,;7.33,-9.38,;7.33,-10.92,;6,-8.61,;6,-7.07,;7.33,-6.3,;7.33,-4.76,;8.66,-3.97,;8.68,-2.43,;7.33,-1.66,;10,-1.66,;4.65,-9.35,;3.32,-8.59,;3.32,-7.05,;1.99,-9.36,;1.76,-10.89,;2.96,-11.84,;2.73,-13.37,;3.92,-14.33,;5.36,-13.77,;6.57,-14.74,;8.01,-14.17,;8.23,-12.64,;7.03,-11.68,;5.59,-12.24,;4.39,-11.29,;.66,-8.58,;-.66,-9.38,;-.66,-10.92,;-2,-8.61,;-2,-7.07,;-.66,-6.29,;.75,-6.93,;1.79,-5.78,;1.01,-4.45,;-.5,-4.76,;-3.33,-9.38,;-4.67,-8.61,;-4.67,-7.07,;-6,-9.38,;-7.33,-8.62,;-8.66,-9.39,;-9.99,-8.62,;-11.33,-9.39,;-11.33,-10.93,;-9.99,-11.69,;-8.66,-10.92,;-7.33,-11.7,;-6,-10.91,;-4.66,-11.68,;-3.33,-10.91,;-4.66,-13.22,;-5.99,-13.99,;-3.32,-13.99,;-3.32,-15.53,;-4.65,-16.3,;-5.98,-15.53,;-4.65,-17.84,;-3.31,-18.61,;-3.31,-20.15,;-1.98,-17.84,;-1.98,-16.29,;-.65,-15.52,;15.32,-9.37,;15.32,-10.91,;16.65,-8.59,;17.98,-9.36,;17.98,-10.91,;19.32,-11.67,;20.64,-10.9,;19.32,-13.21,;19.32,-8.59,;19.32,-7.05,;20.65,-9.36,;21.98,-8.59,;21.98,-7.05,;23.31,-6.28,;24.65,-7.06,;25.98,-6.29,;25.99,-4.75,;24.65,-3.98,;23.32,-4.75,;23.31,-9.36,;24.65,-8.59,;23.31,-10.91,)| InChI=1S/C76H90N16O12/c1-4-5-23-58(68(97)90-64(38-66(94)95)73(102)87-60(67(78)96)32-45-16-7-6-8-17-45)85-71(100)62(34-51-39-83-57-24-14-13-22-54(51)57)89-69(98)59(25-15-28-82-76(79)80)86-70(99)61(33-46-26-27-47-18-9-10-19-48(47)31-46)88-72(101)63(36-52-40-81-42-84-52)91-74(103)65-35-49-20-11-12-21-50(49)41-92(65)75(104)56(77)37-55-43(2)29-53(93)30-44(55)3/h6-14,16-22,24,26-27,29-31,39-40,42,56,58-65,83,93H,4-5,15,23,25,28,32-38,41,77H2,1-3H3,(H2,78,96)(H,81,84)(H,85,100)(H,86,99)(H,87,102)(H,88,101)(H,89,98)(H,90,97)(H,91,103)(H,94,95)(H4,79,80,82) TVINVHGLLFLSBP-UHFFFAOYSA-N 50321597 (3S,6R,9S,12S,15S,18S)-3-((1H-imidazol-5-yl)methyl)-12-((1H-indol-3-yl)methyl)-18-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-1-((R)-2-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-15-butyl-9-(3-guanidinopropyl)-6-(naphthalen-2-ylmethyl)-1,4,7,10,13,16-hexaoxo-2,5,8,11,14,17-hexaazaicosan-20-oic acid::CHEMBL1172249 Mu-type opioid receptor Rattus norvegicus 40 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321597 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321597&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933500 104143126 CHEMBL1172249 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50213690 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:8.20,58.71,93.99,78.84,wD:73.79,48.59,22.31,33.48,4.4,101.107,(24.59,-5.48,;25.93,-4.72,;25.93,-3.18,;24.59,-2.4,;24.59,-.86,;23.26,-.1,;21.93,-.87,;21.93,-2.41,;20.59,-.11,;20.59,1.44,;22,2.07,;23.25,1.19,;24.48,2.12,;23.98,3.58,;24.73,4.92,;23.94,6.24,;22.4,6.22,;21.65,4.87,;22.44,3.55,;19.25,-.87,;17.91,-.12,;17.91,1.43,;16.57,-.89,;16.57,-2.43,;17.91,-3.2,;17.91,-4.73,;19.24,-5.51,;19.24,-7.05,;17.93,-7.8,;20.61,-7.81,;15.25,-.1,;13.92,-.87,;13.92,-2.41,;12.59,-.1,;12.6,1.44,;13.92,2.21,;15.26,1.44,;16.59,2.21,;16.6,3.75,;17.93,4.53,;17.92,6.07,;16.58,6.84,;15.25,6.06,;15.26,4.52,;13.92,3.75,;11.26,-.86,;9.92,-.1,;9.92,1.45,;8.58,-.87,;8.58,-2.41,;9.92,-3.18,;11.32,-2.55,;12.36,-3.69,;11.59,-5.03,;10.08,-4.71,;7.25,-.09,;5.91,-.85,;5.91,-2.39,;4.58,-.08,;4.58,1.46,;5.91,2.23,;7.25,1.47,;8.58,2.24,;8.58,3.78,;7.24,4.55,;5.91,3.78,;3.25,-.85,;1.92,-.07,;1.92,1.47,;.58,-.85,;-.75,-.07,;-2.08,-.85,;-2.08,-2.38,;-3.41,-.07,;-3.41,1.47,;-4.75,-.84,;-6.09,-.08,;-6.09,1.47,;-7.42,-.86,;-7.4,-2.4,;-8.75,-.1,;-10.08,-.88,;-10.06,-2.42,;-8.72,-3.17,;-11.4,-3.2,;-12.73,-2.44,;-14.07,-3.22,;-12.76,-.9,;-11.41,-.13,;-11.43,1.41,;25.93,-.09,;25.93,1.45,;27.26,-.87,;28.59,-.09,;28.59,1.45,;29.93,2.21,;31.25,1.45,;29.93,3.76,;29.93,-.87,;29.93,-2.4,;31.26,-.1,;32.6,-.87,;32.6,-2.4,;33.93,-3.17,;35.28,-2.4,;36.61,-3.17,;36.61,-4.71,;35.27,-5.48,;33.94,-4.71,;33.93,-.1,;35.27,-.86,;33.93,1.45,)| InChI=1S/C80H98N18O14/c1-5-6-25-60(73(106)98-67(40-69(101)102)79(112)94-62(70(82)103)34-48-18-9-7-10-19-48)92-77(110)65(37-53-41-87-59-26-16-15-24-56(53)59)96-74(107)61(27-17-30-86-80(83)84)93-76(109)64(36-50-28-29-51-22-13-14-23-52(51)33-50)95-78(111)66(38-54-42-85-44-89-54)97-75(108)63(35-49-20-11-8-12-21-49)91-68(100)43-88-71(104)47(4)90-72(105)58(81)39-57-45(2)31-55(99)32-46(57)3/h7-16,18-24,26,28-29,31-33,41-42,44,47,58,60-67,87,99H,5-6,17,25,27,30,34-40,43,81H2,1-4H3,(H2,82,103)(H,85,89)(H,88,104)(H,90,105)(H,91,100)(H,92,110)(H,93,109)(H,94,112)(H,95,111)(H,96,107)(H,97,108)(H,98,106)(H,101,102)(H4,83,84,86) AHRZYQWKXXBNHK-UHFFFAOYSA-N 50321606 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxy-2,6-dimethylphenyl)-27-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172253 Gastrin/cholecystokinin type B receptor Homo sapiens 110 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321606 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2126&target=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321606&enzyme=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933506 104143135 CHEMBL1172253 1 MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG 8IA7,7XOW Gastrin/cholecystokinin type B receptor GASR_HUMAN P32239 A8K7P9 O75824 Q16144 Q92492 Q96LC6 Q9NYK7 Q9UBV1 50213691 Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N1CC(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@H](Cc2ccc3ccccc3c2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CSSC[C@@H](N)C1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:69.84,89.95,29.31,10.11,wD:44.48,74.80,19.20,81.87,55.59,(1.42,-5.48,;.09,-4.71,;-1.25,-5.49,;-2.59,-4.72,;-3.92,-5.48,;-2.59,-3.17,;-1.25,-2.41,;-1.25,-.87,;.08,-3.17,;1.41,-2.4,;2.75,-3.17,;2.75,-4.71,;4.08,-2.39,;4.08,-.85,;5.42,-3.16,;6.02,-4.57,;5.09,-5.8,;3.56,-5.61,;5.68,-7.22,;4.75,-8.45,;3.42,-7.68,;2.08,-8.45,;.68,-7.83,;-.35,-8.98,;.42,-10.31,;1.93,-9.98,;4.75,-9.99,;3.42,-10.76,;6.09,-10.76,;6.09,-12.3,;4.75,-13.07,;4.75,-14.61,;6.08,-15.37,;6.09,-16.91,;4.75,-17.69,;4.75,-19.22,;3.42,-19.99,;2.08,-19.22,;2.09,-17.68,;3.42,-16.92,;3.42,-15.39,;7.42,-13.07,;7.42,-14.61,;8.75,-12.3,;10.09,-13.07,;10.09,-14.61,;8.75,-15.38,;8.75,-16.92,;7.42,-17.69,;7.42,-19.23,;6.09,-20,;8.75,-20,;11.42,-12.3,;12.75,-13.07,;11.42,-10.76,;12.75,-9.99,;14.09,-10.76,;15.42,-9.99,;15.57,-8.48,;17.08,-8.15,;17.86,-9.48,;19.37,-9.79,;19.85,-11.26,;18.82,-12.42,;17.3,-12.1,;16.82,-10.63,;12.75,-8.45,;11.42,-7.68,;14.09,-7.68,;14.09,-6.14,;12.75,-5.37,;12.75,-3.83,;10,-3.73,;8.47,-3.54,;7.88,-2.12,;8.81,-.89,;6.35,-1.93,;5.75,-.51,;15.42,-5.37,;16.75,-6.14,;15.42,-3.83,;16.75,-3.06,;18.09,-3.83,;19.42,-3.06,;19.42,-1.52,;20.76,-3.83,;16.75,-1.52,;15.42,-.75,;18.09,-.75,;18.09,.78,;16.75,1.55,;16.75,3.09,;18.09,3.85,;18.09,5.39,;16.76,6.16,;15.42,5.39,;15.43,3.86,;19.42,1.55,;19.42,3.09,;20.76,.78,)| InChI=1S/C68H81N17O13S2/c1-36-21-44(86)22-37(2)46(36)28-47(69)66(97)85-32-57(87)78-54(27-43-31-74-35-77-43)63(94)81-52(25-39-18-19-40-13-6-7-14-41(40)23-39)61(92)79-50(17-10-20-75-68(72)73)60(91)82-53(26-42-30-76-49-16-9-8-15-45(42)49)62(93)84-56(34-100-99-33-48(70)67(85)98)65(96)83-55(29-58(88)89)64(95)80-51(59(71)90)24-38-11-4-3-5-12-38/h3-9,11-16,18-19,21-23,30-31,35,47-48,50-56,76,86H,10,17,20,24-29,32-34,69-70H2,1-2H3,(H2,71,90)(H,74,77)(H,78,87)(H,79,92)(H,80,95)(H,81,94)(H,82,91)(H,83,96)(H,84,93)(H,88,89)(H4,72,73,75) YDLLMSIGAKQIBS-UHFFFAOYSA-N 50321598 (S)-3-((4R,7S,10S,13R,16S,22S)-16-((1H-imidazol-5-yl)methyl)-7-((1H-indol-3-yl)methyl)-22-amino-20-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-10-(3-guanidinopropyl)-13-(naphthalen-2-ylmethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexaazacyclotricosane-4-carboxamido)-4-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid::CHEMBL1172248 Mu-type opioid receptor Rattus norvegicus 13 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321598 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321598&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933501 104143127 CHEMBL1172248 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50213692 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C78H94N18O14/c1-3-4-23-58(71(104)96-65(40-67(99)100)77(110)92-60(68(80)101)35-46-16-7-5-8-17-46)90-75(108)63(38-52-41-85-57-24-14-13-22-55(52)57)94-72(105)59(25-15-32-84-78(81)82)91-74(107)62(37-49-26-29-50-20-11-12-21-51(50)33-49)93-76(109)64(39-53-42-83-44-87-53)95-73(106)61(36-47-18-9-6-10-19-47)89-66(98)43-86-69(102)45(2)88-70(103)56(79)34-48-27-30-54(97)31-28-48/h5-14,16-22,24,26-31,33,41-42,44-45,56,58-65,85,97H,3-4,15,23,25,32,34-40,43,79H2,1-2H3,(H2,80,101)(H,83,87)(H,86,102)(H,88,103)(H,89,98)(H,90,108)(H,91,107)(H,92,110)(H,93,109)(H,94,105)(H,95,106)(H,96,104)(H,99,100)(H4,81,82,84) ZZVLKHHSRQKCEV-UHFFFAOYSA-N 50321607 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxyphenyl)-27-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172252 Gastrin/cholecystokinin type B receptor Homo sapiens 120 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321607 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2126&target=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321607&enzyme=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798112 104143136 CHEMBL1172252 1 MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG 8IA7,7XOW Gastrin/cholecystokinin type B receptor GASR_HUMAN P32239 A8K7P9 O75824 Q16144 Q92492 Q96LC6 Q9NYK7 Q9UBV1 50213693 Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N1CC(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@H](Cc2ccccc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CSSC[C@@H](N)C1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:10.11,65.79,85.90,29.31,wD:19.20,70.75,40.43,77.82,51.54,(-6.99,1.44,;-8.33,2.2,;-9.67,1.43,;-11.01,2.2,;-12.34,1.43,;-11,3.74,;-9.66,4.51,;-9.66,6.05,;-8.33,3.74,;-7,4.51,;-5.67,3.75,;-5.66,2.21,;-4.33,4.52,;-4.34,6.06,;-3,3.75,;-2.4,2.34,;-3.33,1.11,;-4.86,1.3,;-2.73,-.31,;-3.66,-1.53,;-5,-.77,;-6.33,-1.54,;-7.73,-.92,;-8.76,-2.06,;-7.99,-3.4,;-6.48,-3.07,;-3.66,-3.08,;-5,-3.85,;-2.33,-3.85,;-2.33,-5.39,;-3.66,-6.16,;-3.66,-7.7,;-5,-8.46,;-5,-10,;-3.67,-10.77,;-2.33,-10,;-2.34,-8.46,;-1,-6.16,;-1,-7.7,;.34,-5.39,;1.67,-6.16,;1.67,-7.7,;.34,-8.47,;.34,-10.01,;-1,-10.78,;-1,-12.32,;-2.33,-13.09,;.34,-13.09,;3,-5.39,;4.34,-6.16,;3,-3.85,;4.34,-3.08,;5.67,-3.85,;7.01,-3.08,;7.16,-1.56,;8.67,-1.24,;9.44,-2.57,;10.95,-2.88,;11.43,-4.34,;10.4,-5.5,;8.89,-5.18,;8.41,-3.71,;4.34,-1.54,;3,-.77,;5.67,-.77,;5.67,.77,;4.34,1.54,;4.34,3.08,;1.59,3.18,;.06,3.38,;-.54,4.79,;.39,6.02,;-2.07,4.99,;-2.66,6.41,;7.01,1.54,;8.34,.77,;7.01,3.08,;8.34,3.85,;9.67,3.08,;11.01,3.85,;11.01,5.39,;12.34,3.08,;8.34,5.39,;7.01,6.16,;9.67,6.16,;9.67,7.7,;8.34,8.47,;8.34,10.01,;9.68,10.78,;9.68,12.32,;8.34,13.09,;7.01,12.31,;7.01,10.77,;11.01,8.47,;11.01,10.01,;12.34,7.7,)| InChI=1S/C64H79N17O13S2/c1-34-20-40(82)21-35(2)42(34)26-43(65)62(93)81-30-53(83)74-50(25-39-29-70-33-73-39)59(90)77-48(23-37-14-7-4-8-15-37)57(88)75-46(18-11-19-71-64(68)69)56(87)78-49(24-38-28-72-45-17-10-9-16-41(38)45)58(89)80-52(32-96-95-31-44(66)63(81)94)61(92)79-51(27-54(84)85)60(91)76-47(55(67)86)22-36-12-5-3-6-13-36/h3-10,12-17,20-21,28-29,33,43-44,46-52,72,82H,11,18-19,22-27,30-32,65-66H2,1-2H3,(H2,67,86)(H,70,73)(H,74,83)(H,75,88)(H,76,91)(H,77,90)(H,78,87)(H,79,92)(H,80,89)(H,84,85)(H4,68,69,71) OYHTUAKSBPLZSH-UHFFFAOYSA-N 50321599 (S)-3-((4R,7S,10S,13R,16S,22S)-16-((1H-imidazol-5-yl)methyl)-7-((1H-indol-3-yl)methyl)-22-amino-20-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-13-benzyl-10-(3-guanidinopropyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexaazacyclotricosane-4-carboxamido)-4-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid::CHEMBL1172247 Melanocortin receptor 4 Homo sapiens 1585 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321599 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6546&target=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321599&enzyme=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 91933502 104143128 CHEMBL1172247 1 MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY 8QJ2,9K3K,7F58,7F55,7F54,7F53,7PIV,7PIU,7AUE Melanocortin receptor 4 MC4R_HUMAN P32245 B2RAC3 Q16317 Q3MIJ6 50213694 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C74H92N18O14/c1-3-4-24-54(67(100)92-61(38-63(95)96)73(106)88-56(64(76)97)33-44-17-8-5-9-18-44)86-71(104)59(36-48-39-81-53-25-15-14-23-51(48)53)90-68(101)55(26-16-31-80-74(77)78)87-70(103)58(35-46-21-12-7-13-22-46)89-72(105)60(37-49-40-79-42-83-49)91-69(102)57(34-45-19-10-6-11-20-45)85-62(94)41-82-65(98)43(2)84-66(99)52(75)32-47-27-29-50(93)30-28-47/h5-15,17-23,25,27-30,39-40,42-43,52,54-61,81,93H,3-4,16,24,26,31-38,41,75H2,1-2H3,(H2,76,97)(H,79,83)(H,82,98)(H,84,99)(H,85,94)(H,86,104)(H,87,103)(H,88,106)(H,89,105)(H,90,101)(H,91,102)(H,92,100)(H,95,96)(H4,77,78,80) ZUUGDHAKGUQZKD-UHFFFAOYSA-N 50321608 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-15,21-dibenzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxyphenyl)-27-methyl-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172251 Gastrin/cholecystokinin type B receptor Homo sapiens 18 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321608 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2126&target=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321608&enzyme=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798111 104143137 CHEMBL1172251 1 MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG 8IA7,7XOW Gastrin/cholecystokinin type B receptor GASR_HUMAN P32239 A8K7P9 O75824 Q16144 Q92492 Q96LC6 Q9NYK7 Q9UBV1 50213695 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C74H92N18O14/c1-3-4-24-54(67(100)92-61(38-63(95)96)73(106)88-56(64(76)97)33-44-17-8-5-9-18-44)86-71(104)59(36-48-39-81-53-25-15-14-23-51(48)53)90-68(101)55(26-16-31-80-74(77)78)87-70(103)58(35-46-21-12-7-13-22-46)89-72(105)60(37-49-40-79-42-83-49)91-69(102)57(34-45-19-10-6-11-20-45)85-62(94)41-82-65(98)43(2)84-66(99)52(75)32-47-27-29-50(93)30-28-47/h5-15,17-23,25,27-30,39-40,42-43,52,54-61,81,93H,3-4,16,24,26,31-38,41,75H2,1-2H3,(H2,76,97)(H,79,83)(H,82,98)(H,84,99)(H,85,94)(H,86,104)(H,87,103)(H,88,106)(H,89,105)(H,90,101)(H,91,102)(H,92,100)(H,95,96)(H4,77,78,80) ZUUGDHAKGUQZKD-UHFFFAOYSA-N 50321608 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-15,21-dibenzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxyphenyl)-27-methyl-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172251 Mu-type opioid receptor Rattus norvegicus 14 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321608 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321608&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798111 104143137 CHEMBL1172251 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50213696 N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C66H81ClN18O14/c67-40-19-15-38(16-20-40)27-49-62(96)80-47(14-8-24-74-66(70)71)61(95)84-51(29-41-28-39-11-4-5-12-45(39)77-41)64(98)79-46(60(94)85-53(32-56(89)90)65(99)81-48(57(69)91)26-36-9-2-1-3-10-36)13-6-7-23-73-54(87)31-52(82-58(92)44(68)25-37-17-21-43(86)22-18-37)59(93)75-34-55(88)78-50(63(97)83-49)30-42-33-72-35-76-42/h1-5,9-12,15-22,28,33,35,44,46-53,77,86H,6-8,13-14,23-27,29-32,34,68H2,(H2,69,91)(H,72,76)(H,73,87)(H,75,93)(H,78,88)(H,79,98)(H,80,96)(H,81,99)(H,82,92)(H,83,97)(H,84,95)(H,85,94)(H,89,90)(H4,70,71,74) YCEIOOXEUSAMIZ-UHFFFAOYSA-N 50321600 (S)-3-((3S,6S,9S,12S,18R,26S)-12-((1H-imidazol-5-yl)methyl)-3-((1H-indol-2-yl)methyl)-18-((S)-2-amino-3-(4-hydroxyphenyl)propanamido)-9-(4-chlorobenzyl)-6-(3-guanidinopropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,21-heptaazacyclohexacosane-26-carboxamido)-4-((R)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid::CHEMBL1172246 Melanocortin receptor 4 Homo sapiens 32 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321600 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6546&target=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321600&enzyme=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 49798106 104143129 CHEMBL1172246 1 MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY 8QJ2,9K3K,7F58,7F55,7F54,7F53,7PIV,7PIU,7AUE Melanocortin receptor 4 MC4R_HUMAN P32245 B2RAC3 Q16317 Q3MIJ6 50213697 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:8.20,58.71,93.99,78.84,wD:73.79,48.59,22.31,33.48,4.4,101.107,(24.59,-5.48,;25.93,-4.72,;25.93,-3.18,;24.59,-2.4,;24.59,-.86,;23.26,-.1,;21.93,-.87,;21.93,-2.41,;20.59,-.11,;20.59,1.44,;22,2.07,;23.25,1.19,;24.48,2.12,;23.98,3.58,;24.73,4.92,;23.94,6.24,;22.4,6.22,;21.65,4.87,;22.44,3.55,;19.25,-.87,;17.91,-.12,;17.91,1.43,;16.57,-.89,;16.57,-2.43,;17.91,-3.2,;17.91,-4.73,;19.24,-5.51,;19.24,-7.05,;17.93,-7.8,;20.61,-7.81,;15.25,-.1,;13.92,-.87,;13.92,-2.41,;12.59,-.1,;12.6,1.44,;13.92,2.21,;15.26,1.44,;16.59,2.21,;16.6,3.75,;17.93,4.53,;17.92,6.07,;16.58,6.84,;15.25,6.06,;15.26,4.52,;13.92,3.75,;11.26,-.86,;9.92,-.1,;9.92,1.45,;8.58,-.87,;8.58,-2.41,;9.92,-3.18,;11.32,-2.55,;12.36,-3.69,;11.59,-5.03,;10.08,-4.71,;7.25,-.09,;5.91,-.85,;5.91,-2.39,;4.58,-.08,;4.58,1.46,;5.91,2.23,;7.25,1.47,;8.58,2.24,;8.58,3.78,;7.24,4.55,;5.91,3.78,;3.25,-.85,;1.92,-.07,;1.92,1.47,;.58,-.85,;-.75,-.07,;-2.08,-.85,;-2.08,-2.38,;-3.41,-.07,;-3.41,1.47,;-4.75,-.84,;-6.09,-.08,;-6.09,1.47,;-7.42,-.86,;-7.4,-2.4,;-8.75,-.1,;-10.08,-.88,;-10.06,-2.42,;-8.72,-3.17,;-11.4,-3.2,;-12.73,-2.44,;-14.07,-3.22,;-12.76,-.9,;-11.41,-.13,;-11.43,1.41,;25.93,-.09,;25.93,1.45,;27.26,-.87,;28.59,-.09,;28.59,1.45,;29.93,2.21,;31.25,1.45,;29.93,3.76,;29.93,-.87,;29.93,-2.4,;31.26,-.1,;32.6,-.87,;32.6,-2.4,;33.93,-3.17,;35.28,-2.4,;36.61,-3.17,;36.61,-4.71,;35.27,-5.48,;33.94,-4.71,;33.93,-.1,;35.27,-.86,;33.93,1.45,)| InChI=1S/C80H98N18O14/c1-5-6-25-60(73(106)98-67(40-69(101)102)79(112)94-62(70(82)103)34-48-18-9-7-10-19-48)92-77(110)65(37-53-41-87-59-26-16-15-24-56(53)59)96-74(107)61(27-17-30-86-80(83)84)93-76(109)64(36-50-28-29-51-22-13-14-23-52(51)33-50)95-78(111)66(38-54-42-85-44-89-54)97-75(108)63(35-49-20-11-8-12-21-49)91-68(100)43-88-71(104)47(4)90-72(105)58(81)39-57-45(2)31-55(99)32-46(57)3/h7-16,18-24,26,28-29,31-33,41-42,44,47,58,60-67,87,99H,5-6,17,25,27,30,34-40,43,81H2,1-4H3,(H2,82,103)(H,85,89)(H,88,104)(H,90,105)(H,91,100)(H,92,110)(H,93,109)(H,94,112)(H,95,111)(H,96,107)(H,97,108)(H,98,106)(H,101,102)(H4,83,84,86) AHRZYQWKXXBNHK-UHFFFAOYSA-N 50321606 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxy-2,6-dimethylphenyl)-27-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172253 Melanocortin receptor 4 Homo sapiens 158 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321606 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6546&target=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321606&enzyme=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 91933506 104143135 CHEMBL1172253 1 MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY 8QJ2,9K3K,7F58,7F55,7F54,7F53,7PIV,7PIU,7AUE Melanocortin receptor 4 MC4R_HUMAN P32245 B2RAC3 Q16317 Q3MIJ6 50213698 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C78H94N18O14/c1-3-4-23-58(71(104)96-65(40-67(99)100)77(110)92-60(68(80)101)35-46-16-7-5-8-17-46)90-75(108)63(38-52-41-85-57-24-14-13-22-55(52)57)94-72(105)59(25-15-32-84-78(81)82)91-74(107)62(37-49-26-29-50-20-11-12-21-51(50)33-49)93-76(109)64(39-53-42-83-44-87-53)95-73(106)61(36-47-18-9-6-10-19-47)89-66(98)43-86-69(102)45(2)88-70(103)56(79)34-48-27-30-54(97)31-28-48/h5-14,16-22,24,26-31,33,41-42,44-45,56,58-65,85,97H,3-4,15,23,25,32,34-40,43,79H2,1-2H3,(H2,80,101)(H,83,87)(H,86,102)(H,88,103)(H,89,98)(H,90,108)(H,91,107)(H,92,110)(H,93,109)(H,94,105)(H,95,106)(H,96,104)(H,99,100)(H4,81,82,84) ZZVLKHHSRQKCEV-UHFFFAOYSA-N 50321607 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxyphenyl)-27-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172252 Melanocortin receptor 4 Homo sapiens 251 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321607 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6546&target=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321607&enzyme=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 49798112 104143136 CHEMBL1172252 1 MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY 8QJ2,9K3K,7F58,7F55,7F54,7F53,7PIV,7PIU,7AUE Melanocortin receptor 4 MC4R_HUMAN P32245 B2RAC3 Q16317 Q3MIJ6 50213699 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:69.75,8.20,58.71,89.95,wD:48.59,22.31,33.48,4.4,97.103,74.80,(28.82,-7.95,;30.15,-7.19,;30.15,-5.65,;28.82,-4.88,;28.82,-3.34,;27.48,-2.57,;26.15,-3.35,;26.15,-4.89,;24.82,-2.58,;24.82,-1.03,;26.22,-.4,;27.48,-1.28,;28.71,-.35,;28.21,1.11,;28.95,2.45,;28.16,3.77,;26.62,3.74,;25.87,2.4,;26.66,1.08,;23.48,-3.34,;22.13,-2.59,;22.13,-1.04,;20.8,-3.36,;20.8,-4.9,;22.13,-5.67,;22.13,-7.21,;23.47,-7.98,;23.47,-9.52,;22.16,-10.27,;24.84,-10.28,;19.47,-2.57,;18.15,-3.35,;18.15,-4.88,;16.82,-2.57,;16.82,-1.03,;18.15,-.26,;19.48,-1.03,;20.81,-.26,;20.82,1.28,;22.15,2.06,;22.15,3.6,;20.8,4.36,;19.47,3.58,;19.48,2.05,;18.14,1.28,;15.48,-3.33,;14.14,-2.57,;14.14,-1.02,;12.8,-3.34,;12.8,-4.88,;14.14,-5.65,;15.55,-5.02,;16.59,-6.17,;15.81,-7.5,;14.31,-7.18,;11.47,-2.57,;10.13,-3.32,;10.13,-4.86,;8.81,-2.55,;8.81,-1.01,;10.13,-.25,;11.47,-1.01,;12.81,-.24,;12.8,1.31,;11.47,2.07,;10.14,1.3,;7.47,-3.33,;6.13,-2.55,;6.13,-1.01,;4.8,-3.33,;4.8,-4.87,;3.47,-2.56,;2.12,-3.32,;2.13,-4.86,;.8,-2.54,;.81,-1,;-.54,-3.3,;-1.86,-2.52,;-1.85,-.98,;-.51,-.23,;-3.18,-.2,;-4.52,-.96,;-5.84,-.18,;-4.53,-2.49,;-3.2,-3.27,;-3.21,-4.81,;30.15,-2.57,;30.15,-1.03,;31.49,-3.34,;32.82,-2.57,;32.82,-1.02,;34.15,-.26,;35.48,-1.03,;34.15,1.29,;34.15,-3.34,;34.15,-4.88,;35.49,-2.57,;36.82,-3.34,;36.82,-4.88,;38.16,-5.65,;39.5,-4.87,;40.83,-5.65,;40.84,-7.18,;39.5,-7.95,;38.16,-7.19,;38.16,-2.57,;39.49,-3.33,;38.16,-1.02,)| InChI=1S/C78H95N17O13/c1-5-6-25-59(71(102)95-66(40-67(97)98)77(108)90-61(68(80)99)34-47-18-9-7-10-19-47)88-75(106)64(37-52-41-85-58-26-16-15-24-55(52)58)93-72(103)60(27-17-30-84-78(81)82)89-73(104)63(36-49-28-29-50-22-13-14-23-51(50)33-49)92-76(107)65(38-53-42-83-43-86-53)94-74(105)62(35-48-20-11-8-12-21-48)91-69(100)46(4)87-70(101)57(79)39-56-44(2)31-54(96)32-45(56)3/h7-16,18-24,26,28-29,31-33,41-43,46,57,59-66,85,96H,5-6,17,25,27,30,34-40,79H2,1-4H3,(H2,80,99)(H,83,86)(H,87,101)(H,88,106)(H,89,104)(H,90,108)(H,91,100)(H,92,107)(H,93,103)(H,94,105)(H,95,102)(H,97,98)(H4,81,82,84) JMDKMESJXNSGPX-UHFFFAOYSA-N 50321605 (6R,9S,12S,15R,18S,21S,24S,27S)-12-((1H-imidazol-5-yl)methyl)-21-((1H-indol-3-yl)methyl)-27-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-9-benzyl-24-butyl-18-(3-guanidinopropyl)-1-(4-hydroxy-2,6-dimethylphenyl)-6-methyl-15-(naphthalen-2-ylmethyl)-4,7,10,13,16,19,22,25-octaoxo-3,5,8,11,14,17,20,23,26-nonaazanonacosan-29-oic acid::CHEMBL1172428 Melanocortin receptor 4 Homo sapiens 501 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321605 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6546&target=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321605&enzyme=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 91933505 104143134 CHEMBL1172428 1 MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY 8QJ2,9K3K,7F58,7F55,7F54,7F53,7PIV,7PIU,7AUE Melanocortin receptor 4 MC4R_HUMAN P32245 B2RAC3 Q16317 Q3MIJ6 50213700 C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(N)=O InChI=1S/C23H29N5O5/c1-14(27-23(33)18(24)11-16-7-9-17(29)10-8-16)22(32)26-13-20(30)28-19(21(25)31)12-15-5-3-2-4-6-15/h2-10,14,18-19,29H,11-13,24H2,1H3,(H2,25,31)(H,26,32)(H,27,33)(H,28,30) RJEUERNNQHNSKG-UHFFFAOYSA-N 21123 Enkephalin Amide::(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]propanamido]acetamido}-3-phenylpropanamide::YDAGF-NH2 Delta-type opioid receptor Homo sapiens 300 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21123 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=21123&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 5490373 49689196 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 50213701 C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(N)=O InChI=1S/C23H29N5O5/c1-14(27-23(33)18(24)11-16-7-9-17(29)10-8-16)22(32)26-13-20(30)28-19(21(25)31)12-15-5-3-2-4-6-15/h2-10,14,18-19,29H,11-13,24H2,1H3,(H2,25,31)(H,26,32)(H,27,33)(H,28,30) RJEUERNNQHNSKG-UHFFFAOYSA-N 21123 Enkephalin Amide::(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]propanamido]acetamido}-3-phenylpropanamide::YDAGF-NH2 Mu-type opioid receptor Rattus norvegicus 2.8 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21123 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=21123&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 5490373 49689196 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50213702 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CCC(=O)N(C1CCN(CCc2ccccc2)CC1)c1ccccc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C74H92N16O11/c1-2-3-28-57(68(96)88-63(44-66(93)94)73(101)85-59(67(75)95)40-49-21-10-5-11-22-49)83-71(99)61(42-51-45-80-56-29-17-16-27-55(51)56)87-69(97)58(30-18-36-79-74(76)77)84-70(98)60(41-50-23-12-6-13-24-50)86-72(100)62(43-52-46-78-47-81-52)82-64(91)31-32-65(92)90(53-25-14-7-15-26-53)54-34-38-89(39-35-54)37-33-48-19-8-4-9-20-48/h4-17,19-27,29,45-47,54,57-63,80H,2-3,18,28,30-44H2,1H3,(H2,75,95)(H,78,81)(H,82,91)(H,83,99)(H,84,98)(H,85,101)(H,86,100)(H,87,97)(H,88,96)(H,93,94)(H4,76,77,79) WVNNVFIQARDNCG-UHFFFAOYSA-N 50321602 (3S,6S,9S,12S,15R,18S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-15-benzyl-6-butyl-12-(3-guanidinopropyl)-5,8,11,14,17,20,23-heptaoxo-23-((1-phenethylpiperidin-4-yl)(phenyl)amino)-4,7,10,13,16,19-hexaazatricosan-1-oic acid::CHEMBL1172244 Gastrin/cholecystokinin type B receptor Homo sapiens 126 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321602 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2126&target=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321602&enzyme=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798104 104143131 CHEMBL1172244 1 MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG 8IA7,7XOW Gastrin/cholecystokinin type B receptor GASR_HUMAN P32239 A8K7P9 O75824 Q16144 Q92492 Q96LC6 Q9NYK7 Q9UBV1 50213703 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CCC(=O)N(C1CCN(CCc2ccccc2)CC1)c1ccccc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C74H92N16O11/c1-2-3-28-57(68(96)88-63(44-66(93)94)73(101)85-59(67(75)95)40-49-21-10-5-11-22-49)83-71(99)61(42-51-45-80-56-29-17-16-27-55(51)56)87-69(97)58(30-18-36-79-74(76)77)84-70(98)60(41-50-23-12-6-13-24-50)86-72(100)62(43-52-46-78-47-81-52)82-64(91)31-32-65(92)90(53-25-14-7-15-26-53)54-34-38-89(39-35-54)37-33-48-19-8-4-9-20-48/h4-17,19-27,29,45-47,54,57-63,80H,2-3,18,28,30-44H2,1H3,(H2,75,95)(H,78,81)(H,82,91)(H,83,99)(H,84,98)(H,85,101)(H,86,100)(H,87,97)(H,88,96)(H,93,94)(H4,76,77,79) WVNNVFIQARDNCG-UHFFFAOYSA-N 50321602 (3S,6S,9S,12S,15R,18S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-15-benzyl-6-butyl-12-(3-guanidinopropyl)-5,8,11,14,17,20,23-heptaoxo-23-((1-phenethylpiperidin-4-yl)(phenyl)amino)-4,7,10,13,16,19-hexaazatricosan-1-oic acid::CHEMBL1172244 Mu-type opioid receptor Rattus norvegicus 2512 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321602 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321602&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798104 104143131 CHEMBL1172244 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50213704 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C76H90N16O12/c1-4-5-23-58(68(97)90-64(38-66(94)95)73(102)87-60(67(78)96)32-45-16-7-6-8-17-45)85-71(100)62(34-51-39-83-57-24-14-13-22-54(51)57)89-69(98)59(25-15-28-82-76(79)80)86-70(99)61(33-46-26-27-47-18-9-10-19-48(47)31-46)88-72(101)63(36-52-40-81-42-84-52)91-74(103)65-35-49-20-11-12-21-50(49)41-92(65)75(104)56(77)37-55-43(2)29-53(93)30-44(55)3/h6-14,16-22,24,26-27,29-31,39-40,42,56,58-65,83,93H,4-5,15,23,25,28,32-38,41,77H2,1-3H3,(H2,78,96)(H,81,84)(H,85,100)(H,86,99)(H,87,102)(H,88,101)(H,89,98)(H,90,97)(H,91,103)(H,94,95)(H4,79,80,82) TVINVHGLLFLSBP-UHFFFAOYSA-N 50321596 (3S,6R,9S,12S,15S,18S)-3-((1H-imidazol-5-yl)methyl)-12-((1H-indol-3-yl)methyl)-18-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-1-(2-((R)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-15-butyl-9-(3-guanidinopropyl)-6-(naphthalen-2-ylmethyl)-1,4,7,10,13,16-hexaoxo-2,5,8,11,14,17-hexaazaicosan-20-oic acid::CHEMBL2372623 Cholecystokinin receptor type A Homo sapiens 15 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321596 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2125&target=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321596&enzyme=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search 73354785 104143125 CHEMBL2372623 1 MDVVDSLLVNGSNITPPCELGLENETLFCLDQPRPSKEWQPAVQILLYSLIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLLKDFIFGSAVCKTTTYFMGTSVSVSTFNLVAISLERYGAICKPLQSRVWQTKSHALKVIAATWCLSFTIMTPYPIYSNLVPFTKNNNQTANMCRFLLPNDVMQQSWHTFLLLILFLIPGIVMMVAYGLISLELYQGIKFEASQKKSAKERKPSTTSSGKYEDSDGCYLQKTRPPRKLELRQLSTGSSSRANRIRSNSSAANLMAKKRVIRMLIVIVVLFFLCWMPIFSANAWRAYDTASAERRLSGTPISFILLLSYTSSCVNPIIYCFMNKRFRLGFMATFPCCPNPGPPGARGEVGEEEEGGTTGASLSRFSYSHMSASVPPQ 7XOV,7XOU,7EZM,7EZK,7EZH,7MBX,7MBY Cholecystokinin receptor type A CCKAR_HUMAN P32238 B2R9Z5 50213705 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CCC(=O)N(C1CCN(CCc2ccccc2)CC1)c1ccccc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C74H92N16O11/c1-2-3-28-57(68(96)88-63(44-66(93)94)73(101)85-59(67(75)95)40-49-21-10-5-11-22-49)83-71(99)61(42-51-45-80-56-29-17-16-27-55(51)56)87-69(97)58(30-18-36-79-74(76)77)84-70(98)60(41-50-23-12-6-13-24-50)86-72(100)62(43-52-46-78-47-81-52)82-64(91)31-32-65(92)90(53-25-14-7-15-26-53)54-34-38-89(39-35-54)37-33-48-19-8-4-9-20-48/h4-17,19-27,29,45-47,54,57-63,80H,2-3,18,28,30-44H2,1H3,(H2,75,95)(H,78,81)(H,82,91)(H,83,99)(H,84,98)(H,85,101)(H,86,100)(H,87,97)(H,88,96)(H,93,94)(H4,76,77,79) WVNNVFIQARDNCG-UHFFFAOYSA-N 50321602 (3S,6S,9S,12S,15R,18S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-15-benzyl-6-butyl-12-(3-guanidinopropyl)-5,8,11,14,17,20,23-heptaoxo-23-((1-phenethylpiperidin-4-yl)(phenyl)amino)-4,7,10,13,16,19-hexaazatricosan-1-oic acid::CHEMBL1172244 Delta-type opioid receptor Homo sapiens 5012 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321602 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321602&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798104 104143131 CHEMBL1172244 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 50213707 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C76H90N16O12/c1-4-5-23-58(68(97)90-64(38-66(94)95)73(102)87-60(67(78)96)32-45-16-7-6-8-17-45)85-71(100)62(34-51-39-83-57-24-14-13-22-54(51)57)89-69(98)59(25-15-28-82-76(79)80)86-70(99)61(33-46-26-27-47-18-9-10-19-48(47)31-46)88-72(101)63(36-52-40-81-42-84-52)91-74(103)65-35-49-20-11-12-21-50(49)41-92(65)75(104)56(77)37-55-43(2)29-53(93)30-44(55)3/h6-14,16-22,24,26-27,29-31,39-40,42,56,58-65,83,93H,4-5,15,23,25,28,32-38,41,77H2,1-3H3,(H2,78,96)(H,81,84)(H,85,100)(H,86,99)(H,87,102)(H,88,101)(H,89,98)(H,90,97)(H,91,103)(H,94,95)(H4,79,80,82) TVINVHGLLFLSBP-UHFFFAOYSA-N 50321596 (3S,6R,9S,12S,15S,18S)-3-((1H-imidazol-5-yl)methyl)-12-((1H-indol-3-yl)methyl)-18-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-1-(2-((R)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-15-butyl-9-(3-guanidinopropyl)-6-(naphthalen-2-ylmethyl)-1,4,7,10,13,16-hexaoxo-2,5,8,11,14,17-hexaazaicosan-20-oic acid::CHEMBL2372623 Delta-type opioid receptor Homo sapiens 2.0 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321596 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321596&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 73354785 104143125 CHEMBL2372623 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 50213827 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:58.71,74.80,8.20,87.93,69.75,wD:48.59,22.31,4.4,33.48,95.101,(27.14,-11.6,;25.81,-10.83,;25.81,-9.29,;24.47,-8.52,;24.47,-6.97,;23.14,-6.2,;21.8,-6.97,;21.8,-8.5,;20.47,-6.2,;20.47,-4.66,;21.89,-4.07,;23.12,-5,;24.38,-4.1,;23.93,-2.63,;24.71,-1.31,;23.96,.04,;22.43,.05,;21.64,-1.26,;22.38,-2.61,;19.13,-6.97,;17.8,-6.2,;17.8,-4.66,;16.46,-6.97,;16.46,-8.51,;17.8,-9.28,;17.8,-10.82,;19.14,-11.58,;19.13,-13.12,;17.8,-13.89,;20.46,-13.9,;15.12,-6.21,;13.78,-6.97,;13.78,-8.51,;12.45,-6.2,;12.42,-4.66,;13.74,-3.87,;15.09,-4.61,;16.4,-3.81,;16.37,-2.28,;17.69,-1.49,;17.67,.05,;16.32,.8,;15,.01,;15.03,-1.52,;13.71,-2.32,;11.12,-6.97,;9.78,-6.21,;9.78,-4.66,;8.44,-6.98,;8.44,-8.51,;9.78,-9.29,;11.18,-8.65,;12.21,-9.8,;11.45,-11.14,;9.94,-10.82,;7.1,-6.21,;5.76,-6.97,;5.76,-8.5,;4.43,-6.2,;4.43,-4.66,;5.76,-3.89,;7.1,-4.65,;8.42,-3.88,;8.42,-2.34,;7.09,-1.57,;5.75,-2.34,;3.1,-6.99,;1.76,-6.22,;1.76,-4.68,;.42,-6.99,;.42,-8.53,;-.9,-6.21,;-2.25,-6.97,;-2.25,-8.51,;-3.58,-6.2,;-4.91,-6.98,;-3.58,-4.66,;-2.25,-3.89,;-.92,-4.66,;.41,-3.89,;.4,-2.35,;1.77,-1.59,;-.92,-1.58,;-2.25,-2.35,;25.81,-6.21,;25.81,-4.67,;27.15,-6.98,;28.48,-6.21,;28.48,-4.66,;29.82,-3.89,;31.15,-4.66,;29.82,-2.35,;29.82,-6.97,;29.82,-8.51,;31.15,-6.2,;32.49,-6.97,;32.49,-8.5,;33.83,-9.28,;35.16,-8.5,;36.5,-9.28,;36.5,-10.82,;35.16,-11.58,;33.83,-10.81,;33.83,-6.2,;35.15,-6.96,;33.83,-4.65,)| InChI=1S/C76H91N17O13/c1-3-4-23-57(69(100)93-64(40-65(95)96)75(106)88-59(66(78)97)35-45-16-7-5-8-17-45)86-73(104)62(38-51-41-83-56-24-14-13-22-54(51)56)91-70(101)58(25-15-32-82-76(79)80)87-71(102)61(37-48-26-29-49-20-11-12-21-50(49)33-48)90-74(105)63(39-52-42-81-43-84-52)92-72(103)60(36-46-18-9-6-10-19-46)89-67(98)44(2)85-68(99)55(77)34-47-27-30-53(94)31-28-47/h5-14,16-22,24,26-31,33,41-44,55,57-64,83,94H,3-4,15,23,25,32,34-40,77H2,1-2H3,(H2,78,97)(H,81,84)(H,85,99)(H,86,104)(H,87,102)(H,88,106)(H,89,98)(H,90,105)(H,91,101)(H,92,103)(H,93,100)(H,95,96)(H4,79,80,82) NENKRICCIWXRGU-UHFFFAOYSA-N 50321604 (3S,6S,9S,12S,15R,18S,21S,24R,27S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-27-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-28-(4-hydroxyphenyl)-24-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26-octaoxo-4,7,10,13,16,19,22,25-octaazaoctacosan-1-oic acid::CHEMBL1172429 Melanocortin receptor 4 Homo sapiens 631 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321604 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6546&target=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321604&enzyme=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 91933504 104143133 CHEMBL1172429 1 MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY 8QJ2,9K3K,7F58,7F55,7F54,7F53,7PIV,7PIU,7AUE Melanocortin receptor 4 MC4R_HUMAN P32245 B2RAC3 Q16317 Q3MIJ6 50213830 CCCC[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C28H37N5O7/c1-2-3-9-21(31-26(38)20(29)14-18-10-12-19(34)13-11-18)27(39)33-23(16-24(35)36)28(40)32-22(25(30)37)15-17-7-5-4-6-8-17/h4-8,10-13,20-23,34H,2-3,9,14-16,29H2,1H3,(H2,30,37)(H,31,38)(H,32,40)(H,33,39)(H,35,36) WQLXJYHQHWSRFL-UHFFFAOYSA-N 50321609 (S)-4-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-3-((S)-2-((S)-2-amino-3-(4-hydroxyphenyl)propanamido)hexanamido)-4-oxobutanoic acid::CHEMBL1171596 Gastrin/cholecystokinin type B receptor Homo sapiens 61 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321609 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2126&target=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321609&enzyme=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798148 104143138 CHEMBL1171596 1 MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG 8IA7,7XOW Gastrin/cholecystokinin type B receptor GASR_HUMAN P32239 A8K7P9 O75824 Q16144 Q92492 Q96LC6 Q9NYK7 Q9UBV1 50213835 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C76H90N16O12/c1-4-5-23-58(68(97)90-64(38-66(94)95)73(102)87-60(67(78)96)32-45-16-7-6-8-17-45)85-71(100)62(34-51-39-83-57-24-14-13-22-54(51)57)89-69(98)59(25-15-28-82-76(79)80)86-70(99)61(33-46-26-27-47-18-9-10-19-48(47)31-46)88-72(101)63(36-52-40-81-42-84-52)91-74(103)65-35-49-20-11-12-21-50(49)41-92(65)75(104)56(77)37-55-43(2)29-53(93)30-44(55)3/h6-14,16-22,24,26-27,29-31,39-40,42,56,58-65,83,93H,4-5,15,23,25,28,32-38,41,77H2,1-3H3,(H2,78,96)(H,81,84)(H,85,100)(H,86,99)(H,87,102)(H,88,101)(H,89,98)(H,90,97)(H,91,103)(H,94,95)(H4,79,80,82) TVINVHGLLFLSBP-UHFFFAOYSA-N 50321596 (3S,6R,9S,12S,15S,18S)-3-((1H-imidazol-5-yl)methyl)-12-((1H-indol-3-yl)methyl)-18-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-1-(2-((R)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-15-butyl-9-(3-guanidinopropyl)-6-(naphthalen-2-ylmethyl)-1,4,7,10,13,16-hexaoxo-2,5,8,11,14,17-hexaazaicosan-20-oic acid::CHEMBL2372623 Melanocortin receptor 4 Homo sapiens 251 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321596 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6546&target=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321596&enzyme=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 73354785 104143125 CHEMBL2372623 1 MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY 8QJ2,9K3K,7F58,7F55,7F54,7F53,7PIV,7PIU,7AUE Melanocortin receptor 4 MC4R_HUMAN P32245 B2RAC3 Q16317 Q3MIJ6 50213861 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C76H90N16O12/c1-4-5-23-58(68(97)90-64(38-66(94)95)73(102)87-60(67(78)96)32-45-16-7-6-8-17-45)85-71(100)62(34-51-39-83-57-24-14-13-22-54(51)57)89-69(98)59(25-15-28-82-76(79)80)86-70(99)61(33-46-26-27-47-18-9-10-19-48(47)31-46)88-72(101)63(36-52-40-81-42-84-52)91-74(103)65-35-49-20-11-12-21-50(49)41-92(65)75(104)56(77)37-55-43(2)29-53(93)30-44(55)3/h6-14,16-22,24,26-27,29-31,39-40,42,56,58-65,83,93H,4-5,15,23,25,28,32-38,41,77H2,1-3H3,(H2,78,96)(H,81,84)(H,85,100)(H,86,99)(H,87,102)(H,88,101)(H,89,98)(H,90,97)(H,91,103)(H,94,95)(H4,79,80,82) TVINVHGLLFLSBP-UHFFFAOYSA-N 50321596 (3S,6R,9S,12S,15S,18S)-3-((1H-imidazol-5-yl)methyl)-12-((1H-indol-3-yl)methyl)-18-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-1-(2-((R)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-15-butyl-9-(3-guanidinopropyl)-6-(naphthalen-2-ylmethyl)-1,4,7,10,13,16-hexaoxo-2,5,8,11,14,17-hexaazaicosan-20-oic acid::CHEMBL2372623 Gastrin/cholecystokinin type B receptor Homo sapiens 200 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321596 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2126&target=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321596&enzyme=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search 73354785 104143125 CHEMBL2372623 1 MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG 8IA7,7XOW Gastrin/cholecystokinin type B receptor GASR_HUMAN P32239 A8K7P9 O75824 Q16144 Q92492 Q96LC6 Q9NYK7 Q9UBV1 50213862 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:33.48,22.31,4.4,48.59,93.100,wD:70.77,58.62,8.20,85.92,(16.65,-3.98,;15.32,-4.75,;15.32,-6.29,;13.98,-7.06,;13.98,-8.6,;12.65,-9.36,;11.32,-8.59,;11.32,-7.05,;9.99,-9.35,;9.99,-10.9,;11.32,-11.67,;12.72,-11.05,;13.76,-12.19,;12.98,-13.52,;13.46,-14.99,;12.42,-16.14,;10.92,-15.81,;10.44,-14.35,;11.48,-13.21,;8.66,-8.59,;7.33,-9.38,;7.33,-10.92,;6,-8.61,;6,-7.07,;7.33,-6.3,;7.33,-4.76,;8.66,-3.97,;8.68,-2.43,;7.33,-1.66,;10,-1.66,;4.65,-9.35,;3.32,-8.59,;3.32,-7.05,;1.99,-9.36,;1.76,-10.89,;2.96,-11.84,;2.73,-13.37,;3.92,-14.33,;5.36,-13.77,;6.57,-14.74,;8.01,-14.17,;8.23,-12.64,;7.03,-11.68,;5.59,-12.24,;4.39,-11.29,;.66,-8.58,;-.66,-9.38,;-.66,-10.92,;-2,-8.61,;-2,-7.07,;-.66,-6.29,;.75,-6.93,;1.79,-5.78,;1.01,-4.45,;-.5,-4.76,;-3.33,-9.38,;-4.67,-8.61,;-4.67,-7.07,;-6,-9.38,;-7.33,-8.62,;-8.66,-9.39,;-9.99,-8.62,;-11.33,-9.39,;-11.33,-10.93,;-9.99,-11.69,;-8.66,-10.92,;-7.33,-11.7,;-6,-10.91,;-4.66,-11.68,;-3.33,-10.91,;-4.66,-13.22,;-5.99,-13.99,;-3.32,-13.99,;-3.32,-15.53,;-4.65,-16.3,;-5.98,-15.53,;-4.65,-17.84,;-3.31,-18.61,;-3.31,-20.15,;-1.98,-17.84,;-1.98,-16.29,;-.65,-15.52,;15.32,-9.37,;15.32,-10.91,;16.65,-8.59,;17.98,-9.36,;17.98,-10.91,;19.32,-11.67,;20.64,-10.9,;19.32,-13.21,;19.32,-8.59,;19.32,-7.05,;20.65,-9.36,;21.98,-8.59,;21.98,-7.05,;23.31,-6.28,;24.65,-7.06,;25.98,-6.29,;25.99,-4.75,;24.65,-3.98,;23.32,-4.75,;23.31,-9.36,;24.65,-8.59,;23.31,-10.91,)| InChI=1S/C76H90N16O12/c1-4-5-23-58(68(97)90-64(38-66(94)95)73(102)87-60(67(78)96)32-45-16-7-6-8-17-45)85-71(100)62(34-51-39-83-57-24-14-13-22-54(51)57)89-69(98)59(25-15-28-82-76(79)80)86-70(99)61(33-46-26-27-47-18-9-10-19-48(47)31-46)88-72(101)63(36-52-40-81-42-84-52)91-74(103)65-35-49-20-11-12-21-50(49)41-92(65)75(104)56(77)37-55-43(2)29-53(93)30-44(55)3/h6-14,16-22,24,26-27,29-31,39-40,42,56,58-65,83,93H,4-5,15,23,25,28,32-38,41,77H2,1-3H3,(H2,78,96)(H,81,84)(H,85,100)(H,86,99)(H,87,102)(H,88,101)(H,89,98)(H,90,97)(H,91,103)(H,94,95)(H4,79,80,82) TVINVHGLLFLSBP-UHFFFAOYSA-N 50321597 (3S,6R,9S,12S,15S,18S)-3-((1H-imidazol-5-yl)methyl)-12-((1H-indol-3-yl)methyl)-18-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-1-((R)-2-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-15-butyl-9-(3-guanidinopropyl)-6-(naphthalen-2-ylmethyl)-1,4,7,10,13,16-hexaoxo-2,5,8,11,14,17-hexaazaicosan-20-oic acid::CHEMBL1172249 Delta-type opioid receptor Homo sapiens 13 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321597 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321597&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933500 104143126 CHEMBL1172249 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 50213863 Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N1CC(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@H](Cc2ccc3ccccc3c2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CSSC[C@@H](N)C1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:69.84,89.95,29.31,10.11,wD:44.48,74.80,19.20,81.87,55.59,(1.42,-5.48,;.09,-4.71,;-1.25,-5.49,;-2.59,-4.72,;-3.92,-5.48,;-2.59,-3.17,;-1.25,-2.41,;-1.25,-.87,;.08,-3.17,;1.41,-2.4,;2.75,-3.17,;2.75,-4.71,;4.08,-2.39,;4.08,-.85,;5.42,-3.16,;6.02,-4.57,;5.09,-5.8,;3.56,-5.61,;5.68,-7.22,;4.75,-8.45,;3.42,-7.68,;2.08,-8.45,;.68,-7.83,;-.35,-8.98,;.42,-10.31,;1.93,-9.98,;4.75,-9.99,;3.42,-10.76,;6.09,-10.76,;6.09,-12.3,;4.75,-13.07,;4.75,-14.61,;6.08,-15.37,;6.09,-16.91,;4.75,-17.69,;4.75,-19.22,;3.42,-19.99,;2.08,-19.22,;2.09,-17.68,;3.42,-16.92,;3.42,-15.39,;7.42,-13.07,;7.42,-14.61,;8.75,-12.3,;10.09,-13.07,;10.09,-14.61,;8.75,-15.38,;8.75,-16.92,;7.42,-17.69,;7.42,-19.23,;6.09,-20,;8.75,-20,;11.42,-12.3,;12.75,-13.07,;11.42,-10.76,;12.75,-9.99,;14.09,-10.76,;15.42,-9.99,;15.57,-8.48,;17.08,-8.15,;17.86,-9.48,;19.37,-9.79,;19.85,-11.26,;18.82,-12.42,;17.3,-12.1,;16.82,-10.63,;12.75,-8.45,;11.42,-7.68,;14.09,-7.68,;14.09,-6.14,;12.75,-5.37,;12.75,-3.83,;10,-3.73,;8.47,-3.54,;7.88,-2.12,;8.81,-.89,;6.35,-1.93,;5.75,-.51,;15.42,-5.37,;16.75,-6.14,;15.42,-3.83,;16.75,-3.06,;18.09,-3.83,;19.42,-3.06,;19.42,-1.52,;20.76,-3.83,;16.75,-1.52,;15.42,-.75,;18.09,-.75,;18.09,.78,;16.75,1.55,;16.75,3.09,;18.09,3.85,;18.09,5.39,;16.76,6.16,;15.42,5.39,;15.43,3.86,;19.42,1.55,;19.42,3.09,;20.76,.78,)| InChI=1S/C68H81N17O13S2/c1-36-21-44(86)22-37(2)46(36)28-47(69)66(97)85-32-57(87)78-54(27-43-31-74-35-77-43)63(94)81-52(25-39-18-19-40-13-6-7-14-41(40)23-39)61(92)79-50(17-10-20-75-68(72)73)60(91)82-53(26-42-30-76-49-16-9-8-15-45(42)49)62(93)84-56(34-100-99-33-48(70)67(85)98)65(96)83-55(29-58(88)89)64(95)80-51(59(71)90)24-38-11-4-3-5-12-38/h3-9,11-16,18-19,21-23,30-31,35,47-48,50-56,76,86H,10,17,20,24-29,32-34,69-70H2,1-2H3,(H2,71,90)(H,74,77)(H,78,87)(H,79,92)(H,80,95)(H,81,94)(H,82,91)(H,83,96)(H,84,93)(H,88,89)(H4,72,73,75) YDLLMSIGAKQIBS-UHFFFAOYSA-N 50321598 (S)-3-((4R,7S,10S,13R,16S,22S)-16-((1H-imidazol-5-yl)methyl)-7-((1H-indol-3-yl)methyl)-22-amino-20-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-10-(3-guanidinopropyl)-13-(naphthalen-2-ylmethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexaazacyclotricosane-4-carboxamido)-4-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid::CHEMBL1172248 Delta-type opioid receptor Homo sapiens 13 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321598 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321598&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933501 104143127 CHEMBL1172248 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 50213864 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:8.20,58.71,93.99,78.84,wD:73.79,48.59,22.31,33.48,4.4,101.107,(24.59,-5.48,;25.93,-4.72,;25.93,-3.18,;24.59,-2.4,;24.59,-.86,;23.26,-.1,;21.93,-.87,;21.93,-2.41,;20.59,-.11,;20.59,1.44,;22,2.07,;23.25,1.19,;24.48,2.12,;23.98,3.58,;24.73,4.92,;23.94,6.24,;22.4,6.22,;21.65,4.87,;22.44,3.55,;19.25,-.87,;17.91,-.12,;17.91,1.43,;16.57,-.89,;16.57,-2.43,;17.91,-3.2,;17.91,-4.73,;19.24,-5.51,;19.24,-7.05,;17.93,-7.8,;20.61,-7.81,;15.25,-.1,;13.92,-.87,;13.92,-2.41,;12.59,-.1,;12.6,1.44,;13.92,2.21,;15.26,1.44,;16.59,2.21,;16.6,3.75,;17.93,4.53,;17.92,6.07,;16.58,6.84,;15.25,6.06,;15.26,4.52,;13.92,3.75,;11.26,-.86,;9.92,-.1,;9.92,1.45,;8.58,-.87,;8.58,-2.41,;9.92,-3.18,;11.32,-2.55,;12.36,-3.69,;11.59,-5.03,;10.08,-4.71,;7.25,-.09,;5.91,-.85,;5.91,-2.39,;4.58,-.08,;4.58,1.46,;5.91,2.23,;7.25,1.47,;8.58,2.24,;8.58,3.78,;7.24,4.55,;5.91,3.78,;3.25,-.85,;1.92,-.07,;1.92,1.47,;.58,-.85,;-.75,-.07,;-2.08,-.85,;-2.08,-2.38,;-3.41,-.07,;-3.41,1.47,;-4.75,-.84,;-6.09,-.08,;-6.09,1.47,;-7.42,-.86,;-7.4,-2.4,;-8.75,-.1,;-10.08,-.88,;-10.06,-2.42,;-8.72,-3.17,;-11.4,-3.2,;-12.73,-2.44,;-14.07,-3.22,;-12.76,-.9,;-11.41,-.13,;-11.43,1.41,;25.93,-.09,;25.93,1.45,;27.26,-.87,;28.59,-.09,;28.59,1.45,;29.93,2.21,;31.25,1.45,;29.93,3.76,;29.93,-.87,;29.93,-2.4,;31.26,-.1,;32.6,-.87,;32.6,-2.4,;33.93,-3.17,;35.28,-2.4,;36.61,-3.17,;36.61,-4.71,;35.27,-5.48,;33.94,-4.71,;33.93,-.1,;35.27,-.86,;33.93,1.45,)| InChI=1S/C80H98N18O14/c1-5-6-25-60(73(106)98-67(40-69(101)102)79(112)94-62(70(82)103)34-48-18-9-7-10-19-48)92-77(110)65(37-53-41-87-59-26-16-15-24-56(53)59)96-74(107)61(27-17-30-86-80(83)84)93-76(109)64(36-50-28-29-51-22-13-14-23-52(51)33-50)95-78(111)66(38-54-42-85-44-89-54)97-75(108)63(35-49-20-11-8-12-21-49)91-68(100)43-88-71(104)47(4)90-72(105)58(81)39-57-45(2)31-55(99)32-46(57)3/h7-16,18-24,26,28-29,31-33,41-42,44,47,58,60-67,87,99H,5-6,17,25,27,30,34-40,43,81H2,1-4H3,(H2,82,103)(H,85,89)(H,88,104)(H,90,105)(H,91,100)(H,92,110)(H,93,109)(H,94,112)(H,95,111)(H,96,107)(H,97,108)(H,98,106)(H,101,102)(H4,83,84,86) AHRZYQWKXXBNHK-UHFFFAOYSA-N 50321606 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxy-2,6-dimethylphenyl)-27-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172253 Cholecystokinin receptor type A Homo sapiens 18 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321606 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2125&target=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321606&enzyme=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search 91933506 104143135 CHEMBL1172253 1 MDVVDSLLVNGSNITPPCELGLENETLFCLDQPRPSKEWQPAVQILLYSLIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLLKDFIFGSAVCKTTTYFMGTSVSVSTFNLVAISLERYGAICKPLQSRVWQTKSHALKVIAATWCLSFTIMTPYPIYSNLVPFTKNNNQTANMCRFLLPNDVMQQSWHTFLLLILFLIPGIVMMVAYGLISLELYQGIKFEASQKKSAKERKPSTTSSGKYEDSDGCYLQKTRPPRKLELRQLSTGSSSRANRIRSNSSAANLMAKKRVIRMLIVIVVLFFLCWMPIFSANAWRAYDTASAERRLSGTPISFILLLSYTSSCVNPIIYCFMNKRFRLGFMATFPCCPNPGPPGARGEVGEEEEGGTTGASLSRFSYSHMSASVPPQ 7XOV,7XOU,7EZM,7EZK,7EZH,7MBX,7MBY Cholecystokinin receptor type A CCKAR_HUMAN P32238 B2R9Z5 50213865 Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N1CC(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@H](Cc2ccccc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CSSC[C@@H](N)C1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:10.11,65.79,85.90,29.31,wD:19.20,70.75,40.43,77.82,51.54,(-6.99,1.44,;-8.33,2.2,;-9.67,1.43,;-11.01,2.2,;-12.34,1.43,;-11,3.74,;-9.66,4.51,;-9.66,6.05,;-8.33,3.74,;-7,4.51,;-5.67,3.75,;-5.66,2.21,;-4.33,4.52,;-4.34,6.06,;-3,3.75,;-2.4,2.34,;-3.33,1.11,;-4.86,1.3,;-2.73,-.31,;-3.66,-1.53,;-5,-.77,;-6.33,-1.54,;-7.73,-.92,;-8.76,-2.06,;-7.99,-3.4,;-6.48,-3.07,;-3.66,-3.08,;-5,-3.85,;-2.33,-3.85,;-2.33,-5.39,;-3.66,-6.16,;-3.66,-7.7,;-5,-8.46,;-5,-10,;-3.67,-10.77,;-2.33,-10,;-2.34,-8.46,;-1,-6.16,;-1,-7.7,;.34,-5.39,;1.67,-6.16,;1.67,-7.7,;.34,-8.47,;.34,-10.01,;-1,-10.78,;-1,-12.32,;-2.33,-13.09,;.34,-13.09,;3,-5.39,;4.34,-6.16,;3,-3.85,;4.34,-3.08,;5.67,-3.85,;7.01,-3.08,;7.16,-1.56,;8.67,-1.24,;9.44,-2.57,;10.95,-2.88,;11.43,-4.34,;10.4,-5.5,;8.89,-5.18,;8.41,-3.71,;4.34,-1.54,;3,-.77,;5.67,-.77,;5.67,.77,;4.34,1.54,;4.34,3.08,;1.59,3.18,;.06,3.38,;-.54,4.79,;.39,6.02,;-2.07,4.99,;-2.66,6.41,;7.01,1.54,;8.34,.77,;7.01,3.08,;8.34,3.85,;9.67,3.08,;11.01,3.85,;11.01,5.39,;12.34,3.08,;8.34,5.39,;7.01,6.16,;9.67,6.16,;9.67,7.7,;8.34,8.47,;8.34,10.01,;9.68,10.78,;9.68,12.32,;8.34,13.09,;7.01,12.31,;7.01,10.77,;11.01,8.47,;11.01,10.01,;12.34,7.7,)| InChI=1S/C64H79N17O13S2/c1-34-20-40(82)21-35(2)42(34)26-43(65)62(93)81-30-53(83)74-50(25-39-29-70-33-73-39)59(90)77-48(23-37-14-7-4-8-15-37)57(88)75-46(18-11-19-71-64(68)69)56(87)78-49(24-38-28-72-45-17-10-9-16-41(38)45)58(89)80-52(32-96-95-31-44(66)63(81)94)61(92)79-51(27-54(84)85)60(91)76-47(55(67)86)22-36-12-5-3-6-13-36/h3-10,12-17,20-21,28-29,33,43-44,46-52,72,82H,11,18-19,22-27,30-32,65-66H2,1-2H3,(H2,67,86)(H,70,73)(H,74,83)(H,75,88)(H,76,91)(H,77,90)(H,78,87)(H,79,92)(H,80,89)(H,84,85)(H4,68,69,71) OYHTUAKSBPLZSH-UHFFFAOYSA-N 50321599 (S)-3-((4R,7S,10S,13R,16S,22S)-16-((1H-imidazol-5-yl)methyl)-7-((1H-indol-3-yl)methyl)-22-amino-20-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-13-benzyl-10-(3-guanidinopropyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexaazacyclotricosane-4-carboxamido)-4-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid::CHEMBL1172247 Delta-type opioid receptor Homo sapiens 20 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321599 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321599&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933502 104143128 CHEMBL1172247 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 50213866 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:69.75,8.20,58.71,89.95,wD:48.59,22.31,33.48,4.4,97.103,74.80,(28.82,-7.95,;30.15,-7.19,;30.15,-5.65,;28.82,-4.88,;28.82,-3.34,;27.48,-2.57,;26.15,-3.35,;26.15,-4.89,;24.82,-2.58,;24.82,-1.03,;26.22,-.4,;27.48,-1.28,;28.71,-.35,;28.21,1.11,;28.95,2.45,;28.16,3.77,;26.62,3.74,;25.87,2.4,;26.66,1.08,;23.48,-3.34,;22.13,-2.59,;22.13,-1.04,;20.8,-3.36,;20.8,-4.9,;22.13,-5.67,;22.13,-7.21,;23.47,-7.98,;23.47,-9.52,;22.16,-10.27,;24.84,-10.28,;19.47,-2.57,;18.15,-3.35,;18.15,-4.88,;16.82,-2.57,;16.82,-1.03,;18.15,-.26,;19.48,-1.03,;20.81,-.26,;20.82,1.28,;22.15,2.06,;22.15,3.6,;20.8,4.36,;19.47,3.58,;19.48,2.05,;18.14,1.28,;15.48,-3.33,;14.14,-2.57,;14.14,-1.02,;12.8,-3.34,;12.8,-4.88,;14.14,-5.65,;15.55,-5.02,;16.59,-6.17,;15.81,-7.5,;14.31,-7.18,;11.47,-2.57,;10.13,-3.32,;10.13,-4.86,;8.81,-2.55,;8.81,-1.01,;10.13,-.25,;11.47,-1.01,;12.81,-.24,;12.8,1.31,;11.47,2.07,;10.14,1.3,;7.47,-3.33,;6.13,-2.55,;6.13,-1.01,;4.8,-3.33,;4.8,-4.87,;3.47,-2.56,;2.12,-3.32,;2.13,-4.86,;.8,-2.54,;.81,-1,;-.54,-3.3,;-1.86,-2.52,;-1.85,-.98,;-.51,-.23,;-3.18,-.2,;-4.52,-.96,;-5.84,-.18,;-4.53,-2.49,;-3.2,-3.27,;-3.21,-4.81,;30.15,-2.57,;30.15,-1.03,;31.49,-3.34,;32.82,-2.57,;32.82,-1.02,;34.15,-.26,;35.48,-1.03,;34.15,1.29,;34.15,-3.34,;34.15,-4.88,;35.49,-2.57,;36.82,-3.34,;36.82,-4.88,;38.16,-5.65,;39.5,-4.87,;40.83,-5.65,;40.84,-7.18,;39.5,-7.95,;38.16,-7.19,;38.16,-2.57,;39.49,-3.33,;38.16,-1.02,)| InChI=1S/C78H95N17O13/c1-5-6-25-59(71(102)95-66(40-67(97)98)77(108)90-61(68(80)99)34-47-18-9-7-10-19-47)88-75(106)64(37-52-41-85-58-26-16-15-24-55(52)58)93-72(103)60(27-17-30-84-78(81)82)89-73(104)63(36-49-28-29-50-22-13-14-23-51(50)33-49)92-76(107)65(38-53-42-83-43-86-53)94-74(105)62(35-48-20-11-8-12-21-48)91-69(100)46(4)87-70(101)57(79)39-56-44(2)31-54(96)32-45(56)3/h7-16,18-24,26,28-29,31-33,41-43,46,57,59-66,85,96H,5-6,17,25,27,30,34-40,79H2,1-4H3,(H2,80,99)(H,83,86)(H,87,101)(H,88,106)(H,89,104)(H,90,108)(H,91,100)(H,92,107)(H,93,103)(H,94,105)(H,95,102)(H,97,98)(H4,81,82,84) JMDKMESJXNSGPX-UHFFFAOYSA-N 50321605 (6R,9S,12S,15R,18S,21S,24S,27S)-12-((1H-imidazol-5-yl)methyl)-21-((1H-indol-3-yl)methyl)-27-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-9-benzyl-24-butyl-18-(3-guanidinopropyl)-1-(4-hydroxy-2,6-dimethylphenyl)-6-methyl-15-(naphthalen-2-ylmethyl)-4,7,10,13,16,19,22,25-octaoxo-3,5,8,11,14,17,20,23,26-nonaazanonacosan-29-oic acid::CHEMBL1172428 Cholecystokinin receptor type A Homo sapiens 0.794328 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321605 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2125&target=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321605&enzyme=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search 91933505 104143134 CHEMBL1172428 1 MDVVDSLLVNGSNITPPCELGLENETLFCLDQPRPSKEWQPAVQILLYSLIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLLKDFIFGSAVCKTTTYFMGTSVSVSTFNLVAISLERYGAICKPLQSRVWQTKSHALKVIAATWCLSFTIMTPYPIYSNLVPFTKNNNQTANMCRFLLPNDVMQQSWHTFLLLILFLIPGIVMMVAYGLISLELYQGIKFEASQKKSAKERKPSTTSSGKYEDSDGCYLQKTRPPRKLELRQLSTGSSSRANRIRSNSSAANLMAKKRVIRMLIVIVVLFFLCWMPIFSANAWRAYDTASAERRLSGTPISFILLLSYTSSCVNPIIYCFMNKRFRLGFMATFPCCPNPGPPGARGEVGEEEEGGTTGASLSRFSYSHMSASVPPQ 7XOV,7XOU,7EZM,7EZK,7EZH,7MBX,7MBY Cholecystokinin receptor type A CCKAR_HUMAN P32238 B2R9Z5 50213867 N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C66H81ClN18O14/c67-40-19-15-38(16-20-40)27-49-62(96)80-47(14-8-24-74-66(70)71)61(95)84-51(29-41-28-39-11-4-5-12-45(39)77-41)64(98)79-46(60(94)85-53(32-56(89)90)65(99)81-48(57(69)91)26-36-9-2-1-3-10-36)13-6-7-23-73-54(87)31-52(82-58(92)44(68)25-37-17-21-43(86)22-18-37)59(93)75-34-55(88)78-50(63(97)83-49)30-42-33-72-35-76-42/h1-5,9-12,15-22,28,33,35,44,46-53,77,86H,6-8,13-14,23-27,29-32,34,68H2,(H2,69,91)(H,72,76)(H,73,87)(H,75,93)(H,78,88)(H,79,98)(H,80,96)(H,81,99)(H,82,92)(H,83,97)(H,84,95)(H,85,94)(H,89,90)(H4,70,71,74) YCEIOOXEUSAMIZ-UHFFFAOYSA-N 50321600 (S)-3-((3S,6S,9S,12S,18R,26S)-12-((1H-imidazol-5-yl)methyl)-3-((1H-indol-2-yl)methyl)-18-((S)-2-amino-3-(4-hydroxyphenyl)propanamido)-9-(4-chlorobenzyl)-6-(3-guanidinopropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,21-heptaazacyclohexacosane-26-carboxamido)-4-((R)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid::CHEMBL1172246 Delta-type opioid receptor Homo sapiens 2512 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321600 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321600&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798106 104143129 CHEMBL1172246 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 50213868 C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:5.5,1.0,78.83,66.79,55.66,37.39,97.102,wD:22.22,41.55,89.94,(17.54,.39,;18.85,-.37,;20.18,.39,;20.18,1.92,;18.85,2.7,;21.5,2.69,;21.5,4.24,;22.81,1.93,;22.81,.41,;21.51,-.37,;21.53,-1.91,;22.87,-2.67,;22.87,-4.2,;24.18,-1.88,;24.18,-.35,;18.85,-1.92,;20.2,-2.69,;17.54,-2.68,;17.54,-4.23,;16.23,-4.98,;14.91,-4.23,;16.23,-6.53,;14.91,-7.3,;13.6,-6.53,;12.26,-7.31,;12.29,-8.88,;10.96,-9.65,;9.62,-8.89,;9.61,-7.35,;10.94,-6.57,;14.91,-8.85,;16.26,-9.62,;13.6,-9.6,;13.6,-11.15,;12.3,-11.91,;12.3,-13.47,;10.99,-14.22,;10.99,-15.77,;9.67,-16.53,;8.36,-15.77,;8.36,-14.26,;7.02,-16.55,;7.02,-18.1,;8.36,-18.88,;9.61,-17.94,;10.87,-18.83,;10.39,-20.31,;11.18,-21.63,;10.42,-22.98,;8.88,-22.99,;8.1,-21.66,;8.85,-20.32,;5.7,-15.79,;4.36,-16.57,;4.36,-18.12,;3.05,-15.81,;3.05,-14.3,;4.36,-13.54,;4.36,-11.99,;5.67,-11.23,;5.67,-9.68,;4.33,-8.91,;6.98,-8.93,;1.71,-16.59,;.4,-15.83,;.4,-14.32,;-.95,-16.61,;-.95,-18.16,;.4,-18.93,;1.74,-18.14,;3.07,-18.9,;3.08,-20.45,;4.42,-21.21,;1.76,-21.23,;.42,-20.46,;-2.26,-15.85,;-3.61,-16.63,;-3.61,-18.18,;-4.92,-15.87,;-6.26,-16.65,;-4.92,-14.35,;-3.61,-13.6,;-2.21,-14.2,;-1.18,-13.04,;-1.97,-11.71,;-3.47,-12.05,;12.33,-16.55,;12.33,-18.07,;13.67,-15.77,;14.98,-16.53,;14.98,-18.05,;16.33,-18.82,;17.67,-18.05,;16.33,-20.33,;16.33,-15.75,;16.33,-14.2,;17.64,-16.51,;18.98,-15.73,;18.98,-14.18,;20.3,-13.43,;21.63,-14.17,;22.95,-13.39,;22.94,-11.85,;21.61,-11.09,;20.27,-11.87,;20.3,-16.49,;21.64,-15.71,;20.3,-18.01,)| InChI=1S/C74H92ClN19O14/c1-42(87-66(101)52(76)31-45-23-27-50(95)28-24-45)65(100)85-40-62(96)88-58(33-44-15-6-3-7-16-44)68(103)82-29-11-10-19-55(69(104)94-61(37-63(97)98)73(108)91-57(64(78)99)32-43-13-4-2-5-14-43)89-72(107)60(35-47-38-84-54-18-9-8-17-51(47)54)93-70(105)56(20-12-30-83-74(79)80)90-71(106)59(34-46-21-25-48(75)26-22-46)92-67(102)53(77)36-49-39-81-41-86-49/h2-9,13-18,21-28,38-39,41-42,52-53,55-61,84,95H,10-12,19-20,29-37,40,76-77H2,1H3,(H2,78,99)(H,81,86)(H,82,103)(H,85,100)(H,87,101)(H,88,96)(H,89,107)(H,90,106)(H,91,108)(H,92,102)(H,93,105)(H,94,104)(H,97,98)(H4,79,80,83) VEMKPSHWNYIGPG-UHFFFAOYSA-N 50321601 (2S,5R,11S,18S,21S)-2-amino-21-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-18-((S)-2-((S)-2-((R)-2-((S)-2-amino-3-(1H-imidazol-5-yl)propanamido)-3-(4-chlorophenyl)propanamido)-5-guanidinopentanamido)-3-(1H-indol-3-yl)propanamido)-11-benzyl-1-(4-hydroxyphenyl)-5-methyl-3,6,9,12,19-pentaoxo-4,7,10,13,20-pentaazatricosan-23-oic acid::CHEMBL1172245 Delta-type opioid receptor Homo sapiens 7.9 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321601 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321601&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933503 104143130 CHEMBL1172245 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 50213869 N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C66H81ClN18O14/c67-40-19-15-38(16-20-40)27-49-62(96)80-47(14-8-24-74-66(70)71)61(95)84-51(29-41-28-39-11-4-5-12-45(39)77-41)64(98)79-46(60(94)85-53(32-56(89)90)65(99)81-48(57(69)91)26-36-9-2-1-3-10-36)13-6-7-23-73-54(87)31-52(82-58(92)44(68)25-37-17-21-43(86)22-18-37)59(93)75-34-55(88)78-50(63(97)83-49)30-42-33-72-35-76-42/h1-5,9-12,15-22,28,33,35,44,46-53,77,86H,6-8,13-14,23-27,29-32,34,68H2,(H2,69,91)(H,72,76)(H,73,87)(H,75,93)(H,78,88)(H,79,98)(H,80,96)(H,81,99)(H,82,92)(H,83,97)(H,84,95)(H,85,94)(H,89,90)(H4,70,71,74) YCEIOOXEUSAMIZ-UHFFFAOYSA-N 50321600 (S)-3-((3S,6S,9S,12S,18R,26S)-12-((1H-imidazol-5-yl)methyl)-3-((1H-indol-2-yl)methyl)-18-((S)-2-amino-3-(4-hydroxyphenyl)propanamido)-9-(4-chlorobenzyl)-6-(3-guanidinopropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,21-heptaazacyclohexacosane-26-carboxamido)-4-((R)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid::CHEMBL1172246 Cholecystokinin receptor type A Homo sapiens 126 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321600 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2125&target=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321600&enzyme=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search 49798106 104143129 CHEMBL1172246 1 MDVVDSLLVNGSNITPPCELGLENETLFCLDQPRPSKEWQPAVQILLYSLIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLLKDFIFGSAVCKTTTYFMGTSVSVSTFNLVAISLERYGAICKPLQSRVWQTKSHALKVIAATWCLSFTIMTPYPIYSNLVPFTKNNNQTANMCRFLLPNDVMQQSWHTFLLLILFLIPGIVMMVAYGLISLELYQGIKFEASQKKSAKERKPSTTSSGKYEDSDGCYLQKTRPPRKLELRQLSTGSSSRANRIRSNSSAANLMAKKRVIRMLIVIVVLFFLCWMPIFSANAWRAYDTASAERRLSGTPISFILLLSYTSSCVNPIIYCFMNKRFRLGFMATFPCCPNPGPPGARGEVGEEEEGGTTGASLSRFSYSHMSASVPPQ 7XOV,7XOU,7EZM,7EZK,7EZH,7MBX,7MBY Cholecystokinin receptor type A CCKAR_HUMAN P32238 B2R9Z5 50213870 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C74H92N18O14/c1-3-4-24-54(67(100)92-61(38-63(95)96)73(106)88-56(64(76)97)33-44-17-8-5-9-18-44)86-71(104)59(36-48-39-81-53-25-15-14-23-51(48)53)90-68(101)55(26-16-31-80-74(77)78)87-70(103)58(35-46-21-12-7-13-22-46)89-72(105)60(37-49-40-79-42-83-49)91-69(102)57(34-45-19-10-6-11-20-45)85-62(94)41-82-65(98)43(2)84-66(99)52(75)32-47-27-29-50(93)30-28-47/h5-15,17-23,25,27-30,39-40,42-43,52,54-61,81,93H,3-4,16,24,26,31-38,41,75H2,1-2H3,(H2,76,97)(H,79,83)(H,82,98)(H,84,99)(H,85,94)(H,86,104)(H,87,103)(H,88,106)(H,89,105)(H,90,101)(H,91,102)(H,92,100)(H,95,96)(H4,77,78,80) ZUUGDHAKGUQZKD-UHFFFAOYSA-N 50321608 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-15,21-dibenzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxyphenyl)-27-methyl-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172251 Cholecystokinin receptor type A Homo sapiens 1400 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321608 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2125&target=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321608&enzyme=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search 49798111 104143137 CHEMBL1172251 1 MDVVDSLLVNGSNITPPCELGLENETLFCLDQPRPSKEWQPAVQILLYSLIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLLKDFIFGSAVCKTTTYFMGTSVSVSTFNLVAISLERYGAICKPLQSRVWQTKSHALKVIAATWCLSFTIMTPYPIYSNLVPFTKNNNQTANMCRFLLPNDVMQQSWHTFLLLILFLIPGIVMMVAYGLISLELYQGIKFEASQKKSAKERKPSTTSSGKYEDSDGCYLQKTRPPRKLELRQLSTGSSSRANRIRSNSSAANLMAKKRVIRMLIVIVVLFFLCWMPIFSANAWRAYDTASAERRLSGTPISFILLLSYTSSCVNPIIYCFMNKRFRLGFMATFPCCPNPGPPGARGEVGEEEEGGTTGASLSRFSYSHMSASVPPQ 7XOV,7XOU,7EZM,7EZK,7EZH,7MBX,7MBY Cholecystokinin receptor type A CCKAR_HUMAN P32238 B2R9Z5 50213871 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:69.75,8.20,58.71,89.95,wD:48.59,22.31,33.48,4.4,97.103,74.80,(28.82,-7.95,;30.15,-7.19,;30.15,-5.65,;28.82,-4.88,;28.82,-3.34,;27.48,-2.57,;26.15,-3.35,;26.15,-4.89,;24.82,-2.58,;24.82,-1.03,;26.22,-.4,;27.48,-1.28,;28.71,-.35,;28.21,1.11,;28.95,2.45,;28.16,3.77,;26.62,3.74,;25.87,2.4,;26.66,1.08,;23.48,-3.34,;22.13,-2.59,;22.13,-1.04,;20.8,-3.36,;20.8,-4.9,;22.13,-5.67,;22.13,-7.21,;23.47,-7.98,;23.47,-9.52,;22.16,-10.27,;24.84,-10.28,;19.47,-2.57,;18.15,-3.35,;18.15,-4.88,;16.82,-2.57,;16.82,-1.03,;18.15,-.26,;19.48,-1.03,;20.81,-.26,;20.82,1.28,;22.15,2.06,;22.15,3.6,;20.8,4.36,;19.47,3.58,;19.48,2.05,;18.14,1.28,;15.48,-3.33,;14.14,-2.57,;14.14,-1.02,;12.8,-3.34,;12.8,-4.88,;14.14,-5.65,;15.55,-5.02,;16.59,-6.17,;15.81,-7.5,;14.31,-7.18,;11.47,-2.57,;10.13,-3.32,;10.13,-4.86,;8.81,-2.55,;8.81,-1.01,;10.13,-.25,;11.47,-1.01,;12.81,-.24,;12.8,1.31,;11.47,2.07,;10.14,1.3,;7.47,-3.33,;6.13,-2.55,;6.13,-1.01,;4.8,-3.33,;4.8,-4.87,;3.47,-2.56,;2.12,-3.32,;2.13,-4.86,;.8,-2.54,;.81,-1,;-.54,-3.3,;-1.86,-2.52,;-1.85,-.98,;-.51,-.23,;-3.18,-.2,;-4.52,-.96,;-5.84,-.18,;-4.53,-2.49,;-3.2,-3.27,;-3.21,-4.81,;30.15,-2.57,;30.15,-1.03,;31.49,-3.34,;32.82,-2.57,;32.82,-1.02,;34.15,-.26,;35.48,-1.03,;34.15,1.29,;34.15,-3.34,;34.15,-4.88,;35.49,-2.57,;36.82,-3.34,;36.82,-4.88,;38.16,-5.65,;39.5,-4.87,;40.83,-5.65,;40.84,-7.18,;39.5,-7.95,;38.16,-7.19,;38.16,-2.57,;39.49,-3.33,;38.16,-1.02,)| InChI=1S/C78H95N17O13/c1-5-6-25-59(71(102)95-66(40-67(97)98)77(108)90-61(68(80)99)34-47-18-9-7-10-19-47)88-75(106)64(37-52-41-85-58-26-16-15-24-55(52)58)93-72(103)60(27-17-30-84-78(81)82)89-73(104)63(36-49-28-29-50-22-13-14-23-51(50)33-49)92-76(107)65(38-53-42-83-43-86-53)94-74(105)62(35-48-20-11-8-12-21-48)91-69(100)46(4)87-70(101)57(79)39-56-44(2)31-54(96)32-45(56)3/h7-16,18-24,26,28-29,31-33,41-43,46,57,59-66,85,96H,5-6,17,25,27,30,34-40,79H2,1-4H3,(H2,80,99)(H,83,86)(H,87,101)(H,88,106)(H,89,104)(H,90,108)(H,91,100)(H,92,107)(H,93,103)(H,94,105)(H,95,102)(H,97,98)(H4,81,82,84) JMDKMESJXNSGPX-UHFFFAOYSA-N 50321605 (6R,9S,12S,15R,18S,21S,24S,27S)-12-((1H-imidazol-5-yl)methyl)-21-((1H-indol-3-yl)methyl)-27-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-9-benzyl-24-butyl-18-(3-guanidinopropyl)-1-(4-hydroxy-2,6-dimethylphenyl)-6-methyl-15-(naphthalen-2-ylmethyl)-4,7,10,13,16,19,22,25-octaoxo-3,5,8,11,14,17,20,23,26-nonaazanonacosan-29-oic acid::CHEMBL1172428 Delta-type opioid receptor Homo sapiens 3.7 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321605 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321605&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933505 104143134 CHEMBL1172428 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 50213872 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C78H94N18O14/c1-3-4-23-58(71(104)96-65(40-67(99)100)77(110)92-60(68(80)101)35-46-16-7-5-8-17-46)90-75(108)63(38-52-41-85-57-24-14-13-22-55(52)57)94-72(105)59(25-15-32-84-78(81)82)91-74(107)62(37-49-26-29-50-20-11-12-21-51(50)33-49)93-76(109)64(39-53-42-83-44-87-53)95-73(106)61(36-47-18-9-6-10-19-47)89-66(98)43-86-69(102)45(2)88-70(103)56(79)34-48-27-30-54(97)31-28-48/h5-14,16-22,24,26-31,33,41-42,44-45,56,58-65,85,97H,3-4,15,23,25,32,34-40,43,79H2,1-2H3,(H2,80,101)(H,83,87)(H,86,102)(H,88,103)(H,89,98)(H,90,108)(H,91,107)(H,92,110)(H,93,109)(H,94,105)(H,95,106)(H,96,104)(H,99,100)(H4,81,82,84) ZZVLKHHSRQKCEV-UHFFFAOYSA-N 50321607 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxyphenyl)-27-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172252 Cholecystokinin receptor type A Homo sapiens 9.0 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321607 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2125&target=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321607&enzyme=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search 49798112 104143136 CHEMBL1172252 1 MDVVDSLLVNGSNITPPCELGLENETLFCLDQPRPSKEWQPAVQILLYSLIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLLKDFIFGSAVCKTTTYFMGTSVSVSTFNLVAISLERYGAICKPLQSRVWQTKSHALKVIAATWCLSFTIMTPYPIYSNLVPFTKNNNQTANMCRFLLPNDVMQQSWHTFLLLILFLIPGIVMMVAYGLISLELYQGIKFEASQKKSAKERKPSTTSSGKYEDSDGCYLQKTRPPRKLELRQLSTGSSSRANRIRSNSSAANLMAKKRVIRMLIVIVVLFFLCWMPIFSANAWRAYDTASAERRLSGTPISFILLLSYTSSCVNPIIYCFMNKRFRLGFMATFPCCPNPGPPGARGEVGEEEEGGTTGASLSRFSYSHMSASVPPQ 7XOV,7XOU,7EZM,7EZK,7EZH,7MBX,7MBY Cholecystokinin receptor type A CCKAR_HUMAN P32238 B2R9Z5 50213873 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:8.20,58.71,93.99,78.84,wD:73.79,48.59,22.31,33.48,4.4,101.107,(24.59,-5.48,;25.93,-4.72,;25.93,-3.18,;24.59,-2.4,;24.59,-.86,;23.26,-.1,;21.93,-.87,;21.93,-2.41,;20.59,-.11,;20.59,1.44,;22,2.07,;23.25,1.19,;24.48,2.12,;23.98,3.58,;24.73,4.92,;23.94,6.24,;22.4,6.22,;21.65,4.87,;22.44,3.55,;19.25,-.87,;17.91,-.12,;17.91,1.43,;16.57,-.89,;16.57,-2.43,;17.91,-3.2,;17.91,-4.73,;19.24,-5.51,;19.24,-7.05,;17.93,-7.8,;20.61,-7.81,;15.25,-.1,;13.92,-.87,;13.92,-2.41,;12.59,-.1,;12.6,1.44,;13.92,2.21,;15.26,1.44,;16.59,2.21,;16.6,3.75,;17.93,4.53,;17.92,6.07,;16.58,6.84,;15.25,6.06,;15.26,4.52,;13.92,3.75,;11.26,-.86,;9.92,-.1,;9.92,1.45,;8.58,-.87,;8.58,-2.41,;9.92,-3.18,;11.32,-2.55,;12.36,-3.69,;11.59,-5.03,;10.08,-4.71,;7.25,-.09,;5.91,-.85,;5.91,-2.39,;4.58,-.08,;4.58,1.46,;5.91,2.23,;7.25,1.47,;8.58,2.24,;8.58,3.78,;7.24,4.55,;5.91,3.78,;3.25,-.85,;1.92,-.07,;1.92,1.47,;.58,-.85,;-.75,-.07,;-2.08,-.85,;-2.08,-2.38,;-3.41,-.07,;-3.41,1.47,;-4.75,-.84,;-6.09,-.08,;-6.09,1.47,;-7.42,-.86,;-7.4,-2.4,;-8.75,-.1,;-10.08,-.88,;-10.06,-2.42,;-8.72,-3.17,;-11.4,-3.2,;-12.73,-2.44,;-14.07,-3.22,;-12.76,-.9,;-11.41,-.13,;-11.43,1.41,;25.93,-.09,;25.93,1.45,;27.26,-.87,;28.59,-.09,;28.59,1.45,;29.93,2.21,;31.25,1.45,;29.93,3.76,;29.93,-.87,;29.93,-2.4,;31.26,-.1,;32.6,-.87,;32.6,-2.4,;33.93,-3.17,;35.28,-2.4,;36.61,-3.17,;36.61,-4.71,;35.27,-5.48,;33.94,-4.71,;33.93,-.1,;35.27,-.86,;33.93,1.45,)| InChI=1S/C80H98N18O14/c1-5-6-25-60(73(106)98-67(40-69(101)102)79(112)94-62(70(82)103)34-48-18-9-7-10-19-48)92-77(110)65(37-53-41-87-59-26-16-15-24-56(53)59)96-74(107)61(27-17-30-86-80(83)84)93-76(109)64(36-50-28-29-51-22-13-14-23-52(51)33-50)95-78(111)66(38-54-42-85-44-89-54)97-75(108)63(35-49-20-11-8-12-21-49)91-68(100)43-88-71(104)47(4)90-72(105)58(81)39-57-45(2)31-55(99)32-46(57)3/h7-16,18-24,26,28-29,31-33,41-42,44,47,58,60-67,87,99H,5-6,17,25,27,30,34-40,43,81H2,1-4H3,(H2,82,103)(H,85,89)(H,88,104)(H,90,105)(H,91,100)(H,92,110)(H,93,109)(H,94,112)(H,95,111)(H,96,107)(H,97,108)(H,98,106)(H,101,102)(H4,83,84,86) AHRZYQWKXXBNHK-UHFFFAOYSA-N 50321606 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxy-2,6-dimethylphenyl)-27-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172253 Delta-type opioid receptor Homo sapiens 0.398107 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321606 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321606&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933506 104143135 CHEMBL1172253 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 50213874 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:33.48,22.31,4.4,48.59,93.100,wD:70.77,58.62,8.20,85.92,(16.65,-3.98,;15.32,-4.75,;15.32,-6.29,;13.98,-7.06,;13.98,-8.6,;12.65,-9.36,;11.32,-8.59,;11.32,-7.05,;9.99,-9.35,;9.99,-10.9,;11.32,-11.67,;12.72,-11.05,;13.76,-12.19,;12.98,-13.52,;13.46,-14.99,;12.42,-16.14,;10.92,-15.81,;10.44,-14.35,;11.48,-13.21,;8.66,-8.59,;7.33,-9.38,;7.33,-10.92,;6,-8.61,;6,-7.07,;7.33,-6.3,;7.33,-4.76,;8.66,-3.97,;8.68,-2.43,;7.33,-1.66,;10,-1.66,;4.65,-9.35,;3.32,-8.59,;3.32,-7.05,;1.99,-9.36,;1.76,-10.89,;2.96,-11.84,;2.73,-13.37,;3.92,-14.33,;5.36,-13.77,;6.57,-14.74,;8.01,-14.17,;8.23,-12.64,;7.03,-11.68,;5.59,-12.24,;4.39,-11.29,;.66,-8.58,;-.66,-9.38,;-.66,-10.92,;-2,-8.61,;-2,-7.07,;-.66,-6.29,;.75,-6.93,;1.79,-5.78,;1.01,-4.45,;-.5,-4.76,;-3.33,-9.38,;-4.67,-8.61,;-4.67,-7.07,;-6,-9.38,;-7.33,-8.62,;-8.66,-9.39,;-9.99,-8.62,;-11.33,-9.39,;-11.33,-10.93,;-9.99,-11.69,;-8.66,-10.92,;-7.33,-11.7,;-6,-10.91,;-4.66,-11.68,;-3.33,-10.91,;-4.66,-13.22,;-5.99,-13.99,;-3.32,-13.99,;-3.32,-15.53,;-4.65,-16.3,;-5.98,-15.53,;-4.65,-17.84,;-3.31,-18.61,;-3.31,-20.15,;-1.98,-17.84,;-1.98,-16.29,;-.65,-15.52,;15.32,-9.37,;15.32,-10.91,;16.65,-8.59,;17.98,-9.36,;17.98,-10.91,;19.32,-11.67,;20.64,-10.9,;19.32,-13.21,;19.32,-8.59,;19.32,-7.05,;20.65,-9.36,;21.98,-8.59,;21.98,-7.05,;23.31,-6.28,;24.65,-7.06,;25.98,-6.29,;25.99,-4.75,;24.65,-3.98,;23.32,-4.75,;23.31,-9.36,;24.65,-8.59,;23.31,-10.91,)| InChI=1S/C76H90N16O12/c1-4-5-23-58(68(97)90-64(38-66(94)95)73(102)87-60(67(78)96)32-45-16-7-6-8-17-45)85-71(100)62(34-51-39-83-57-24-14-13-22-54(51)57)89-69(98)59(25-15-28-82-76(79)80)86-70(99)61(33-46-26-27-47-18-9-10-19-48(47)31-46)88-72(101)63(36-52-40-81-42-84-52)91-74(103)65-35-49-20-11-12-21-50(49)41-92(65)75(104)56(77)37-55-43(2)29-53(93)30-44(55)3/h6-14,16-22,24,26-27,29-31,39-40,42,56,58-65,83,93H,4-5,15,23,25,28,32-38,41,77H2,1-3H3,(H2,78,96)(H,81,84)(H,85,100)(H,86,99)(H,87,102)(H,88,101)(H,89,98)(H,90,97)(H,91,103)(H,94,95)(H4,79,80,82) TVINVHGLLFLSBP-UHFFFAOYSA-N 50321597 (3S,6R,9S,12S,15S,18S)-3-((1H-imidazol-5-yl)methyl)-12-((1H-indol-3-yl)methyl)-18-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-1-((R)-2-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-15-butyl-9-(3-guanidinopropyl)-6-(naphthalen-2-ylmethyl)-1,4,7,10,13,16-hexaoxo-2,5,8,11,14,17-hexaazaicosan-20-oic acid::CHEMBL1172249 Cholecystokinin receptor type A Homo sapiens 32 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321597 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2125&target=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321597&enzyme=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search 91933500 104143126 CHEMBL1172249 1 MDVVDSLLVNGSNITPPCELGLENETLFCLDQPRPSKEWQPAVQILLYSLIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLLKDFIFGSAVCKTTTYFMGTSVSVSTFNLVAISLERYGAICKPLQSRVWQTKSHALKVIAATWCLSFTIMTPYPIYSNLVPFTKNNNQTANMCRFLLPNDVMQQSWHTFLLLILFLIPGIVMMVAYGLISLELYQGIKFEASQKKSAKERKPSTTSSGKYEDSDGCYLQKTRPPRKLELRQLSTGSSSRANRIRSNSSAANLMAKKRVIRMLIVIVVLFFLCWMPIFSANAWRAYDTASAERRLSGTPISFILLLSYTSSCVNPIIYCFMNKRFRLGFMATFPCCPNPGPPGARGEVGEEEEGGTTGASLSRFSYSHMSASVPPQ 7XOV,7XOU,7EZM,7EZK,7EZH,7MBX,7MBY Cholecystokinin receptor type A CCKAR_HUMAN P32238 B2R9Z5 50213875 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C78H94N18O14/c1-3-4-23-58(71(104)96-65(40-67(99)100)77(110)92-60(68(80)101)35-46-16-7-5-8-17-46)90-75(108)63(38-52-41-85-57-24-14-13-22-55(52)57)94-72(105)59(25-15-32-84-78(81)82)91-74(107)62(37-49-26-29-50-20-11-12-21-51(50)33-49)93-76(109)64(39-53-42-83-44-87-53)95-73(106)61(36-47-18-9-6-10-19-47)89-66(98)43-86-69(102)45(2)88-70(103)56(79)34-48-27-30-54(97)31-28-48/h5-14,16-22,24,26-31,33,41-42,44-45,56,58-65,85,97H,3-4,15,23,25,32,34-40,43,79H2,1-2H3,(H2,80,101)(H,83,87)(H,86,102)(H,88,103)(H,89,98)(H,90,108)(H,91,107)(H,92,110)(H,93,109)(H,94,105)(H,95,106)(H,96,104)(H,99,100)(H4,81,82,84) ZZVLKHHSRQKCEV-UHFFFAOYSA-N 50321607 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxyphenyl)-27-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172252 Delta-type opioid receptor Homo sapiens 6.3 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321607 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321607&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798112 104143136 CHEMBL1172252 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 50213876 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](N)Cc1ccccc1)C(N)=O |r,wU:58.63,8.20,wD:22.31,33.48,48.59,4.4,(22.78,-12.38,;21.45,-11.61,;21.45,-10.08,;20.11,-9.3,;20.11,-7.76,;18.78,-6.99,;17.44,-7.76,;17.44,-9.3,;16.11,-7,;16.11,-5.45,;17.56,-4.97,;18.82,-5.85,;20.05,-4.93,;19.56,-3.47,;20.31,-2.13,;19.53,-.81,;17.99,-.83,;17.23,-2.16,;18.02,-3.49,;14.76,-7.76,;13.43,-6.99,;13.43,-5.44,;12.09,-7.76,;12.09,-9.29,;13.43,-10.06,;13.43,-11.6,;14.76,-12.37,;14.77,-13.91,;13.42,-14.67,;16.1,-14.68,;10.76,-6.98,;9.43,-7.76,;9.43,-9.29,;8.11,-6.99,;7.8,-5.48,;8.95,-4.46,;8.64,-2.95,;9.79,-1.93,;11.25,-2.41,;12.4,-1.39,;13.86,-1.87,;14.17,-3.39,;13.02,-4.41,;11.56,-3.92,;10.41,-4.94,;6.77,-7.75,;5.43,-6.99,;5.43,-5.44,;4.1,-7.76,;4.1,-9.3,;5.55,-9.81,;6.83,-8.93,;8.05,-9.87,;7.53,-11.32,;5.99,-11.28,;2.76,-6.99,;1.44,-7.77,;1.44,-9.31,;.1,-7,;-1.24,-7.76,;.1,-5.46,;1.43,-4.69,;2.76,-5.45,;4.1,-4.68,;4.1,-3.14,;2.76,-2.38,;1.43,-3.15,;21.45,-6.99,;22.78,-7.77,;21.45,-5.45,)| InChI=1S/C51H63N13O6/c1-2-3-17-40(45(53)65)60-49(69)43(26-35-28-58-39-18-10-9-16-37(35)39)64-47(67)41(19-11-22-57-51(54)55)61-48(68)42(25-32-20-21-33-14-7-8-15-34(33)23-32)63-50(70)44(27-36-29-56-30-59-36)62-46(66)38(52)24-31-12-5-4-6-13-31/h4-10,12-16,18,20-21,23,28-30,38,40-44,58H,2-3,11,17,19,22,24-27,52H2,1H3,(H2,53,65)(H,56,59)(H,60,69)(H,61,68)(H,62,66)(H,63,70)(H,64,67)(H4,54,55,57) XXLABAZYHFXNHA-UHFFFAOYSA-N 50321603 (S)-2-((2S,5S,8R,11S,14S)-11-((1H-imidazol-5-yl)methyl)-2-((1H-indol-3-yl)methyl)-14-amino-5-(3-guanidinopropyl)-8-(naphthalen-2-ylmethyl)-4,7,10,13-tetraoxo-15-phenyl-3,6,9,12-tetraazapentadecanamido)hexanamide::CHEMBL1172619 Melanocortin receptor 4 Homo sapiens 200 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321603 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6546&target=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321603&enzyme=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 49798149 104143132 CHEMBL1172619 1 MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY 8QJ2,9K3K,7F58,7F55,7F54,7F53,7PIV,7PIU,7AUE Melanocortin receptor 4 MC4R_HUMAN P32245 B2RAC3 Q16317 Q3MIJ6 50213877 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C74H92N18O14/c1-3-4-24-54(67(100)92-61(38-63(95)96)73(106)88-56(64(76)97)33-44-17-8-5-9-18-44)86-71(104)59(36-48-39-81-53-25-15-14-23-51(48)53)90-68(101)55(26-16-31-80-74(77)78)87-70(103)58(35-46-21-12-7-13-22-46)89-72(105)60(37-49-40-79-42-83-49)91-69(102)57(34-45-19-10-6-11-20-45)85-62(94)41-82-65(98)43(2)84-66(99)52(75)32-47-27-29-50(93)30-28-47/h5-15,17-23,25,27-30,39-40,42-43,52,54-61,81,93H,3-4,16,24,26,31-38,41,75H2,1-2H3,(H2,76,97)(H,79,83)(H,82,98)(H,84,99)(H,85,94)(H,86,104)(H,87,103)(H,88,106)(H,89,105)(H,90,101)(H,91,102)(H,92,100)(H,95,96)(H4,77,78,80) ZUUGDHAKGUQZKD-UHFFFAOYSA-N 50321608 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-15,21-dibenzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxyphenyl)-27-methyl-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172251 Delta-type opioid receptor Homo sapiens 6.2 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321608 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321608&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798111 104143137 CHEMBL1172251 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 50914699 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CCC(=O)N(C1CCN(CCc2ccccc2)CC1)c1ccccc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C74H92N16O11/c1-2-3-28-57(68(96)88-63(44-66(93)94)73(101)85-59(67(75)95)40-49-21-10-5-11-22-49)83-71(99)61(42-51-45-80-56-29-17-16-27-55(51)56)87-69(97)58(30-18-36-79-74(76)77)84-70(98)60(41-50-23-12-6-13-24-50)86-72(100)62(43-52-46-78-47-81-52)82-64(91)31-32-65(92)90(53-25-14-7-15-26-53)54-34-38-89(39-35-54)37-33-48-19-8-4-9-20-48/h4-17,19-27,29,45-47,54,57-63,80H,2-3,18,28,30-44H2,1H3,(H2,75,95)(H,78,81)(H,82,91)(H,83,99)(H,84,98)(H,85,101)(H,86,100)(H,87,97)(H,88,96)(H,93,94)(H4,76,77,79) WVNNVFIQARDNCG-UHFFFAOYSA-N 50321602 (3S,6S,9S,12S,15R,18S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-15-benzyl-6-butyl-12-(3-guanidinopropyl)-5,8,11,14,17,20,23-heptaoxo-23-((1-phenethylpiperidin-4-yl)(phenyl)amino)-4,7,10,13,16,19-hexaazatricosan-1-oic acid::CHEMBL1172244 Gastrin/cholecystokinin type B receptor Homo sapiens 160 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321602 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2126&target=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321602&enzyme=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798104 104143131 CHEMBL1172244 1 MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG 8IA7,7XOW Gastrin/cholecystokinin type B receptor GASR_HUMAN P32239 A8K7P9 O75824 Q16144 Q92492 Q96LC6 Q9NYK7 Q9UBV1 50914700 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CCC(=O)N(C1CCN(CCc2ccccc2)CC1)c1ccccc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C74H92N16O11/c1-2-3-28-57(68(96)88-63(44-66(93)94)73(101)85-59(67(75)95)40-49-21-10-5-11-22-49)83-71(99)61(42-51-45-80-56-29-17-16-27-55(51)56)87-69(97)58(30-18-36-79-74(76)77)84-70(98)60(41-50-23-12-6-13-24-50)86-72(100)62(43-52-46-78-47-81-52)82-64(91)31-32-65(92)90(53-25-14-7-15-26-53)54-34-38-89(39-35-54)37-33-48-19-8-4-9-20-48/h4-17,19-27,29,45-47,54,57-63,80H,2-3,18,28,30-44H2,1H3,(H2,75,95)(H,78,81)(H,82,91)(H,83,99)(H,84,98)(H,85,101)(H,86,100)(H,87,97)(H,88,96)(H,93,94)(H4,76,77,79) WVNNVFIQARDNCG-UHFFFAOYSA-N 50321602 (3S,6S,9S,12S,15R,18S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-15-benzyl-6-butyl-12-(3-guanidinopropyl)-5,8,11,14,17,20,23-heptaoxo-23-((1-phenethylpiperidin-4-yl)(phenyl)amino)-4,7,10,13,16,19-hexaazatricosan-1-oic acid::CHEMBL1172244 Cholecystokinin receptor type A Homo sapiens >10000 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321602 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2125&target=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321602&enzyme=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search 49798104 104143131 CHEMBL1172244 1 MDVVDSLLVNGSNITPPCELGLENETLFCLDQPRPSKEWQPAVQILLYSLIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLLKDFIFGSAVCKTTTYFMGTSVSVSTFNLVAISLERYGAICKPLQSRVWQTKSHALKVIAATWCLSFTIMTPYPIYSNLVPFTKNNNQTANMCRFLLPNDVMQQSWHTFLLLILFLIPGIVMMVAYGLISLELYQGIKFEASQKKSAKERKPSTTSSGKYEDSDGCYLQKTRPPRKLELRQLSTGSSSRANRIRSNSSAANLMAKKRVIRMLIVIVVLFFLCWMPIFSANAWRAYDTASAERRLSGTPISFILLLSYTSSCVNPIIYCFMNKRFRLGFMATFPCCPNPGPPGARGEVGEEEEGGTTGASLSRFSYSHMSASVPPQ 7XOV,7XOU,7EZM,7EZK,7EZH,7MBX,7MBY Cholecystokinin receptor type A CCKAR_HUMAN P32238 B2R9Z5 50914701 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CCC(=O)N(C1CCN(CCc2ccccc2)CC1)c1ccccc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C74H92N16O11/c1-2-3-28-57(68(96)88-63(44-66(93)94)73(101)85-59(67(75)95)40-49-21-10-5-11-22-49)83-71(99)61(42-51-45-80-56-29-17-16-27-55(51)56)87-69(97)58(30-18-36-79-74(76)77)84-70(98)60(41-50-23-12-6-13-24-50)86-72(100)62(43-52-46-78-47-81-52)82-64(91)31-32-65(92)90(53-25-14-7-15-26-53)54-34-38-89(39-35-54)37-33-48-19-8-4-9-20-48/h4-17,19-27,29,45-47,54,57-63,80H,2-3,18,28,30-44H2,1H3,(H2,75,95)(H,78,81)(H,82,91)(H,83,99)(H,84,98)(H,85,101)(H,86,100)(H,87,97)(H,88,96)(H,93,94)(H4,76,77,79) WVNNVFIQARDNCG-UHFFFAOYSA-N 50321602 (3S,6S,9S,12S,15R,18S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-15-benzyl-6-butyl-12-(3-guanidinopropyl)-5,8,11,14,17,20,23-heptaoxo-23-((1-phenethylpiperidin-4-yl)(phenyl)amino)-4,7,10,13,16,19-hexaazatricosan-1-oic acid::CHEMBL1172244 Mu-type opioid receptor Rattus norvegicus 1240 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321602 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321602&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798104 104143131 CHEMBL1172244 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50914703 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](N)Cc1ccccc1)C(N)=O |r,wU:58.63,8.20,wD:22.31,33.48,48.59,4.4,(22.78,-12.38,;21.45,-11.61,;21.45,-10.08,;20.11,-9.3,;20.11,-7.76,;18.78,-6.99,;17.44,-7.76,;17.44,-9.3,;16.11,-7,;16.11,-5.45,;17.56,-4.97,;18.82,-5.85,;20.05,-4.93,;19.56,-3.47,;20.31,-2.13,;19.53,-.81,;17.99,-.83,;17.23,-2.16,;18.02,-3.49,;14.76,-7.76,;13.43,-6.99,;13.43,-5.44,;12.09,-7.76,;12.09,-9.29,;13.43,-10.06,;13.43,-11.6,;14.76,-12.37,;14.77,-13.91,;13.42,-14.67,;16.1,-14.68,;10.76,-6.98,;9.43,-7.76,;9.43,-9.29,;8.11,-6.99,;7.8,-5.48,;8.95,-4.46,;8.64,-2.95,;9.79,-1.93,;11.25,-2.41,;12.4,-1.39,;13.86,-1.87,;14.17,-3.39,;13.02,-4.41,;11.56,-3.92,;10.41,-4.94,;6.77,-7.75,;5.43,-6.99,;5.43,-5.44,;4.1,-7.76,;4.1,-9.3,;5.55,-9.81,;6.83,-8.93,;8.05,-9.87,;7.53,-11.32,;5.99,-11.28,;2.76,-6.99,;1.44,-7.77,;1.44,-9.31,;.1,-7,;-1.24,-7.76,;.1,-5.46,;1.43,-4.69,;2.76,-5.45,;4.1,-4.68,;4.1,-3.14,;2.76,-2.38,;1.43,-3.15,;21.45,-6.99,;22.78,-7.77,;21.45,-5.45,)| InChI=1S/C51H63N13O6/c1-2-3-17-40(45(53)65)60-49(69)43(26-35-28-58-39-18-10-9-16-37(35)39)64-47(67)41(19-11-22-57-51(54)55)61-48(68)42(25-32-20-21-33-14-7-8-15-34(33)23-32)63-50(70)44(27-36-29-56-30-59-36)62-46(66)38(52)24-31-12-5-4-6-13-31/h4-10,12-16,18,20-21,23,28-30,38,40-44,58H,2-3,11,17,19,22,24-27,52H2,1H3,(H2,53,65)(H,56,59)(H,60,69)(H,61,68)(H,62,66)(H,63,70)(H,64,67)(H4,54,55,57) XXLABAZYHFXNHA-UHFFFAOYSA-N 50321603 (S)-2-((2S,5S,8R,11S,14S)-11-((1H-imidazol-5-yl)methyl)-2-((1H-indol-3-yl)methyl)-14-amino-5-(3-guanidinopropyl)-8-(naphthalen-2-ylmethyl)-4,7,10,13-tetraoxo-15-phenyl-3,6,9,12-tetraazapentadecanamido)hexanamide::CHEMBL1172619 Melanocortin receptor 4 Homo sapiens 200 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321603 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6546&target=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321603&enzyme=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 49798149 104143132 CHEMBL1172619 1 MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY 8QJ2,9K3K,7F58,7F55,7F54,7F53,7PIV,7PIU,7AUE Melanocortin receptor 4 MC4R_HUMAN P32245 B2RAC3 Q16317 Q3MIJ6 50914704 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:58.71,74.80,8.20,87.93,69.75,wD:48.59,22.31,4.4,33.48,95.101,(27.14,-11.6,;25.81,-10.83,;25.81,-9.29,;24.47,-8.52,;24.47,-6.97,;23.14,-6.2,;21.8,-6.97,;21.8,-8.5,;20.47,-6.2,;20.47,-4.66,;21.89,-4.07,;23.12,-5,;24.38,-4.1,;23.93,-2.63,;24.71,-1.31,;23.96,.04,;22.43,.05,;21.64,-1.26,;22.38,-2.61,;19.13,-6.97,;17.8,-6.2,;17.8,-4.66,;16.46,-6.97,;16.46,-8.51,;17.8,-9.28,;17.8,-10.82,;19.14,-11.58,;19.13,-13.12,;17.8,-13.89,;20.46,-13.9,;15.12,-6.21,;13.78,-6.97,;13.78,-8.51,;12.45,-6.2,;12.42,-4.66,;13.74,-3.87,;15.09,-4.61,;16.4,-3.81,;16.37,-2.28,;17.69,-1.49,;17.67,.05,;16.32,.8,;15,.01,;15.03,-1.52,;13.71,-2.32,;11.12,-6.97,;9.78,-6.21,;9.78,-4.66,;8.44,-6.98,;8.44,-8.51,;9.78,-9.29,;11.18,-8.65,;12.21,-9.8,;11.45,-11.14,;9.94,-10.82,;7.1,-6.21,;5.76,-6.97,;5.76,-8.5,;4.43,-6.2,;4.43,-4.66,;5.76,-3.89,;7.1,-4.65,;8.42,-3.88,;8.42,-2.34,;7.09,-1.57,;5.75,-2.34,;3.1,-6.99,;1.76,-6.22,;1.76,-4.68,;.42,-6.99,;.42,-8.53,;-.9,-6.21,;-2.25,-6.97,;-2.25,-8.51,;-3.58,-6.2,;-4.91,-6.98,;-3.58,-4.66,;-2.25,-3.89,;-.92,-4.66,;.41,-3.89,;.4,-2.35,;1.77,-1.59,;-.92,-1.58,;-2.25,-2.35,;25.81,-6.21,;25.81,-4.67,;27.15,-6.98,;28.48,-6.21,;28.48,-4.66,;29.82,-3.89,;31.15,-4.66,;29.82,-2.35,;29.82,-6.97,;29.82,-8.51,;31.15,-6.2,;32.49,-6.97,;32.49,-8.5,;33.83,-9.28,;35.16,-8.5,;36.5,-9.28,;36.5,-10.82,;35.16,-11.58,;33.83,-10.81,;33.83,-6.2,;35.15,-6.96,;33.83,-4.65,)| InChI=1S/C76H91N17O13/c1-3-4-23-57(69(100)93-64(40-65(95)96)75(106)88-59(66(78)97)35-45-16-7-5-8-17-45)86-73(104)62(38-51-41-83-56-24-14-13-22-54(51)56)91-70(101)58(25-15-32-82-76(79)80)87-71(102)61(37-48-26-29-49-20-11-12-21-50(49)33-48)90-74(105)63(39-52-42-81-43-84-52)92-72(103)60(36-46-18-9-6-10-19-46)89-67(98)44(2)85-68(99)55(77)34-47-27-30-53(94)31-28-47/h5-14,16-22,24,26-31,33,41-44,55,57-64,83,94H,3-4,15,23,25,32,34-40,77H2,1-2H3,(H2,78,97)(H,81,84)(H,85,99)(H,86,104)(H,87,102)(H,88,106)(H,89,98)(H,90,105)(H,91,101)(H,92,103)(H,93,100)(H,95,96)(H4,79,80,82) NENKRICCIWXRGU-UHFFFAOYSA-N 50321604 (3S,6S,9S,12S,15R,18S,21S,24R,27S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-27-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-28-(4-hydroxyphenyl)-24-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26-octaoxo-4,7,10,13,16,19,22,25-octaazaoctacosan-1-oic acid::CHEMBL1172429 Melanocortin receptor 4 Homo sapiens 631 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321604 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6546&target=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321604&enzyme=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 91933504 104143133 CHEMBL1172429 1 MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY 8QJ2,9K3K,7F58,7F55,7F54,7F53,7PIV,7PIU,7AUE Melanocortin receptor 4 MC4R_HUMAN P32245 B2RAC3 Q16317 Q3MIJ6 50914705 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:69.75,8.20,58.71,89.95,wD:48.59,22.31,33.48,4.4,97.103,74.80,(28.82,-7.95,;30.15,-7.19,;30.15,-5.65,;28.82,-4.88,;28.82,-3.34,;27.48,-2.57,;26.15,-3.35,;26.15,-4.89,;24.82,-2.58,;24.82,-1.03,;26.22,-.4,;27.48,-1.28,;28.71,-.35,;28.21,1.11,;28.95,2.45,;28.16,3.77,;26.62,3.74,;25.87,2.4,;26.66,1.08,;23.48,-3.34,;22.13,-2.59,;22.13,-1.04,;20.8,-3.36,;20.8,-4.9,;22.13,-5.67,;22.13,-7.21,;23.47,-7.98,;23.47,-9.52,;22.16,-10.27,;24.84,-10.28,;19.47,-2.57,;18.15,-3.35,;18.15,-4.88,;16.82,-2.57,;16.82,-1.03,;18.15,-.26,;19.48,-1.03,;20.81,-.26,;20.82,1.28,;22.15,2.06,;22.15,3.6,;20.8,4.36,;19.47,3.58,;19.48,2.05,;18.14,1.28,;15.48,-3.33,;14.14,-2.57,;14.14,-1.02,;12.8,-3.34,;12.8,-4.88,;14.14,-5.65,;15.55,-5.02,;16.59,-6.17,;15.81,-7.5,;14.31,-7.18,;11.47,-2.57,;10.13,-3.32,;10.13,-4.86,;8.81,-2.55,;8.81,-1.01,;10.13,-.25,;11.47,-1.01,;12.81,-.24,;12.8,1.31,;11.47,2.07,;10.14,1.3,;7.47,-3.33,;6.13,-2.55,;6.13,-1.01,;4.8,-3.33,;4.8,-4.87,;3.47,-2.56,;2.12,-3.32,;2.13,-4.86,;.8,-2.54,;.81,-1,;-.54,-3.3,;-1.86,-2.52,;-1.85,-.98,;-.51,-.23,;-3.18,-.2,;-4.52,-.96,;-5.84,-.18,;-4.53,-2.49,;-3.2,-3.27,;-3.21,-4.81,;30.15,-2.57,;30.15,-1.03,;31.49,-3.34,;32.82,-2.57,;32.82,-1.02,;34.15,-.26,;35.48,-1.03,;34.15,1.29,;34.15,-3.34,;34.15,-4.88,;35.49,-2.57,;36.82,-3.34,;36.82,-4.88,;38.16,-5.65,;39.5,-4.87,;40.83,-5.65,;40.84,-7.18,;39.5,-7.95,;38.16,-7.19,;38.16,-2.57,;39.49,-3.33,;38.16,-1.02,)| InChI=1S/C78H95N17O13/c1-5-6-25-59(71(102)95-66(40-67(97)98)77(108)90-61(68(80)99)34-47-18-9-7-10-19-47)88-75(106)64(37-52-41-85-58-26-16-15-24-55(52)58)93-72(103)60(27-17-30-84-78(81)82)89-73(104)63(36-49-28-29-50-22-13-14-23-51(50)33-49)92-76(107)65(38-53-42-83-43-86-53)94-74(105)62(35-48-20-11-8-12-21-48)91-69(100)46(4)87-70(101)57(79)39-56-44(2)31-54(96)32-45(56)3/h7-16,18-24,26,28-29,31-33,41-43,46,57,59-66,85,96H,5-6,17,25,27,30,34-40,79H2,1-4H3,(H2,80,99)(H,83,86)(H,87,101)(H,88,106)(H,89,104)(H,90,108)(H,91,100)(H,92,107)(H,93,103)(H,94,105)(H,95,102)(H,97,98)(H4,81,82,84) JMDKMESJXNSGPX-UHFFFAOYSA-N 50321605 (6R,9S,12S,15R,18S,21S,24S,27S)-12-((1H-imidazol-5-yl)methyl)-21-((1H-indol-3-yl)methyl)-27-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-9-benzyl-24-butyl-18-(3-guanidinopropyl)-1-(4-hydroxy-2,6-dimethylphenyl)-6-methyl-15-(naphthalen-2-ylmethyl)-4,7,10,13,16,19,22,25-octaoxo-3,5,8,11,14,17,20,23,26-nonaazanonacosan-29-oic acid::CHEMBL1172428 Melanocortin receptor 4 Homo sapiens 501 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321605 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6546&target=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321605&enzyme=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 91933505 104143134 CHEMBL1172428 1 MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY 8QJ2,9K3K,7F58,7F55,7F54,7F53,7PIV,7PIU,7AUE Melanocortin receptor 4 MC4R_HUMAN P32245 B2RAC3 Q16317 Q3MIJ6 50914706 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:8.20,58.71,93.99,78.84,wD:73.79,48.59,22.31,33.48,4.4,101.107,(24.59,-5.48,;25.93,-4.72,;25.93,-3.18,;24.59,-2.4,;24.59,-.86,;23.26,-.1,;21.93,-.87,;21.93,-2.41,;20.59,-.11,;20.59,1.44,;22,2.07,;23.25,1.19,;24.48,2.12,;23.98,3.58,;24.73,4.92,;23.94,6.24,;22.4,6.22,;21.65,4.87,;22.44,3.55,;19.25,-.87,;17.91,-.12,;17.91,1.43,;16.57,-.89,;16.57,-2.43,;17.91,-3.2,;17.91,-4.73,;19.24,-5.51,;19.24,-7.05,;17.93,-7.8,;20.61,-7.81,;15.25,-.1,;13.92,-.87,;13.92,-2.41,;12.59,-.1,;12.6,1.44,;13.92,2.21,;15.26,1.44,;16.59,2.21,;16.6,3.75,;17.93,4.53,;17.92,6.07,;16.58,6.84,;15.25,6.06,;15.26,4.52,;13.92,3.75,;11.26,-.86,;9.92,-.1,;9.92,1.45,;8.58,-.87,;8.58,-2.41,;9.92,-3.18,;11.32,-2.55,;12.36,-3.69,;11.59,-5.03,;10.08,-4.71,;7.25,-.09,;5.91,-.85,;5.91,-2.39,;4.58,-.08,;4.58,1.46,;5.91,2.23,;7.25,1.47,;8.58,2.24,;8.58,3.78,;7.24,4.55,;5.91,3.78,;3.25,-.85,;1.92,-.07,;1.92,1.47,;.58,-.85,;-.75,-.07,;-2.08,-.85,;-2.08,-2.38,;-3.41,-.07,;-3.41,1.47,;-4.75,-.84,;-6.09,-.08,;-6.09,1.47,;-7.42,-.86,;-7.4,-2.4,;-8.75,-.1,;-10.08,-.88,;-10.06,-2.42,;-8.72,-3.17,;-11.4,-3.2,;-12.73,-2.44,;-14.07,-3.22,;-12.76,-.9,;-11.41,-.13,;-11.43,1.41,;25.93,-.09,;25.93,1.45,;27.26,-.87,;28.59,-.09,;28.59,1.45,;29.93,2.21,;31.25,1.45,;29.93,3.76,;29.93,-.87,;29.93,-2.4,;31.26,-.1,;32.6,-.87,;32.6,-2.4,;33.93,-3.17,;35.28,-2.4,;36.61,-3.17,;36.61,-4.71,;35.27,-5.48,;33.94,-4.71,;33.93,-.1,;35.27,-.86,;33.93,1.45,)| InChI=1S/C80H98N18O14/c1-5-6-25-60(73(106)98-67(40-69(101)102)79(112)94-62(70(82)103)34-48-18-9-7-10-19-48)92-77(110)65(37-53-41-87-59-26-16-15-24-56(53)59)96-74(107)61(27-17-30-86-80(83)84)93-76(109)64(36-50-28-29-51-22-13-14-23-52(51)33-50)95-78(111)66(38-54-42-85-44-89-54)97-75(108)63(35-49-20-11-8-12-21-49)91-68(100)43-88-71(104)47(4)90-72(105)58(81)39-57-45(2)31-55(99)32-46(57)3/h7-16,18-24,26,28-29,31-33,41-42,44,47,58,60-67,87,99H,5-6,17,25,27,30,34-40,43,81H2,1-4H3,(H2,82,103)(H,85,89)(H,88,104)(H,90,105)(H,91,100)(H,92,110)(H,93,109)(H,94,112)(H,95,111)(H,96,107)(H,97,108)(H,98,106)(H,101,102)(H4,83,84,86) AHRZYQWKXXBNHK-UHFFFAOYSA-N 50321606 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxy-2,6-dimethylphenyl)-27-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172253 Melanocortin receptor 4 Homo sapiens 158 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321606 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6546&target=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321606&enzyme=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 91933506 104143135 CHEMBL1172253 1 MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY 8QJ2,9K3K,7F58,7F55,7F54,7F53,7PIV,7PIU,7AUE Melanocortin receptor 4 MC4R_HUMAN P32245 B2RAC3 Q16317 Q3MIJ6 50914707 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C78H94N18O14/c1-3-4-23-58(71(104)96-65(40-67(99)100)77(110)92-60(68(80)101)35-46-16-7-5-8-17-46)90-75(108)63(38-52-41-85-57-24-14-13-22-55(52)57)94-72(105)59(25-15-32-84-78(81)82)91-74(107)62(37-49-26-29-50-20-11-12-21-51(50)33-49)93-76(109)64(39-53-42-83-44-87-53)95-73(106)61(36-47-18-9-6-10-19-47)89-66(98)43-86-69(102)45(2)88-70(103)56(79)34-48-27-30-54(97)31-28-48/h5-14,16-22,24,26-31,33,41-42,44-45,56,58-65,85,97H,3-4,15,23,25,32,34-40,43,79H2,1-2H3,(H2,80,101)(H,83,87)(H,86,102)(H,88,103)(H,89,98)(H,90,108)(H,91,107)(H,92,110)(H,93,109)(H,94,105)(H,95,106)(H,96,104)(H,99,100)(H4,81,82,84) ZZVLKHHSRQKCEV-UHFFFAOYSA-N 50321607 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxyphenyl)-27-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172252 Melanocortin receptor 4 Homo sapiens 251 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321607 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6546&target=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321607&enzyme=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 49798112 104143136 CHEMBL1172252 1 MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY 8QJ2,9K3K,7F58,7F55,7F54,7F53,7PIV,7PIU,7AUE Melanocortin receptor 4 MC4R_HUMAN P32245 B2RAC3 Q16317 Q3MIJ6 50914708 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C74H92N18O14/c1-3-4-24-54(67(100)92-61(38-63(95)96)73(106)88-56(64(76)97)33-44-17-8-5-9-18-44)86-71(104)59(36-48-39-81-53-25-15-14-23-51(48)53)90-68(101)55(26-16-31-80-74(77)78)87-70(103)58(35-46-21-12-7-13-22-46)89-72(105)60(37-49-40-79-42-83-49)91-69(102)57(34-45-19-10-6-11-20-45)85-62(94)41-82-65(98)43(2)84-66(99)52(75)32-47-27-29-50(93)30-28-47/h5-15,17-23,25,27-30,39-40,42-43,52,54-61,81,93H,3-4,16,24,26,31-38,41,75H2,1-2H3,(H2,76,97)(H,79,83)(H,82,98)(H,84,99)(H,85,94)(H,86,104)(H,87,103)(H,88,106)(H,89,105)(H,90,101)(H,91,102)(H,92,100)(H,95,96)(H4,77,78,80) ZUUGDHAKGUQZKD-UHFFFAOYSA-N 50321608 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-15,21-dibenzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxyphenyl)-27-methyl-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172251 Melanocortin receptor 4 Homo sapiens 1259 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321608 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6546&target=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321608&enzyme=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 49798111 104143137 CHEMBL1172251 1 MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY 8QJ2,9K3K,7F58,7F55,7F54,7F53,7PIV,7PIU,7AUE Melanocortin receptor 4 MC4R_HUMAN P32245 B2RAC3 Q16317 Q3MIJ6 50914709 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C76H90N16O12/c1-4-5-23-58(68(97)90-64(38-66(94)95)73(102)87-60(67(78)96)32-45-16-7-6-8-17-45)85-71(100)62(34-51-39-83-57-24-14-13-22-54(51)57)89-69(98)59(25-15-28-82-76(79)80)86-70(99)61(33-46-26-27-47-18-9-10-19-48(47)31-46)88-72(101)63(36-52-40-81-42-84-52)91-74(103)65-35-49-20-11-12-21-50(49)41-92(65)75(104)56(77)37-55-43(2)29-53(93)30-44(55)3/h6-14,16-22,24,26-27,29-31,39-40,42,56,58-65,83,93H,4-5,15,23,25,28,32-38,41,77H2,1-3H3,(H2,78,96)(H,81,84)(H,85,100)(H,86,99)(H,87,102)(H,88,101)(H,89,98)(H,90,97)(H,91,103)(H,94,95)(H4,79,80,82) TVINVHGLLFLSBP-UHFFFAOYSA-N 50321596 (3S,6R,9S,12S,15S,18S)-3-((1H-imidazol-5-yl)methyl)-12-((1H-indol-3-yl)methyl)-18-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-1-(2-((R)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-15-butyl-9-(3-guanidinopropyl)-6-(naphthalen-2-ylmethyl)-1,4,7,10,13,16-hexaoxo-2,5,8,11,14,17-hexaazaicosan-20-oic acid::CHEMBL2372623 Melanocortin receptor 4 Homo sapiens 251 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321596 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6546&target=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321596&enzyme=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 73354785 104143125 CHEMBL2372623 1 MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY 8QJ2,9K3K,7F58,7F55,7F54,7F53,7PIV,7PIU,7AUE Melanocortin receptor 4 MC4R_HUMAN P32245 B2RAC3 Q16317 Q3MIJ6 50914710 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:33.48,22.31,4.4,48.59,93.100,wD:70.77,58.62,8.20,85.92,(16.65,-3.98,;15.32,-4.75,;15.32,-6.29,;13.98,-7.06,;13.98,-8.6,;12.65,-9.36,;11.32,-8.59,;11.32,-7.05,;9.99,-9.35,;9.99,-10.9,;11.32,-11.67,;12.72,-11.05,;13.76,-12.19,;12.98,-13.52,;13.46,-14.99,;12.42,-16.14,;10.92,-15.81,;10.44,-14.35,;11.48,-13.21,;8.66,-8.59,;7.33,-9.38,;7.33,-10.92,;6,-8.61,;6,-7.07,;7.33,-6.3,;7.33,-4.76,;8.66,-3.97,;8.68,-2.43,;7.33,-1.66,;10,-1.66,;4.65,-9.35,;3.32,-8.59,;3.32,-7.05,;1.99,-9.36,;1.76,-10.89,;2.96,-11.84,;2.73,-13.37,;3.92,-14.33,;5.36,-13.77,;6.57,-14.74,;8.01,-14.17,;8.23,-12.64,;7.03,-11.68,;5.59,-12.24,;4.39,-11.29,;.66,-8.58,;-.66,-9.38,;-.66,-10.92,;-2,-8.61,;-2,-7.07,;-.66,-6.29,;.75,-6.93,;1.79,-5.78,;1.01,-4.45,;-.5,-4.76,;-3.33,-9.38,;-4.67,-8.61,;-4.67,-7.07,;-6,-9.38,;-7.33,-8.62,;-8.66,-9.39,;-9.99,-8.62,;-11.33,-9.39,;-11.33,-10.93,;-9.99,-11.69,;-8.66,-10.92,;-7.33,-11.7,;-6,-10.91,;-4.66,-11.68,;-3.33,-10.91,;-4.66,-13.22,;-5.99,-13.99,;-3.32,-13.99,;-3.32,-15.53,;-4.65,-16.3,;-5.98,-15.53,;-4.65,-17.84,;-3.31,-18.61,;-3.31,-20.15,;-1.98,-17.84,;-1.98,-16.29,;-.65,-15.52,;15.32,-9.37,;15.32,-10.91,;16.65,-8.59,;17.98,-9.36,;17.98,-10.91,;19.32,-11.67,;20.64,-10.9,;19.32,-13.21,;19.32,-8.59,;19.32,-7.05,;20.65,-9.36,;21.98,-8.59,;21.98,-7.05,;23.31,-6.28,;24.65,-7.06,;25.98,-6.29,;25.99,-4.75,;24.65,-3.98,;23.32,-4.75,;23.31,-9.36,;24.65,-8.59,;23.31,-10.91,)| InChI=1S/C76H90N16O12/c1-4-5-23-58(68(97)90-64(38-66(94)95)73(102)87-60(67(78)96)32-45-16-7-6-8-17-45)85-71(100)62(34-51-39-83-57-24-14-13-22-54(51)57)89-69(98)59(25-15-28-82-76(79)80)86-70(99)61(33-46-26-27-47-18-9-10-19-48(47)31-46)88-72(101)63(36-52-40-81-42-84-52)91-74(103)65-35-49-20-11-12-21-50(49)41-92(65)75(104)56(77)37-55-43(2)29-53(93)30-44(55)3/h6-14,16-22,24,26-27,29-31,39-40,42,56,58-65,83,93H,4-5,15,23,25,28,32-38,41,77H2,1-3H3,(H2,78,96)(H,81,84)(H,85,100)(H,86,99)(H,87,102)(H,88,101)(H,89,98)(H,90,97)(H,91,103)(H,94,95)(H4,79,80,82) TVINVHGLLFLSBP-UHFFFAOYSA-N 50321597 (3S,6R,9S,12S,15S,18S)-3-((1H-imidazol-5-yl)methyl)-12-((1H-indol-3-yl)methyl)-18-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-1-((R)-2-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-15-butyl-9-(3-guanidinopropyl)-6-(naphthalen-2-ylmethyl)-1,4,7,10,13,16-hexaoxo-2,5,8,11,14,17-hexaazaicosan-20-oic acid::CHEMBL1172249 Melanocortin receptor 4 Homo sapiens 160 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321597 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6546&target=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321597&enzyme=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 91933500 104143126 CHEMBL1172249 1 MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY 8QJ2,9K3K,7F58,7F55,7F54,7F53,7PIV,7PIU,7AUE Melanocortin receptor 4 MC4R_HUMAN P32245 B2RAC3 Q16317 Q3MIJ6 50914711 Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N1CC(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@H](Cc2ccc3ccccc3c2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CSSC[C@@H](N)C1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:69.84,89.95,29.31,10.11,wD:44.48,74.80,19.20,81.87,55.59,(1.42,-5.48,;.09,-4.71,;-1.25,-5.49,;-2.59,-4.72,;-3.92,-5.48,;-2.59,-3.17,;-1.25,-2.41,;-1.25,-.87,;.08,-3.17,;1.41,-2.4,;2.75,-3.17,;2.75,-4.71,;4.08,-2.39,;4.08,-.85,;5.42,-3.16,;6.02,-4.57,;5.09,-5.8,;3.56,-5.61,;5.68,-7.22,;4.75,-8.45,;3.42,-7.68,;2.08,-8.45,;.68,-7.83,;-.35,-8.98,;.42,-10.31,;1.93,-9.98,;4.75,-9.99,;3.42,-10.76,;6.09,-10.76,;6.09,-12.3,;4.75,-13.07,;4.75,-14.61,;6.08,-15.37,;6.09,-16.91,;4.75,-17.69,;4.75,-19.22,;3.42,-19.99,;2.08,-19.22,;2.09,-17.68,;3.42,-16.92,;3.42,-15.39,;7.42,-13.07,;7.42,-14.61,;8.75,-12.3,;10.09,-13.07,;10.09,-14.61,;8.75,-15.38,;8.75,-16.92,;7.42,-17.69,;7.42,-19.23,;6.09,-20,;8.75,-20,;11.42,-12.3,;12.75,-13.07,;11.42,-10.76,;12.75,-9.99,;14.09,-10.76,;15.42,-9.99,;15.57,-8.48,;17.08,-8.15,;17.86,-9.48,;19.37,-9.79,;19.85,-11.26,;18.82,-12.42,;17.3,-12.1,;16.82,-10.63,;12.75,-8.45,;11.42,-7.68,;14.09,-7.68,;14.09,-6.14,;12.75,-5.37,;12.75,-3.83,;10,-3.73,;8.47,-3.54,;7.88,-2.12,;8.81,-.89,;6.35,-1.93,;5.75,-.51,;15.42,-5.37,;16.75,-6.14,;15.42,-3.83,;16.75,-3.06,;18.09,-3.83,;19.42,-3.06,;19.42,-1.52,;20.76,-3.83,;16.75,-1.52,;15.42,-.75,;18.09,-.75,;18.09,.78,;16.75,1.55,;16.75,3.09,;18.09,3.85,;18.09,5.39,;16.76,6.16,;15.42,5.39,;15.43,3.86,;19.42,1.55,;19.42,3.09,;20.76,.78,)| InChI=1S/C68H81N17O13S2/c1-36-21-44(86)22-37(2)46(36)28-47(69)66(97)85-32-57(87)78-54(27-43-31-74-35-77-43)63(94)81-52(25-39-18-19-40-13-6-7-14-41(40)23-39)61(92)79-50(17-10-20-75-68(72)73)60(91)82-53(26-42-30-76-49-16-9-8-15-45(42)49)62(93)84-56(34-100-99-33-48(70)67(85)98)65(96)83-55(29-58(88)89)64(95)80-51(59(71)90)24-38-11-4-3-5-12-38/h3-9,11-16,18-19,21-23,30-31,35,47-48,50-56,76,86H,10,17,20,24-29,32-34,69-70H2,1-2H3,(H2,71,90)(H,74,77)(H,78,87)(H,79,92)(H,80,95)(H,81,94)(H,82,91)(H,83,96)(H,84,93)(H,88,89)(H4,72,73,75) YDLLMSIGAKQIBS-UHFFFAOYSA-N 50321598 (S)-3-((4R,7S,10S,13R,16S,22S)-16-((1H-imidazol-5-yl)methyl)-7-((1H-indol-3-yl)methyl)-22-amino-20-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-10-(3-guanidinopropyl)-13-(naphthalen-2-ylmethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexaazacyclotricosane-4-carboxamido)-4-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid::CHEMBL1172248 Melanocortin receptor 4 Homo sapiens 398 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321598 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6546&target=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321598&enzyme=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 91933501 104143127 CHEMBL1172248 1 MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY 8QJ2,9K3K,7F58,7F55,7F54,7F53,7PIV,7PIU,7AUE Melanocortin receptor 4 MC4R_HUMAN P32245 B2RAC3 Q16317 Q3MIJ6 50914712 Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N1CC(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@H](Cc2ccccc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CSSC[C@@H](N)C1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:10.11,65.79,85.90,29.31,wD:19.20,70.75,40.43,77.82,51.54,(-6.99,1.44,;-8.33,2.2,;-9.67,1.43,;-11.01,2.2,;-12.34,1.43,;-11,3.74,;-9.66,4.51,;-9.66,6.05,;-8.33,3.74,;-7,4.51,;-5.67,3.75,;-5.66,2.21,;-4.33,4.52,;-4.34,6.06,;-3,3.75,;-2.4,2.34,;-3.33,1.11,;-4.86,1.3,;-2.73,-.31,;-3.66,-1.53,;-5,-.77,;-6.33,-1.54,;-7.73,-.92,;-8.76,-2.06,;-7.99,-3.4,;-6.48,-3.07,;-3.66,-3.08,;-5,-3.85,;-2.33,-3.85,;-2.33,-5.39,;-3.66,-6.16,;-3.66,-7.7,;-5,-8.46,;-5,-10,;-3.67,-10.77,;-2.33,-10,;-2.34,-8.46,;-1,-6.16,;-1,-7.7,;.34,-5.39,;1.67,-6.16,;1.67,-7.7,;.34,-8.47,;.34,-10.01,;-1,-10.78,;-1,-12.32,;-2.33,-13.09,;.34,-13.09,;3,-5.39,;4.34,-6.16,;3,-3.85,;4.34,-3.08,;5.67,-3.85,;7.01,-3.08,;7.16,-1.56,;8.67,-1.24,;9.44,-2.57,;10.95,-2.88,;11.43,-4.34,;10.4,-5.5,;8.89,-5.18,;8.41,-3.71,;4.34,-1.54,;3,-.77,;5.67,-.77,;5.67,.77,;4.34,1.54,;4.34,3.08,;1.59,3.18,;.06,3.38,;-.54,4.79,;.39,6.02,;-2.07,4.99,;-2.66,6.41,;7.01,1.54,;8.34,.77,;7.01,3.08,;8.34,3.85,;9.67,3.08,;11.01,3.85,;11.01,5.39,;12.34,3.08,;8.34,5.39,;7.01,6.16,;9.67,6.16,;9.67,7.7,;8.34,8.47,;8.34,10.01,;9.68,10.78,;9.68,12.32,;8.34,13.09,;7.01,12.31,;7.01,10.77,;11.01,8.47,;11.01,10.01,;12.34,7.7,)| InChI=1S/C64H79N17O13S2/c1-34-20-40(82)21-35(2)42(34)26-43(65)62(93)81-30-53(83)74-50(25-39-29-70-33-73-39)59(90)77-48(23-37-14-7-4-8-15-37)57(88)75-46(18-11-19-71-64(68)69)56(87)78-49(24-38-28-72-45-17-10-9-16-41(38)45)58(89)80-52(32-96-95-31-44(66)63(81)94)61(92)79-51(27-54(84)85)60(91)76-47(55(67)86)22-36-12-5-3-6-13-36/h3-10,12-17,20-21,28-29,33,43-44,46-52,72,82H,11,18-19,22-27,30-32,65-66H2,1-2H3,(H2,67,86)(H,70,73)(H,74,83)(H,75,88)(H,76,91)(H,77,90)(H,78,87)(H,79,92)(H,80,89)(H,84,85)(H4,68,69,71) OYHTUAKSBPLZSH-UHFFFAOYSA-N 50321599 (S)-3-((4R,7S,10S,13R,16S,22S)-16-((1H-imidazol-5-yl)methyl)-7-((1H-indol-3-yl)methyl)-22-amino-20-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-13-benzyl-10-(3-guanidinopropyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexaazacyclotricosane-4-carboxamido)-4-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid::CHEMBL1172247 Melanocortin receptor 4 Homo sapiens 1585 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321599 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6546&target=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321599&enzyme=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 91933502 104143128 CHEMBL1172247 1 MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY 8QJ2,9K3K,7F58,7F55,7F54,7F53,7PIV,7PIU,7AUE Melanocortin receptor 4 MC4R_HUMAN P32245 B2RAC3 Q16317 Q3MIJ6 50914713 N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C66H81ClN18O14/c67-40-19-15-38(16-20-40)27-49-62(96)80-47(14-8-24-74-66(70)71)61(95)84-51(29-41-28-39-11-4-5-12-45(39)77-41)64(98)79-46(60(94)85-53(32-56(89)90)65(99)81-48(57(69)91)26-36-9-2-1-3-10-36)13-6-7-23-73-54(87)31-52(82-58(92)44(68)25-37-17-21-43(86)22-18-37)59(93)75-34-55(88)78-50(63(97)83-49)30-42-33-72-35-76-42/h1-5,9-12,15-22,28,33,35,44,46-53,77,86H,6-8,13-14,23-27,29-32,34,68H2,(H2,69,91)(H,72,76)(H,73,87)(H,75,93)(H,78,88)(H,79,98)(H,80,96)(H,81,99)(H,82,92)(H,83,97)(H,84,95)(H,85,94)(H,89,90)(H4,70,71,74) YCEIOOXEUSAMIZ-UHFFFAOYSA-N 50321600 (S)-3-((3S,6S,9S,12S,18R,26S)-12-((1H-imidazol-5-yl)methyl)-3-((1H-indol-2-yl)methyl)-18-((S)-2-amino-3-(4-hydroxyphenyl)propanamido)-9-(4-chlorobenzyl)-6-(3-guanidinopropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,21-heptaazacyclohexacosane-26-carboxamido)-4-((R)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid::CHEMBL1172246 Melanocortin receptor 4 Homo sapiens 32 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321600 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6546&target=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321600&enzyme=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 49798106 104143129 CHEMBL1172246 1 MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY 8QJ2,9K3K,7F58,7F55,7F54,7F53,7PIV,7PIU,7AUE Melanocortin receptor 4 MC4R_HUMAN P32245 B2RAC3 Q16317 Q3MIJ6 50914714 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CCC(=O)N(C1CCN(CCc2ccccc2)CC1)c1ccccc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C74H92N16O11/c1-2-3-28-57(68(96)88-63(44-66(93)94)73(101)85-59(67(75)95)40-49-21-10-5-11-22-49)83-71(99)61(42-51-45-80-56-29-17-16-27-55(51)56)87-69(97)58(30-18-36-79-74(76)77)84-70(98)60(41-50-23-12-6-13-24-50)86-72(100)62(43-52-46-78-47-81-52)82-64(91)31-32-65(92)90(53-25-14-7-15-26-53)54-34-38-89(39-35-54)37-33-48-19-8-4-9-20-48/h4-17,19-27,29,45-47,54,57-63,80H,2-3,18,28,30-44H2,1H3,(H2,75,95)(H,78,81)(H,82,91)(H,83,99)(H,84,98)(H,85,101)(H,86,100)(H,87,97)(H,88,96)(H,93,94)(H4,76,77,79) WVNNVFIQARDNCG-UHFFFAOYSA-N 50321602 (3S,6S,9S,12S,15R,18S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-15-benzyl-6-butyl-12-(3-guanidinopropyl)-5,8,11,14,17,20,23-heptaoxo-23-((1-phenethylpiperidin-4-yl)(phenyl)amino)-4,7,10,13,16,19-hexaazatricosan-1-oic acid::CHEMBL1172244 Melanocortin receptor 4 Homo sapiens 398 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321602 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6546&target=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321602&enzyme=Melanocortin+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 49798104 104143131 CHEMBL1172244 1 MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY 8QJ2,9K3K,7F58,7F55,7F54,7F53,7PIV,7PIU,7AUE Melanocortin receptor 4 MC4R_HUMAN P32245 B2RAC3 Q16317 Q3MIJ6 50914715 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:58.71,74.80,8.20,87.93,69.75,wD:48.59,22.31,4.4,33.48,95.101,(27.14,-11.6,;25.81,-10.83,;25.81,-9.29,;24.47,-8.52,;24.47,-6.97,;23.14,-6.2,;21.8,-6.97,;21.8,-8.5,;20.47,-6.2,;20.47,-4.66,;21.89,-4.07,;23.12,-5,;24.38,-4.1,;23.93,-2.63,;24.71,-1.31,;23.96,.04,;22.43,.05,;21.64,-1.26,;22.38,-2.61,;19.13,-6.97,;17.8,-6.2,;17.8,-4.66,;16.46,-6.97,;16.46,-8.51,;17.8,-9.28,;17.8,-10.82,;19.14,-11.58,;19.13,-13.12,;17.8,-13.89,;20.46,-13.9,;15.12,-6.21,;13.78,-6.97,;13.78,-8.51,;12.45,-6.2,;12.42,-4.66,;13.74,-3.87,;15.09,-4.61,;16.4,-3.81,;16.37,-2.28,;17.69,-1.49,;17.67,.05,;16.32,.8,;15,.01,;15.03,-1.52,;13.71,-2.32,;11.12,-6.97,;9.78,-6.21,;9.78,-4.66,;8.44,-6.98,;8.44,-8.51,;9.78,-9.29,;11.18,-8.65,;12.21,-9.8,;11.45,-11.14,;9.94,-10.82,;7.1,-6.21,;5.76,-6.97,;5.76,-8.5,;4.43,-6.2,;4.43,-4.66,;5.76,-3.89,;7.1,-4.65,;8.42,-3.88,;8.42,-2.34,;7.09,-1.57,;5.75,-2.34,;3.1,-6.99,;1.76,-6.22,;1.76,-4.68,;.42,-6.99,;.42,-8.53,;-.9,-6.21,;-2.25,-6.97,;-2.25,-8.51,;-3.58,-6.2,;-4.91,-6.98,;-3.58,-4.66,;-2.25,-3.89,;-.92,-4.66,;.41,-3.89,;.4,-2.35,;1.77,-1.59,;-.92,-1.58,;-2.25,-2.35,;25.81,-6.21,;25.81,-4.67,;27.15,-6.98,;28.48,-6.21,;28.48,-4.66,;29.82,-3.89,;31.15,-4.66,;29.82,-2.35,;29.82,-6.97,;29.82,-8.51,;31.15,-6.2,;32.49,-6.97,;32.49,-8.5,;33.83,-9.28,;35.16,-8.5,;36.5,-9.28,;36.5,-10.82,;35.16,-11.58,;33.83,-10.81,;33.83,-6.2,;35.15,-6.96,;33.83,-4.65,)| InChI=1S/C76H91N17O13/c1-3-4-23-57(69(100)93-64(40-65(95)96)75(106)88-59(66(78)97)35-45-16-7-5-8-17-45)86-73(104)62(38-51-41-83-56-24-14-13-22-54(51)56)91-70(101)58(25-15-32-82-76(79)80)87-71(102)61(37-48-26-29-49-20-11-12-21-50(49)33-48)90-74(105)63(39-52-42-81-43-84-52)92-72(103)60(36-46-18-9-6-10-19-46)89-67(98)44(2)85-68(99)55(77)34-47-27-30-53(94)31-28-47/h5-14,16-22,24,26-31,33,41-44,55,57-64,83,94H,3-4,15,23,25,32,34-40,77H2,1-2H3,(H2,78,97)(H,81,84)(H,85,99)(H,86,104)(H,87,102)(H,88,106)(H,89,98)(H,90,105)(H,91,101)(H,92,103)(H,93,100)(H,95,96)(H4,79,80,82) NENKRICCIWXRGU-UHFFFAOYSA-N 50321604 (3S,6S,9S,12S,15R,18S,21S,24R,27S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-27-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-28-(4-hydroxyphenyl)-24-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26-octaoxo-4,7,10,13,16,19,22,25-octaazaoctacosan-1-oic acid::CHEMBL1172429 Mu-type opioid receptor Cavia porcellus 2300 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321604 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000882&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321604&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933504 104143133 CHEMBL1172429 1 YTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKTVNVCNWI Mu-type opioid receptor OPRM_CAVPO P97266 50914716 Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N1CC(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@H](Cc2ccc3ccccc3c2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CSSC[C@@H](N)C1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:69.84,89.95,29.31,10.11,wD:44.48,74.80,19.20,81.87,55.59,(1.42,-5.48,;.09,-4.71,;-1.25,-5.49,;-2.59,-4.72,;-3.92,-5.48,;-2.59,-3.17,;-1.25,-2.41,;-1.25,-.87,;.08,-3.17,;1.41,-2.4,;2.75,-3.17,;2.75,-4.71,;4.08,-2.39,;4.08,-.85,;5.42,-3.16,;6.02,-4.57,;5.09,-5.8,;3.56,-5.61,;5.68,-7.22,;4.75,-8.45,;3.42,-7.68,;2.08,-8.45,;.68,-7.83,;-.35,-8.98,;.42,-10.31,;1.93,-9.98,;4.75,-9.99,;3.42,-10.76,;6.09,-10.76,;6.09,-12.3,;4.75,-13.07,;4.75,-14.61,;6.08,-15.37,;6.09,-16.91,;4.75,-17.69,;4.75,-19.22,;3.42,-19.99,;2.08,-19.22,;2.09,-17.68,;3.42,-16.92,;3.42,-15.39,;7.42,-13.07,;7.42,-14.61,;8.75,-12.3,;10.09,-13.07,;10.09,-14.61,;8.75,-15.38,;8.75,-16.92,;7.42,-17.69,;7.42,-19.23,;6.09,-20,;8.75,-20,;11.42,-12.3,;12.75,-13.07,;11.42,-10.76,;12.75,-9.99,;14.09,-10.76,;15.42,-9.99,;15.57,-8.48,;17.08,-8.15,;17.86,-9.48,;19.37,-9.79,;19.85,-11.26,;18.82,-12.42,;17.3,-12.1,;16.82,-10.63,;12.75,-8.45,;11.42,-7.68,;14.09,-7.68,;14.09,-6.14,;12.75,-5.37,;12.75,-3.83,;10,-3.73,;8.47,-3.54,;7.88,-2.12,;8.81,-.89,;6.35,-1.93,;5.75,-.51,;15.42,-5.37,;16.75,-6.14,;15.42,-3.83,;16.75,-3.06,;18.09,-3.83,;19.42,-3.06,;19.42,-1.52,;20.76,-3.83,;16.75,-1.52,;15.42,-.75,;18.09,-.75,;18.09,.78,;16.75,1.55,;16.75,3.09,;18.09,3.85,;18.09,5.39,;16.76,6.16,;15.42,5.39,;15.43,3.86,;19.42,1.55,;19.42,3.09,;20.76,.78,)| InChI=1S/C68H81N17O13S2/c1-36-21-44(86)22-37(2)46(36)28-47(69)66(97)85-32-57(87)78-54(27-43-31-74-35-77-43)63(94)81-52(25-39-18-19-40-13-6-7-14-41(40)23-39)61(92)79-50(17-10-20-75-68(72)73)60(91)82-53(26-42-30-76-49-16-9-8-15-45(42)49)62(93)84-56(34-100-99-33-48(70)67(85)98)65(96)83-55(29-58(88)89)64(95)80-51(59(71)90)24-38-11-4-3-5-12-38/h3-9,11-16,18-19,21-23,30-31,35,47-48,50-56,76,86H,10,17,20,24-29,32-34,69-70H2,1-2H3,(H2,71,90)(H,74,77)(H,78,87)(H,79,92)(H,80,95)(H,81,94)(H,82,91)(H,83,96)(H,84,93)(H,88,89)(H4,72,73,75) YDLLMSIGAKQIBS-UHFFFAOYSA-N 50321598 (S)-3-((4R,7S,10S,13R,16S,22S)-16-((1H-imidazol-5-yl)methyl)-7-((1H-indol-3-yl)methyl)-22-amino-20-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-10-(3-guanidinopropyl)-13-(naphthalen-2-ylmethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexaazacyclotricosane-4-carboxamido)-4-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid::CHEMBL1172248 Delta-type opioid receptor Mus musculus 610 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321598 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000865&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321598&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933501 104143127 CHEMBL1172248 1 MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA 4EJ4 Delta-type opioid receptor OPRD_MOUSE P32300 50914717 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:33.48,22.31,4.4,48.59,93.100,wD:70.77,58.62,8.20,85.92,(16.65,-3.98,;15.32,-4.75,;15.32,-6.29,;13.98,-7.06,;13.98,-8.6,;12.65,-9.36,;11.32,-8.59,;11.32,-7.05,;9.99,-9.35,;9.99,-10.9,;11.32,-11.67,;12.72,-11.05,;13.76,-12.19,;12.98,-13.52,;13.46,-14.99,;12.42,-16.14,;10.92,-15.81,;10.44,-14.35,;11.48,-13.21,;8.66,-8.59,;7.33,-9.38,;7.33,-10.92,;6,-8.61,;6,-7.07,;7.33,-6.3,;7.33,-4.76,;8.66,-3.97,;8.68,-2.43,;7.33,-1.66,;10,-1.66,;4.65,-9.35,;3.32,-8.59,;3.32,-7.05,;1.99,-9.36,;1.76,-10.89,;2.96,-11.84,;2.73,-13.37,;3.92,-14.33,;5.36,-13.77,;6.57,-14.74,;8.01,-14.17,;8.23,-12.64,;7.03,-11.68,;5.59,-12.24,;4.39,-11.29,;.66,-8.58,;-.66,-9.38,;-.66,-10.92,;-2,-8.61,;-2,-7.07,;-.66,-6.29,;.75,-6.93,;1.79,-5.78,;1.01,-4.45,;-.5,-4.76,;-3.33,-9.38,;-4.67,-8.61,;-4.67,-7.07,;-6,-9.38,;-7.33,-8.62,;-8.66,-9.39,;-9.99,-8.62,;-11.33,-9.39,;-11.33,-10.93,;-9.99,-11.69,;-8.66,-10.92,;-7.33,-11.7,;-6,-10.91,;-4.66,-11.68,;-3.33,-10.91,;-4.66,-13.22,;-5.99,-13.99,;-3.32,-13.99,;-3.32,-15.53,;-4.65,-16.3,;-5.98,-15.53,;-4.65,-17.84,;-3.31,-18.61,;-3.31,-20.15,;-1.98,-17.84,;-1.98,-16.29,;-.65,-15.52,;15.32,-9.37,;15.32,-10.91,;16.65,-8.59,;17.98,-9.36,;17.98,-10.91,;19.32,-11.67,;20.64,-10.9,;19.32,-13.21,;19.32,-8.59,;19.32,-7.05,;20.65,-9.36,;21.98,-8.59,;21.98,-7.05,;23.31,-6.28,;24.65,-7.06,;25.98,-6.29,;25.99,-4.75,;24.65,-3.98,;23.32,-4.75,;23.31,-9.36,;24.65,-8.59,;23.31,-10.91,)| InChI=1S/C76H90N16O12/c1-4-5-23-58(68(97)90-64(38-66(94)95)73(102)87-60(67(78)96)32-45-16-7-6-8-17-45)85-71(100)62(34-51-39-83-57-24-14-13-22-54(51)57)89-69(98)59(25-15-28-82-76(79)80)86-70(99)61(33-46-26-27-47-18-9-10-19-48(47)31-46)88-72(101)63(36-52-40-81-42-84-52)91-74(103)65-35-49-20-11-12-21-50(49)41-92(65)75(104)56(77)37-55-43(2)29-53(93)30-44(55)3/h6-14,16-22,24,26-27,29-31,39-40,42,56,58-65,83,93H,4-5,15,23,25,28,32-38,41,77H2,1-3H3,(H2,78,96)(H,81,84)(H,85,100)(H,86,99)(H,87,102)(H,88,101)(H,89,98)(H,90,97)(H,91,103)(H,94,95)(H4,79,80,82) TVINVHGLLFLSBP-UHFFFAOYSA-N 50321597 (3S,6R,9S,12S,15S,18S)-3-((1H-imidazol-5-yl)methyl)-12-((1H-indol-3-yl)methyl)-18-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-1-((R)-2-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-15-butyl-9-(3-guanidinopropyl)-6-(naphthalen-2-ylmethyl)-1,4,7,10,13,16-hexaoxo-2,5,8,11,14,17-hexaazaicosan-20-oic acid::CHEMBL1172249 Mu-type opioid receptor Cavia porcellus 570 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321597 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000882&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321597&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933500 104143126 CHEMBL1172249 1 YTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKTVNVCNWI Mu-type opioid receptor OPRM_CAVPO P97266 50914718 C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:5.5,1.0,78.83,66.79,55.66,37.39,97.102,wD:22.22,41.55,89.94,(17.54,.39,;18.85,-.37,;20.18,.39,;20.18,1.92,;18.85,2.7,;21.5,2.69,;21.5,4.24,;22.81,1.93,;22.81,.41,;21.51,-.37,;21.53,-1.91,;22.87,-2.67,;22.87,-4.2,;24.18,-1.88,;24.18,-.35,;18.85,-1.92,;20.2,-2.69,;17.54,-2.68,;17.54,-4.23,;16.23,-4.98,;14.91,-4.23,;16.23,-6.53,;14.91,-7.3,;13.6,-6.53,;12.26,-7.31,;12.29,-8.88,;10.96,-9.65,;9.62,-8.89,;9.61,-7.35,;10.94,-6.57,;14.91,-8.85,;16.26,-9.62,;13.6,-9.6,;13.6,-11.15,;12.3,-11.91,;12.3,-13.47,;10.99,-14.22,;10.99,-15.77,;9.67,-16.53,;8.36,-15.77,;8.36,-14.26,;7.02,-16.55,;7.02,-18.1,;8.36,-18.88,;9.61,-17.94,;10.87,-18.83,;10.39,-20.31,;11.18,-21.63,;10.42,-22.98,;8.88,-22.99,;8.1,-21.66,;8.85,-20.32,;5.7,-15.79,;4.36,-16.57,;4.36,-18.12,;3.05,-15.81,;3.05,-14.3,;4.36,-13.54,;4.36,-11.99,;5.67,-11.23,;5.67,-9.68,;4.33,-8.91,;6.98,-8.93,;1.71,-16.59,;.4,-15.83,;.4,-14.32,;-.95,-16.61,;-.95,-18.16,;.4,-18.93,;1.74,-18.14,;3.07,-18.9,;3.08,-20.45,;4.42,-21.21,;1.76,-21.23,;.42,-20.46,;-2.26,-15.85,;-3.61,-16.63,;-3.61,-18.18,;-4.92,-15.87,;-6.26,-16.65,;-4.92,-14.35,;-3.61,-13.6,;-2.21,-14.2,;-1.18,-13.04,;-1.97,-11.71,;-3.47,-12.05,;12.33,-16.55,;12.33,-18.07,;13.67,-15.77,;14.98,-16.53,;14.98,-18.05,;16.33,-18.82,;17.67,-18.05,;16.33,-20.33,;16.33,-15.75,;16.33,-14.2,;17.64,-16.51,;18.98,-15.73,;18.98,-14.18,;20.3,-13.43,;21.63,-14.17,;22.95,-13.39,;22.94,-11.85,;21.61,-11.09,;20.27,-11.87,;20.3,-16.49,;21.64,-15.71,;20.3,-18.01,)| InChI=1S/C74H92ClN19O14/c1-42(87-66(101)52(76)31-45-23-27-50(95)28-24-45)65(100)85-40-62(96)88-58(33-44-15-6-3-7-16-44)68(103)82-29-11-10-19-55(69(104)94-61(37-63(97)98)73(108)91-57(64(78)99)32-43-13-4-2-5-14-43)89-72(107)60(35-47-38-84-54-18-9-8-17-51(47)54)93-70(105)56(20-12-30-83-74(79)80)90-71(106)59(34-46-21-25-48(75)26-22-46)92-67(102)53(77)36-49-39-81-41-86-49/h2-9,13-18,21-28,38-39,41-42,52-53,55-61,84,95H,10-12,19-20,29-37,40,76-77H2,1H3,(H2,78,99)(H,81,86)(H,82,103)(H,85,100)(H,87,101)(H,88,96)(H,89,107)(H,90,106)(H,91,108)(H,92,102)(H,93,105)(H,94,104)(H,97,98)(H4,79,80,83) VEMKPSHWNYIGPG-UHFFFAOYSA-N 50321601 (2S,5R,11S,18S,21S)-2-amino-21-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-18-((S)-2-((S)-2-((R)-2-((S)-2-amino-3-(1H-imidazol-5-yl)propanamido)-3-(4-chlorophenyl)propanamido)-5-guanidinopentanamido)-3-(1H-indol-3-yl)propanamido)-11-benzyl-1-(4-hydroxyphenyl)-5-methyl-3,6,9,12,19-pentaoxo-4,7,10,13,20-pentaazatricosan-23-oic acid::CHEMBL1172245 Mu-type opioid receptor Cavia porcellus 330 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321601 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000882&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321601&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933503 104143130 CHEMBL1172245 1 YTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKTVNVCNWI Mu-type opioid receptor OPRM_CAVPO P97266 50914719 Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N1CC(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@H](Cc2ccccc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CSSC[C@@H](N)C1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:10.11,65.79,85.90,29.31,wD:19.20,70.75,40.43,77.82,51.54,(-6.99,1.44,;-8.33,2.2,;-9.67,1.43,;-11.01,2.2,;-12.34,1.43,;-11,3.74,;-9.66,4.51,;-9.66,6.05,;-8.33,3.74,;-7,4.51,;-5.67,3.75,;-5.66,2.21,;-4.33,4.52,;-4.34,6.06,;-3,3.75,;-2.4,2.34,;-3.33,1.11,;-4.86,1.3,;-2.73,-.31,;-3.66,-1.53,;-5,-.77,;-6.33,-1.54,;-7.73,-.92,;-8.76,-2.06,;-7.99,-3.4,;-6.48,-3.07,;-3.66,-3.08,;-5,-3.85,;-2.33,-3.85,;-2.33,-5.39,;-3.66,-6.16,;-3.66,-7.7,;-5,-8.46,;-5,-10,;-3.67,-10.77,;-2.33,-10,;-2.34,-8.46,;-1,-6.16,;-1,-7.7,;.34,-5.39,;1.67,-6.16,;1.67,-7.7,;.34,-8.47,;.34,-10.01,;-1,-10.78,;-1,-12.32,;-2.33,-13.09,;.34,-13.09,;3,-5.39,;4.34,-6.16,;3,-3.85,;4.34,-3.08,;5.67,-3.85,;7.01,-3.08,;7.16,-1.56,;8.67,-1.24,;9.44,-2.57,;10.95,-2.88,;11.43,-4.34,;10.4,-5.5,;8.89,-5.18,;8.41,-3.71,;4.34,-1.54,;3,-.77,;5.67,-.77,;5.67,.77,;4.34,1.54,;4.34,3.08,;1.59,3.18,;.06,3.38,;-.54,4.79,;.39,6.02,;-2.07,4.99,;-2.66,6.41,;7.01,1.54,;8.34,.77,;7.01,3.08,;8.34,3.85,;9.67,3.08,;11.01,3.85,;11.01,5.39,;12.34,3.08,;8.34,5.39,;7.01,6.16,;9.67,6.16,;9.67,7.7,;8.34,8.47,;8.34,10.01,;9.68,10.78,;9.68,12.32,;8.34,13.09,;7.01,12.31,;7.01,10.77,;11.01,8.47,;11.01,10.01,;12.34,7.7,)| InChI=1S/C64H79N17O13S2/c1-34-20-40(82)21-35(2)42(34)26-43(65)62(93)81-30-53(83)74-50(25-39-29-70-33-73-39)59(90)77-48(23-37-14-7-4-8-15-37)57(88)75-46(18-11-19-71-64(68)69)56(87)78-49(24-38-28-72-45-17-10-9-16-41(38)45)58(89)80-52(32-96-95-31-44(66)63(81)94)61(92)79-51(27-54(84)85)60(91)76-47(55(67)86)22-36-12-5-3-6-13-36/h3-10,12-17,20-21,28-29,33,43-44,46-52,72,82H,11,18-19,22-27,30-32,65-66H2,1-2H3,(H2,67,86)(H,70,73)(H,74,83)(H,75,88)(H,76,91)(H,77,90)(H,78,87)(H,79,92)(H,80,89)(H,84,85)(H4,68,69,71) OYHTUAKSBPLZSH-UHFFFAOYSA-N 50321599 (S)-3-((4R,7S,10S,13R,16S,22S)-16-((1H-imidazol-5-yl)methyl)-7-((1H-indol-3-yl)methyl)-22-amino-20-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-13-benzyl-10-(3-guanidinopropyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexaazacyclotricosane-4-carboxamido)-4-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid::CHEMBL1172247 Delta-type opioid receptor Mus musculus 410 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321599 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000865&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321599&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933502 104143128 CHEMBL1172247 1 MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA 4EJ4 Delta-type opioid receptor OPRD_MOUSE P32300 50914720 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:58.71,74.80,8.20,87.93,69.75,wD:48.59,22.31,4.4,33.48,95.101,(27.14,-11.6,;25.81,-10.83,;25.81,-9.29,;24.47,-8.52,;24.47,-6.97,;23.14,-6.2,;21.8,-6.97,;21.8,-8.5,;20.47,-6.2,;20.47,-4.66,;21.89,-4.07,;23.12,-5,;24.38,-4.1,;23.93,-2.63,;24.71,-1.31,;23.96,.04,;22.43,.05,;21.64,-1.26,;22.38,-2.61,;19.13,-6.97,;17.8,-6.2,;17.8,-4.66,;16.46,-6.97,;16.46,-8.51,;17.8,-9.28,;17.8,-10.82,;19.14,-11.58,;19.13,-13.12,;17.8,-13.89,;20.46,-13.9,;15.12,-6.21,;13.78,-6.97,;13.78,-8.51,;12.45,-6.2,;12.42,-4.66,;13.74,-3.87,;15.09,-4.61,;16.4,-3.81,;16.37,-2.28,;17.69,-1.49,;17.67,.05,;16.32,.8,;15,.01,;15.03,-1.52,;13.71,-2.32,;11.12,-6.97,;9.78,-6.21,;9.78,-4.66,;8.44,-6.98,;8.44,-8.51,;9.78,-9.29,;11.18,-8.65,;12.21,-9.8,;11.45,-11.14,;9.94,-10.82,;7.1,-6.21,;5.76,-6.97,;5.76,-8.5,;4.43,-6.2,;4.43,-4.66,;5.76,-3.89,;7.1,-4.65,;8.42,-3.88,;8.42,-2.34,;7.09,-1.57,;5.75,-2.34,;3.1,-6.99,;1.76,-6.22,;1.76,-4.68,;.42,-6.99,;.42,-8.53,;-.9,-6.21,;-2.25,-6.97,;-2.25,-8.51,;-3.58,-6.2,;-4.91,-6.98,;-3.58,-4.66,;-2.25,-3.89,;-.92,-4.66,;.41,-3.89,;.4,-2.35,;1.77,-1.59,;-.92,-1.58,;-2.25,-2.35,;25.81,-6.21,;25.81,-4.67,;27.15,-6.98,;28.48,-6.21,;28.48,-4.66,;29.82,-3.89,;31.15,-4.66,;29.82,-2.35,;29.82,-6.97,;29.82,-8.51,;31.15,-6.2,;32.49,-6.97,;32.49,-8.5,;33.83,-9.28,;35.16,-8.5,;36.5,-9.28,;36.5,-10.82,;35.16,-11.58,;33.83,-10.81,;33.83,-6.2,;35.15,-6.96,;33.83,-4.65,)| InChI=1S/C76H91N17O13/c1-3-4-23-57(69(100)93-64(40-65(95)96)75(106)88-59(66(78)97)35-45-16-7-5-8-17-45)86-73(104)62(38-51-41-83-56-24-14-13-22-54(51)56)91-70(101)58(25-15-32-82-76(79)80)87-71(102)61(37-48-26-29-49-20-11-12-21-50(49)33-48)90-74(105)63(39-52-42-81-43-84-52)92-72(103)60(36-46-18-9-6-10-19-46)89-67(98)44(2)85-68(99)55(77)34-47-27-30-53(94)31-28-47/h5-14,16-22,24,26-31,33,41-44,55,57-64,83,94H,3-4,15,23,25,32,34-40,77H2,1-2H3,(H2,78,97)(H,81,84)(H,85,99)(H,86,104)(H,87,102)(H,88,106)(H,89,98)(H,90,105)(H,91,101)(H,92,103)(H,93,100)(H,95,96)(H4,79,80,82) NENKRICCIWXRGU-UHFFFAOYSA-N 50321604 (3S,6S,9S,12S,15R,18S,21S,24R,27S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-27-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-28-(4-hydroxyphenyl)-24-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26-octaoxo-4,7,10,13,16,19,22,25-octaazaoctacosan-1-oic acid::CHEMBL1172429 Delta-type opioid receptor Mus musculus 370 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321604 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000865&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321604&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933504 104143133 CHEMBL1172429 1 MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA 4EJ4 Delta-type opioid receptor OPRD_MOUSE P32300 50914721 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CCC(=O)N(C1CCN(CCc2ccccc2)CC1)c1ccccc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C74H92N16O11/c1-2-3-28-57(68(96)88-63(44-66(93)94)73(101)85-59(67(75)95)40-49-21-10-5-11-22-49)83-71(99)61(42-51-45-80-56-29-17-16-27-55(51)56)87-69(97)58(30-18-36-79-74(76)77)84-70(98)60(41-50-23-12-6-13-24-50)86-72(100)62(43-52-46-78-47-81-52)82-64(91)31-32-65(92)90(53-25-14-7-15-26-53)54-34-38-89(39-35-54)37-33-48-19-8-4-9-20-48/h4-17,19-27,29,45-47,54,57-63,80H,2-3,18,28,30-44H2,1H3,(H2,75,95)(H,78,81)(H,82,91)(H,83,99)(H,84,98)(H,85,101)(H,86,100)(H,87,97)(H,88,96)(H,93,94)(H4,76,77,79) WVNNVFIQARDNCG-UHFFFAOYSA-N 50321602 (3S,6S,9S,12S,15R,18S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-15-benzyl-6-butyl-12-(3-guanidinopropyl)-5,8,11,14,17,20,23-heptaoxo-23-((1-phenethylpiperidin-4-yl)(phenyl)amino)-4,7,10,13,16,19-hexaazatricosan-1-oic acid::CHEMBL1172244 Delta-type opioid receptor Mus musculus 730 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321602 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000865&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321602&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798104 104143131 CHEMBL1172244 1 MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA 4EJ4 Delta-type opioid receptor OPRD_MOUSE P32300 50914722 Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N1CC(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@H](Cc2ccc3ccccc3c2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CSSC[C@@H](N)C1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:69.84,89.95,29.31,10.11,wD:44.48,74.80,19.20,81.87,55.59,(1.42,-5.48,;.09,-4.71,;-1.25,-5.49,;-2.59,-4.72,;-3.92,-5.48,;-2.59,-3.17,;-1.25,-2.41,;-1.25,-.87,;.08,-3.17,;1.41,-2.4,;2.75,-3.17,;2.75,-4.71,;4.08,-2.39,;4.08,-.85,;5.42,-3.16,;6.02,-4.57,;5.09,-5.8,;3.56,-5.61,;5.68,-7.22,;4.75,-8.45,;3.42,-7.68,;2.08,-8.45,;.68,-7.83,;-.35,-8.98,;.42,-10.31,;1.93,-9.98,;4.75,-9.99,;3.42,-10.76,;6.09,-10.76,;6.09,-12.3,;4.75,-13.07,;4.75,-14.61,;6.08,-15.37,;6.09,-16.91,;4.75,-17.69,;4.75,-19.22,;3.42,-19.99,;2.08,-19.22,;2.09,-17.68,;3.42,-16.92,;3.42,-15.39,;7.42,-13.07,;7.42,-14.61,;8.75,-12.3,;10.09,-13.07,;10.09,-14.61,;8.75,-15.38,;8.75,-16.92,;7.42,-17.69,;7.42,-19.23,;6.09,-20,;8.75,-20,;11.42,-12.3,;12.75,-13.07,;11.42,-10.76,;12.75,-9.99,;14.09,-10.76,;15.42,-9.99,;15.57,-8.48,;17.08,-8.15,;17.86,-9.48,;19.37,-9.79,;19.85,-11.26,;18.82,-12.42,;17.3,-12.1,;16.82,-10.63,;12.75,-8.45,;11.42,-7.68,;14.09,-7.68,;14.09,-6.14,;12.75,-5.37,;12.75,-3.83,;10,-3.73,;8.47,-3.54,;7.88,-2.12,;8.81,-.89,;6.35,-1.93,;5.75,-.51,;15.42,-5.37,;16.75,-6.14,;15.42,-3.83,;16.75,-3.06,;18.09,-3.83,;19.42,-3.06,;19.42,-1.52,;20.76,-3.83,;16.75,-1.52,;15.42,-.75,;18.09,-.75,;18.09,.78,;16.75,1.55,;16.75,3.09,;18.09,3.85,;18.09,5.39,;16.76,6.16,;15.42,5.39,;15.43,3.86,;19.42,1.55,;19.42,3.09,;20.76,.78,)| InChI=1S/C68H81N17O13S2/c1-36-21-44(86)22-37(2)46(36)28-47(69)66(97)85-32-57(87)78-54(27-43-31-74-35-77-43)63(94)81-52(25-39-18-19-40-13-6-7-14-41(40)23-39)61(92)79-50(17-10-20-75-68(72)73)60(91)82-53(26-42-30-76-49-16-9-8-15-45(42)49)62(93)84-56(34-100-99-33-48(70)67(85)98)65(96)83-55(29-58(88)89)64(95)80-51(59(71)90)24-38-11-4-3-5-12-38/h3-9,11-16,18-19,21-23,30-31,35,47-48,50-56,76,86H,10,17,20,24-29,32-34,69-70H2,1-2H3,(H2,71,90)(H,74,77)(H,78,87)(H,79,92)(H,80,95)(H,81,94)(H,82,91)(H,83,96)(H,84,93)(H,88,89)(H4,72,73,75) YDLLMSIGAKQIBS-UHFFFAOYSA-N 50321598 (S)-3-((4R,7S,10S,13R,16S,22S)-16-((1H-imidazol-5-yl)methyl)-7-((1H-indol-3-yl)methyl)-22-amino-20-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-10-(3-guanidinopropyl)-13-(naphthalen-2-ylmethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexaazacyclotricosane-4-carboxamido)-4-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid::CHEMBL1172248 Mu-type opioid receptor Cavia porcellus 280 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321598 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000882&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321598&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933501 104143127 CHEMBL1172248 1 YTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKTVNVCNWI Mu-type opioid receptor OPRM_CAVPO P97266 50914723 C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:5.5,1.0,78.83,66.79,55.66,37.39,97.102,wD:22.22,41.55,89.94,(17.54,.39,;18.85,-.37,;20.18,.39,;20.18,1.92,;18.85,2.7,;21.5,2.69,;21.5,4.24,;22.81,1.93,;22.81,.41,;21.51,-.37,;21.53,-1.91,;22.87,-2.67,;22.87,-4.2,;24.18,-1.88,;24.18,-.35,;18.85,-1.92,;20.2,-2.69,;17.54,-2.68,;17.54,-4.23,;16.23,-4.98,;14.91,-4.23,;16.23,-6.53,;14.91,-7.3,;13.6,-6.53,;12.26,-7.31,;12.29,-8.88,;10.96,-9.65,;9.62,-8.89,;9.61,-7.35,;10.94,-6.57,;14.91,-8.85,;16.26,-9.62,;13.6,-9.6,;13.6,-11.15,;12.3,-11.91,;12.3,-13.47,;10.99,-14.22,;10.99,-15.77,;9.67,-16.53,;8.36,-15.77,;8.36,-14.26,;7.02,-16.55,;7.02,-18.1,;8.36,-18.88,;9.61,-17.94,;10.87,-18.83,;10.39,-20.31,;11.18,-21.63,;10.42,-22.98,;8.88,-22.99,;8.1,-21.66,;8.85,-20.32,;5.7,-15.79,;4.36,-16.57,;4.36,-18.12,;3.05,-15.81,;3.05,-14.3,;4.36,-13.54,;4.36,-11.99,;5.67,-11.23,;5.67,-9.68,;4.33,-8.91,;6.98,-8.93,;1.71,-16.59,;.4,-15.83,;.4,-14.32,;-.95,-16.61,;-.95,-18.16,;.4,-18.93,;1.74,-18.14,;3.07,-18.9,;3.08,-20.45,;4.42,-21.21,;1.76,-21.23,;.42,-20.46,;-2.26,-15.85,;-3.61,-16.63,;-3.61,-18.18,;-4.92,-15.87,;-6.26,-16.65,;-4.92,-14.35,;-3.61,-13.6,;-2.21,-14.2,;-1.18,-13.04,;-1.97,-11.71,;-3.47,-12.05,;12.33,-16.55,;12.33,-18.07,;13.67,-15.77,;14.98,-16.53,;14.98,-18.05,;16.33,-18.82,;17.67,-18.05,;16.33,-20.33,;16.33,-15.75,;16.33,-14.2,;17.64,-16.51,;18.98,-15.73,;18.98,-14.18,;20.3,-13.43,;21.63,-14.17,;22.95,-13.39,;22.94,-11.85,;21.61,-11.09,;20.27,-11.87,;20.3,-16.49,;21.64,-15.71,;20.3,-18.01,)| InChI=1S/C74H92ClN19O14/c1-42(87-66(101)52(76)31-45-23-27-50(95)28-24-45)65(100)85-40-62(96)88-58(33-44-15-6-3-7-16-44)68(103)82-29-11-10-19-55(69(104)94-61(37-63(97)98)73(108)91-57(64(78)99)32-43-13-4-2-5-14-43)89-72(107)60(35-47-38-84-54-18-9-8-17-51(47)54)93-70(105)56(20-12-30-83-74(79)80)90-71(106)59(34-46-21-25-48(75)26-22-46)92-67(102)53(77)36-49-39-81-41-86-49/h2-9,13-18,21-28,38-39,41-42,52-53,55-61,84,95H,10-12,19-20,29-37,40,76-77H2,1H3,(H2,78,99)(H,81,86)(H,82,103)(H,85,100)(H,87,101)(H,88,96)(H,89,107)(H,90,106)(H,91,108)(H,92,102)(H,93,105)(H,94,104)(H,97,98)(H4,79,80,83) VEMKPSHWNYIGPG-UHFFFAOYSA-N 50321601 (2S,5R,11S,18S,21S)-2-amino-21-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-18-((S)-2-((S)-2-((R)-2-((S)-2-amino-3-(1H-imidazol-5-yl)propanamido)-3-(4-chlorophenyl)propanamido)-5-guanidinopentanamido)-3-(1H-indol-3-yl)propanamido)-11-benzyl-1-(4-hydroxyphenyl)-5-methyl-3,6,9,12,19-pentaoxo-4,7,10,13,20-pentaazatricosan-23-oic acid::CHEMBL1172245 Delta-type opioid receptor Mus musculus 240 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321601 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000865&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321601&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933503 104143130 CHEMBL1172245 1 MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA 4EJ4 Delta-type opioid receptor OPRD_MOUSE P32300 50914724 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:33.48,22.31,4.4,48.59,93.100,wD:70.77,58.62,8.20,85.92,(16.65,-3.98,;15.32,-4.75,;15.32,-6.29,;13.98,-7.06,;13.98,-8.6,;12.65,-9.36,;11.32,-8.59,;11.32,-7.05,;9.99,-9.35,;9.99,-10.9,;11.32,-11.67,;12.72,-11.05,;13.76,-12.19,;12.98,-13.52,;13.46,-14.99,;12.42,-16.14,;10.92,-15.81,;10.44,-14.35,;11.48,-13.21,;8.66,-8.59,;7.33,-9.38,;7.33,-10.92,;6,-8.61,;6,-7.07,;7.33,-6.3,;7.33,-4.76,;8.66,-3.97,;8.68,-2.43,;7.33,-1.66,;10,-1.66,;4.65,-9.35,;3.32,-8.59,;3.32,-7.05,;1.99,-9.36,;1.76,-10.89,;2.96,-11.84,;2.73,-13.37,;3.92,-14.33,;5.36,-13.77,;6.57,-14.74,;8.01,-14.17,;8.23,-12.64,;7.03,-11.68,;5.59,-12.24,;4.39,-11.29,;.66,-8.58,;-.66,-9.38,;-.66,-10.92,;-2,-8.61,;-2,-7.07,;-.66,-6.29,;.75,-6.93,;1.79,-5.78,;1.01,-4.45,;-.5,-4.76,;-3.33,-9.38,;-4.67,-8.61,;-4.67,-7.07,;-6,-9.38,;-7.33,-8.62,;-8.66,-9.39,;-9.99,-8.62,;-11.33,-9.39,;-11.33,-10.93,;-9.99,-11.69,;-8.66,-10.92,;-7.33,-11.7,;-6,-10.91,;-4.66,-11.68,;-3.33,-10.91,;-4.66,-13.22,;-5.99,-13.99,;-3.32,-13.99,;-3.32,-15.53,;-4.65,-16.3,;-5.98,-15.53,;-4.65,-17.84,;-3.31,-18.61,;-3.31,-20.15,;-1.98,-17.84,;-1.98,-16.29,;-.65,-15.52,;15.32,-9.37,;15.32,-10.91,;16.65,-8.59,;17.98,-9.36,;17.98,-10.91,;19.32,-11.67,;20.64,-10.9,;19.32,-13.21,;19.32,-8.59,;19.32,-7.05,;20.65,-9.36,;21.98,-8.59,;21.98,-7.05,;23.31,-6.28,;24.65,-7.06,;25.98,-6.29,;25.99,-4.75,;24.65,-3.98,;23.32,-4.75,;23.31,-9.36,;24.65,-8.59,;23.31,-10.91,)| InChI=1S/C76H90N16O12/c1-4-5-23-58(68(97)90-64(38-66(94)95)73(102)87-60(67(78)96)32-45-16-7-6-8-17-45)85-71(100)62(34-51-39-83-57-24-14-13-22-54(51)57)89-69(98)59(25-15-28-82-76(79)80)86-70(99)61(33-46-26-27-47-18-9-10-19-48(47)31-46)88-72(101)63(36-52-40-81-42-84-52)91-74(103)65-35-49-20-11-12-21-50(49)41-92(65)75(104)56(77)37-55-43(2)29-53(93)30-44(55)3/h6-14,16-22,24,26-27,29-31,39-40,42,56,58-65,83,93H,4-5,15,23,25,28,32-38,41,77H2,1-3H3,(H2,78,96)(H,81,84)(H,85,100)(H,86,99)(H,87,102)(H,88,101)(H,89,98)(H,90,97)(H,91,103)(H,94,95)(H4,79,80,82) TVINVHGLLFLSBP-UHFFFAOYSA-N 50321597 (3S,6R,9S,12S,15S,18S)-3-((1H-imidazol-5-yl)methyl)-12-((1H-indol-3-yl)methyl)-18-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-1-((R)-2-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-15-butyl-9-(3-guanidinopropyl)-6-(naphthalen-2-ylmethyl)-1,4,7,10,13,16-hexaoxo-2,5,8,11,14,17-hexaazaicosan-20-oic acid::CHEMBL1172249 Delta-type opioid receptor Mus musculus 130 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321597 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000865&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321597&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933500 104143126 CHEMBL1172249 1 MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA 4EJ4 Delta-type opioid receptor OPRD_MOUSE P32300 50914725 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C78H94N18O14/c1-3-4-23-58(71(104)96-65(40-67(99)100)77(110)92-60(68(80)101)35-46-16-7-5-8-17-46)90-75(108)63(38-52-41-85-57-24-14-13-22-55(52)57)94-72(105)59(25-15-32-84-78(81)82)91-74(107)62(37-49-26-29-50-20-11-12-21-51(50)33-49)93-76(109)64(39-53-42-83-44-87-53)95-73(106)61(36-47-18-9-6-10-19-47)89-66(98)43-86-69(102)45(2)88-70(103)56(79)34-48-27-30-54(97)31-28-48/h5-14,16-22,24,26-31,33,41-42,44-45,56,58-65,85,97H,3-4,15,23,25,32,34-40,43,79H2,1-2H3,(H2,80,101)(H,83,87)(H,86,102)(H,88,103)(H,89,98)(H,90,108)(H,91,107)(H,92,110)(H,93,109)(H,94,105)(H,95,106)(H,96,104)(H,99,100)(H4,81,82,84) ZZVLKHHSRQKCEV-UHFFFAOYSA-N 50321607 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxyphenyl)-27-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172252 Mu-type opioid receptor Cavia porcellus 200 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321607 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000882&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321607&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798112 104143136 CHEMBL1172252 1 YTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKTVNVCNWI Mu-type opioid receptor OPRM_CAVPO P97266 50914726 Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N1CC(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@H](Cc2ccccc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CSSC[C@@H](N)C1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:10.11,65.79,85.90,29.31,wD:19.20,70.75,40.43,77.82,51.54,(-6.99,1.44,;-8.33,2.2,;-9.67,1.43,;-11.01,2.2,;-12.34,1.43,;-11,3.74,;-9.66,4.51,;-9.66,6.05,;-8.33,3.74,;-7,4.51,;-5.67,3.75,;-5.66,2.21,;-4.33,4.52,;-4.34,6.06,;-3,3.75,;-2.4,2.34,;-3.33,1.11,;-4.86,1.3,;-2.73,-.31,;-3.66,-1.53,;-5,-.77,;-6.33,-1.54,;-7.73,-.92,;-8.76,-2.06,;-7.99,-3.4,;-6.48,-3.07,;-3.66,-3.08,;-5,-3.85,;-2.33,-3.85,;-2.33,-5.39,;-3.66,-6.16,;-3.66,-7.7,;-5,-8.46,;-5,-10,;-3.67,-10.77,;-2.33,-10,;-2.34,-8.46,;-1,-6.16,;-1,-7.7,;.34,-5.39,;1.67,-6.16,;1.67,-7.7,;.34,-8.47,;.34,-10.01,;-1,-10.78,;-1,-12.32,;-2.33,-13.09,;.34,-13.09,;3,-5.39,;4.34,-6.16,;3,-3.85,;4.34,-3.08,;5.67,-3.85,;7.01,-3.08,;7.16,-1.56,;8.67,-1.24,;9.44,-2.57,;10.95,-2.88,;11.43,-4.34,;10.4,-5.5,;8.89,-5.18,;8.41,-3.71,;4.34,-1.54,;3,-.77,;5.67,-.77,;5.67,.77,;4.34,1.54,;4.34,3.08,;1.59,3.18,;.06,3.38,;-.54,4.79,;.39,6.02,;-2.07,4.99,;-2.66,6.41,;7.01,1.54,;8.34,.77,;7.01,3.08,;8.34,3.85,;9.67,3.08,;11.01,3.85,;11.01,5.39,;12.34,3.08,;8.34,5.39,;7.01,6.16,;9.67,6.16,;9.67,7.7,;8.34,8.47,;8.34,10.01,;9.68,10.78,;9.68,12.32,;8.34,13.09,;7.01,12.31,;7.01,10.77,;11.01,8.47,;11.01,10.01,;12.34,7.7,)| InChI=1S/C64H79N17O13S2/c1-34-20-40(82)21-35(2)42(34)26-43(65)62(93)81-30-53(83)74-50(25-39-29-70-33-73-39)59(90)77-48(23-37-14-7-4-8-15-37)57(88)75-46(18-11-19-71-64(68)69)56(87)78-49(24-38-28-72-45-17-10-9-16-41(38)45)58(89)80-52(32-96-95-31-44(66)63(81)94)61(92)79-51(27-54(84)85)60(91)76-47(55(67)86)22-36-12-5-3-6-13-36/h3-10,12-17,20-21,28-29,33,43-44,46-52,72,82H,11,18-19,22-27,30-32,65-66H2,1-2H3,(H2,67,86)(H,70,73)(H,74,83)(H,75,88)(H,76,91)(H,77,90)(H,78,87)(H,79,92)(H,80,89)(H,84,85)(H4,68,69,71) OYHTUAKSBPLZSH-UHFFFAOYSA-N 50321599 (S)-3-((4R,7S,10S,13R,16S,22S)-16-((1H-imidazol-5-yl)methyl)-7-((1H-indol-3-yl)methyl)-22-amino-20-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-13-benzyl-10-(3-guanidinopropyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexaazacyclotricosane-4-carboxamido)-4-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid::CHEMBL1172247 Mu-type opioid receptor Cavia porcellus 190 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321599 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000882&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321599&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933502 104143128 CHEMBL1172247 1 YTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKTVNVCNWI Mu-type opioid receptor OPRM_CAVPO P97266 50914727 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:69.75,8.20,58.71,89.95,wD:48.59,22.31,33.48,4.4,97.103,74.80,(28.82,-7.95,;30.15,-7.19,;30.15,-5.65,;28.82,-4.88,;28.82,-3.34,;27.48,-2.57,;26.15,-3.35,;26.15,-4.89,;24.82,-2.58,;24.82,-1.03,;26.22,-.4,;27.48,-1.28,;28.71,-.35,;28.21,1.11,;28.95,2.45,;28.16,3.77,;26.62,3.74,;25.87,2.4,;26.66,1.08,;23.48,-3.34,;22.13,-2.59,;22.13,-1.04,;20.8,-3.36,;20.8,-4.9,;22.13,-5.67,;22.13,-7.21,;23.47,-7.98,;23.47,-9.52,;22.16,-10.27,;24.84,-10.28,;19.47,-2.57,;18.15,-3.35,;18.15,-4.88,;16.82,-2.57,;16.82,-1.03,;18.15,-.26,;19.48,-1.03,;20.81,-.26,;20.82,1.28,;22.15,2.06,;22.15,3.6,;20.8,4.36,;19.47,3.58,;19.48,2.05,;18.14,1.28,;15.48,-3.33,;14.14,-2.57,;14.14,-1.02,;12.8,-3.34,;12.8,-4.88,;14.14,-5.65,;15.55,-5.02,;16.59,-6.17,;15.81,-7.5,;14.31,-7.18,;11.47,-2.57,;10.13,-3.32,;10.13,-4.86,;8.81,-2.55,;8.81,-1.01,;10.13,-.25,;11.47,-1.01,;12.81,-.24,;12.8,1.31,;11.47,2.07,;10.14,1.3,;7.47,-3.33,;6.13,-2.55,;6.13,-1.01,;4.8,-3.33,;4.8,-4.87,;3.47,-2.56,;2.12,-3.32,;2.13,-4.86,;.8,-2.54,;.81,-1,;-.54,-3.3,;-1.86,-2.52,;-1.85,-.98,;-.51,-.23,;-3.18,-.2,;-4.52,-.96,;-5.84,-.18,;-4.53,-2.49,;-3.2,-3.27,;-3.21,-4.81,;30.15,-2.57,;30.15,-1.03,;31.49,-3.34,;32.82,-2.57,;32.82,-1.02,;34.15,-.26,;35.48,-1.03,;34.15,1.29,;34.15,-3.34,;34.15,-4.88,;35.49,-2.57,;36.82,-3.34,;36.82,-4.88,;38.16,-5.65,;39.5,-4.87,;40.83,-5.65,;40.84,-7.18,;39.5,-7.95,;38.16,-7.19,;38.16,-2.57,;39.49,-3.33,;38.16,-1.02,)| InChI=1S/C78H95N17O13/c1-5-6-25-59(71(102)95-66(40-67(97)98)77(108)90-61(68(80)99)34-47-18-9-7-10-19-47)88-75(106)64(37-52-41-85-58-26-16-15-24-55(52)58)93-72(103)60(27-17-30-84-78(81)82)89-73(104)63(36-49-28-29-50-22-13-14-23-51(50)33-49)92-76(107)65(38-53-42-83-43-86-53)94-74(105)62(35-48-20-11-8-12-21-48)91-69(100)46(4)87-70(101)57(79)39-56-44(2)31-54(96)32-45(56)3/h7-16,18-24,26,28-29,31-33,41-43,46,57,59-66,85,96H,5-6,17,25,27,30,34-40,79H2,1-4H3,(H2,80,99)(H,83,86)(H,87,101)(H,88,106)(H,89,104)(H,90,108)(H,91,100)(H,92,107)(H,93,103)(H,94,105)(H,95,102)(H,97,98)(H4,81,82,84) JMDKMESJXNSGPX-UHFFFAOYSA-N 50321605 (6R,9S,12S,15R,18S,21S,24S,27S)-12-((1H-imidazol-5-yl)methyl)-21-((1H-indol-3-yl)methyl)-27-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-9-benzyl-24-butyl-18-(3-guanidinopropyl)-1-(4-hydroxy-2,6-dimethylphenyl)-6-methyl-15-(naphthalen-2-ylmethyl)-4,7,10,13,16,19,22,25-octaoxo-3,5,8,11,14,17,20,23,26-nonaazanonacosan-29-oic acid::CHEMBL1172428 Delta-type opioid receptor Mus musculus 110 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321605 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000865&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321605&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933505 104143134 CHEMBL1172428 1 MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA 4EJ4 Delta-type opioid receptor OPRD_MOUSE P32300 50914728 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C78H94N18O14/c1-3-4-23-58(71(104)96-65(40-67(99)100)77(110)92-60(68(80)101)35-46-16-7-5-8-17-46)90-75(108)63(38-52-41-85-57-24-14-13-22-55(52)57)94-72(105)59(25-15-32-84-78(81)82)91-74(107)62(37-49-26-29-50-20-11-12-21-51(50)33-49)93-76(109)64(39-53-42-83-44-87-53)95-73(106)61(36-47-18-9-6-10-19-47)89-66(98)43-86-69(102)45(2)88-70(103)56(79)34-48-27-30-54(97)31-28-48/h5-14,16-22,24,26-31,33,41-42,44-45,56,58-65,85,97H,3-4,15,23,25,32,34-40,43,79H2,1-2H3,(H2,80,101)(H,83,87)(H,86,102)(H,88,103)(H,89,98)(H,90,108)(H,91,107)(H,92,110)(H,93,109)(H,94,105)(H,95,106)(H,96,104)(H,99,100)(H4,81,82,84) ZZVLKHHSRQKCEV-UHFFFAOYSA-N 50321607 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxyphenyl)-27-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172252 Delta-type opioid receptor Mus musculus 60 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321607 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000865&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321607&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798112 104143136 CHEMBL1172252 1 MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA 4EJ4 Delta-type opioid receptor OPRD_MOUSE P32300 50914729 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C74H92N18O14/c1-3-4-24-54(67(100)92-61(38-63(95)96)73(106)88-56(64(76)97)33-44-17-8-5-9-18-44)86-71(104)59(36-48-39-81-53-25-15-14-23-51(48)53)90-68(101)55(26-16-31-80-74(77)78)87-70(103)58(35-46-21-12-7-13-22-46)89-72(105)60(37-49-40-79-42-83-49)91-69(102)57(34-45-19-10-6-11-20-45)85-62(94)41-82-65(98)43(2)84-66(99)52(75)32-47-27-29-50(93)30-28-47/h5-15,17-23,25,27-30,39-40,42-43,52,54-61,81,93H,3-4,16,24,26,31-38,41,75H2,1-2H3,(H2,76,97)(H,79,83)(H,82,98)(H,84,99)(H,85,94)(H,86,104)(H,87,103)(H,88,106)(H,89,105)(H,90,101)(H,91,102)(H,92,100)(H,95,96)(H4,77,78,80) ZUUGDHAKGUQZKD-UHFFFAOYSA-N 50321608 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-15,21-dibenzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxyphenyl)-27-methyl-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172251 Mu-type opioid receptor Cavia porcellus 130 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321608 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000882&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321608&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798111 104143137 CHEMBL1172251 1 YTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKTVNVCNWI Mu-type opioid receptor OPRM_CAVPO P97266 50914730 C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(N)=O InChI=1S/C23H29N5O5/c1-14(27-23(33)18(24)11-16-7-9-17(29)10-8-16)22(32)26-13-20(30)28-19(21(25)31)12-15-5-3-2-4-6-15/h2-10,14,18-19,29H,11-13,24H2,1H3,(H2,25,31)(H,26,32)(H,27,33)(H,28,30) RJEUERNNQHNSKG-UHFFFAOYSA-N 21123 Enkephalin Amide::(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]propanamido]acetamido}-3-phenylpropanamide::YDAGF-NH2 Delta-type opioid receptor Mus musculus 120 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21123 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000865&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=21123&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 5490373 49689196 1 MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA 4EJ4 Delta-type opioid receptor OPRD_MOUSE P32300 50914731 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:69.75,8.20,58.71,89.95,wD:48.59,22.31,33.48,4.4,97.103,74.80,(28.82,-7.95,;30.15,-7.19,;30.15,-5.65,;28.82,-4.88,;28.82,-3.34,;27.48,-2.57,;26.15,-3.35,;26.15,-4.89,;24.82,-2.58,;24.82,-1.03,;26.22,-.4,;27.48,-1.28,;28.71,-.35,;28.21,1.11,;28.95,2.45,;28.16,3.77,;26.62,3.74,;25.87,2.4,;26.66,1.08,;23.48,-3.34,;22.13,-2.59,;22.13,-1.04,;20.8,-3.36,;20.8,-4.9,;22.13,-5.67,;22.13,-7.21,;23.47,-7.98,;23.47,-9.52,;22.16,-10.27,;24.84,-10.28,;19.47,-2.57,;18.15,-3.35,;18.15,-4.88,;16.82,-2.57,;16.82,-1.03,;18.15,-.26,;19.48,-1.03,;20.81,-.26,;20.82,1.28,;22.15,2.06,;22.15,3.6,;20.8,4.36,;19.47,3.58,;19.48,2.05,;18.14,1.28,;15.48,-3.33,;14.14,-2.57,;14.14,-1.02,;12.8,-3.34,;12.8,-4.88,;14.14,-5.65,;15.55,-5.02,;16.59,-6.17,;15.81,-7.5,;14.31,-7.18,;11.47,-2.57,;10.13,-3.32,;10.13,-4.86,;8.81,-2.55,;8.81,-1.01,;10.13,-.25,;11.47,-1.01,;12.81,-.24,;12.8,1.31,;11.47,2.07,;10.14,1.3,;7.47,-3.33,;6.13,-2.55,;6.13,-1.01,;4.8,-3.33,;4.8,-4.87,;3.47,-2.56,;2.12,-3.32,;2.13,-4.86,;.8,-2.54,;.81,-1,;-.54,-3.3,;-1.86,-2.52,;-1.85,-.98,;-.51,-.23,;-3.18,-.2,;-4.52,-.96,;-5.84,-.18,;-4.53,-2.49,;-3.2,-3.27,;-3.21,-4.81,;30.15,-2.57,;30.15,-1.03,;31.49,-3.34,;32.82,-2.57,;32.82,-1.02,;34.15,-.26,;35.48,-1.03,;34.15,1.29,;34.15,-3.34,;34.15,-4.88,;35.49,-2.57,;36.82,-3.34,;36.82,-4.88,;38.16,-5.65,;39.5,-4.87,;40.83,-5.65,;40.84,-7.18,;39.5,-7.95,;38.16,-7.19,;38.16,-2.57,;39.49,-3.33,;38.16,-1.02,)| InChI=1S/C78H95N17O13/c1-5-6-25-59(71(102)95-66(40-67(97)98)77(108)90-61(68(80)99)34-47-18-9-7-10-19-47)88-75(106)64(37-52-41-85-58-26-16-15-24-55(52)58)93-72(103)60(27-17-30-84-78(81)82)89-73(104)63(36-49-28-29-50-22-13-14-23-51(50)33-49)92-76(107)65(38-53-42-83-43-86-53)94-74(105)62(35-48-20-11-8-12-21-48)91-69(100)46(4)87-70(101)57(79)39-56-44(2)31-54(96)32-45(56)3/h7-16,18-24,26,28-29,31-33,41-43,46,57,59-66,85,96H,5-6,17,25,27,30,34-40,79H2,1-4H3,(H2,80,99)(H,83,86)(H,87,101)(H,88,106)(H,89,104)(H,90,108)(H,91,100)(H,92,107)(H,93,103)(H,94,105)(H,95,102)(H,97,98)(H4,81,82,84) JMDKMESJXNSGPX-UHFFFAOYSA-N 50321605 (6R,9S,12S,15R,18S,21S,24S,27S)-12-((1H-imidazol-5-yl)methyl)-21-((1H-indol-3-yl)methyl)-27-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-9-benzyl-24-butyl-18-(3-guanidinopropyl)-1-(4-hydroxy-2,6-dimethylphenyl)-6-methyl-15-(naphthalen-2-ylmethyl)-4,7,10,13,16,19,22,25-octaoxo-3,5,8,11,14,17,20,23,26-nonaazanonacosan-29-oic acid::CHEMBL1172428 Mu-type opioid receptor Cavia porcellus 66 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321605 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000882&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321605&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933505 104143134 CHEMBL1172428 1 YTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKTVNVCNWI Mu-type opioid receptor OPRM_CAVPO P97266 50914732 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C74H92N18O14/c1-3-4-24-54(67(100)92-61(38-63(95)96)73(106)88-56(64(76)97)33-44-17-8-5-9-18-44)86-71(104)59(36-48-39-81-53-25-15-14-23-51(48)53)90-68(101)55(26-16-31-80-74(77)78)87-70(103)58(35-46-21-12-7-13-22-46)89-72(105)60(37-49-40-79-42-83-49)91-69(102)57(34-45-19-10-6-11-20-45)85-62(94)41-82-65(98)43(2)84-66(99)52(75)32-47-27-29-50(93)30-28-47/h5-15,17-23,25,27-30,39-40,42-43,52,54-61,81,93H,3-4,16,24,26,31-38,41,75H2,1-2H3,(H2,76,97)(H,79,83)(H,82,98)(H,84,99)(H,85,94)(H,86,104)(H,87,103)(H,88,106)(H,89,105)(H,90,101)(H,91,102)(H,92,100)(H,95,96)(H4,77,78,80) ZUUGDHAKGUQZKD-UHFFFAOYSA-N 50321608 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-15,21-dibenzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxyphenyl)-27-methyl-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172251 Delta-type opioid receptor Mus musculus 40 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321608 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000865&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321608&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798111 104143137 CHEMBL1172251 1 MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA 4EJ4 Delta-type opioid receptor OPRD_MOUSE P32300 50914733 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:8.20,58.71,93.99,78.84,wD:73.79,48.59,22.31,33.48,4.4,101.107,(24.59,-5.48,;25.93,-4.72,;25.93,-3.18,;24.59,-2.4,;24.59,-.86,;23.26,-.1,;21.93,-.87,;21.93,-2.41,;20.59,-.11,;20.59,1.44,;22,2.07,;23.25,1.19,;24.48,2.12,;23.98,3.58,;24.73,4.92,;23.94,6.24,;22.4,6.22,;21.65,4.87,;22.44,3.55,;19.25,-.87,;17.91,-.12,;17.91,1.43,;16.57,-.89,;16.57,-2.43,;17.91,-3.2,;17.91,-4.73,;19.24,-5.51,;19.24,-7.05,;17.93,-7.8,;20.61,-7.81,;15.25,-.1,;13.92,-.87,;13.92,-2.41,;12.59,-.1,;12.6,1.44,;13.92,2.21,;15.26,1.44,;16.59,2.21,;16.6,3.75,;17.93,4.53,;17.92,6.07,;16.58,6.84,;15.25,6.06,;15.26,4.52,;13.92,3.75,;11.26,-.86,;9.92,-.1,;9.92,1.45,;8.58,-.87,;8.58,-2.41,;9.92,-3.18,;11.32,-2.55,;12.36,-3.69,;11.59,-5.03,;10.08,-4.71,;7.25,-.09,;5.91,-.85,;5.91,-2.39,;4.58,-.08,;4.58,1.46,;5.91,2.23,;7.25,1.47,;8.58,2.24,;8.58,3.78,;7.24,4.55,;5.91,3.78,;3.25,-.85,;1.92,-.07,;1.92,1.47,;.58,-.85,;-.75,-.07,;-2.08,-.85,;-2.08,-2.38,;-3.41,-.07,;-3.41,1.47,;-4.75,-.84,;-6.09,-.08,;-6.09,1.47,;-7.42,-.86,;-7.4,-2.4,;-8.75,-.1,;-10.08,-.88,;-10.06,-2.42,;-8.72,-3.17,;-11.4,-3.2,;-12.73,-2.44,;-14.07,-3.22,;-12.76,-.9,;-11.41,-.13,;-11.43,1.41,;25.93,-.09,;25.93,1.45,;27.26,-.87,;28.59,-.09,;28.59,1.45,;29.93,2.21,;31.25,1.45,;29.93,3.76,;29.93,-.87,;29.93,-2.4,;31.26,-.1,;32.6,-.87,;32.6,-2.4,;33.93,-3.17,;35.28,-2.4,;36.61,-3.17,;36.61,-4.71,;35.27,-5.48,;33.94,-4.71,;33.93,-.1,;35.27,-.86,;33.93,1.45,)| InChI=1S/C80H98N18O14/c1-5-6-25-60(73(106)98-67(40-69(101)102)79(112)94-62(70(82)103)34-48-18-9-7-10-19-48)92-77(110)65(37-53-41-87-59-26-16-15-24-56(53)59)96-74(107)61(27-17-30-86-80(83)84)93-76(109)64(36-50-28-29-51-22-13-14-23-52(51)33-50)95-78(111)66(38-54-42-85-44-89-54)97-75(108)63(35-49-20-11-8-12-21-49)91-68(100)43-88-71(104)47(4)90-72(105)58(81)39-57-45(2)31-55(99)32-46(57)3/h7-16,18-24,26,28-29,31-33,41-42,44,47,58,60-67,87,99H,5-6,17,25,27,30,34-40,43,81H2,1-4H3,(H2,82,103)(H,85,89)(H,88,104)(H,90,105)(H,91,100)(H,92,110)(H,93,109)(H,94,112)(H,95,111)(H,96,107)(H,97,108)(H,98,106)(H,101,102)(H4,83,84,86) AHRZYQWKXXBNHK-UHFFFAOYSA-N 50321606 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxy-2,6-dimethylphenyl)-27-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172253 Delta-type opioid receptor Mus musculus 11 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321606 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000865&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321606&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933506 104143135 CHEMBL1172253 1 MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA 4EJ4 Delta-type opioid receptor OPRD_MOUSE P32300 50914734 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:8.20,58.71,93.99,78.84,wD:73.79,48.59,22.31,33.48,4.4,101.107,(24.59,-5.48,;25.93,-4.72,;25.93,-3.18,;24.59,-2.4,;24.59,-.86,;23.26,-.1,;21.93,-.87,;21.93,-2.41,;20.59,-.11,;20.59,1.44,;22,2.07,;23.25,1.19,;24.48,2.12,;23.98,3.58,;24.73,4.92,;23.94,6.24,;22.4,6.22,;21.65,4.87,;22.44,3.55,;19.25,-.87,;17.91,-.12,;17.91,1.43,;16.57,-.89,;16.57,-2.43,;17.91,-3.2,;17.91,-4.73,;19.24,-5.51,;19.24,-7.05,;17.93,-7.8,;20.61,-7.81,;15.25,-.1,;13.92,-.87,;13.92,-2.41,;12.59,-.1,;12.6,1.44,;13.92,2.21,;15.26,1.44,;16.59,2.21,;16.6,3.75,;17.93,4.53,;17.92,6.07,;16.58,6.84,;15.25,6.06,;15.26,4.52,;13.92,3.75,;11.26,-.86,;9.92,-.1,;9.92,1.45,;8.58,-.87,;8.58,-2.41,;9.92,-3.18,;11.32,-2.55,;12.36,-3.69,;11.59,-5.03,;10.08,-4.71,;7.25,-.09,;5.91,-.85,;5.91,-2.39,;4.58,-.08,;4.58,1.46,;5.91,2.23,;7.25,1.47,;8.58,2.24,;8.58,3.78,;7.24,4.55,;5.91,3.78,;3.25,-.85,;1.92,-.07,;1.92,1.47,;.58,-.85,;-.75,-.07,;-2.08,-.85,;-2.08,-2.38,;-3.41,-.07,;-3.41,1.47,;-4.75,-.84,;-6.09,-.08,;-6.09,1.47,;-7.42,-.86,;-7.4,-2.4,;-8.75,-.1,;-10.08,-.88,;-10.06,-2.42,;-8.72,-3.17,;-11.4,-3.2,;-12.73,-2.44,;-14.07,-3.22,;-12.76,-.9,;-11.41,-.13,;-11.43,1.41,;25.93,-.09,;25.93,1.45,;27.26,-.87,;28.59,-.09,;28.59,1.45,;29.93,2.21,;31.25,1.45,;29.93,3.76,;29.93,-.87,;29.93,-2.4,;31.26,-.1,;32.6,-.87,;32.6,-2.4,;33.93,-3.17,;35.28,-2.4,;36.61,-3.17,;36.61,-4.71,;35.27,-5.48,;33.94,-4.71,;33.93,-.1,;35.27,-.86,;33.93,1.45,)| InChI=1S/C80H98N18O14/c1-5-6-25-60(73(106)98-67(40-69(101)102)79(112)94-62(70(82)103)34-48-18-9-7-10-19-48)92-77(110)65(37-53-41-87-59-26-16-15-24-56(53)59)96-74(107)61(27-17-30-86-80(83)84)93-76(109)64(36-50-28-29-51-22-13-14-23-52(51)33-50)95-78(111)66(38-54-42-85-44-89-54)97-75(108)63(35-49-20-11-8-12-21-49)91-68(100)43-88-71(104)47(4)90-72(105)58(81)39-57-45(2)31-55(99)32-46(57)3/h7-16,18-24,26,28-29,31-33,41-42,44,47,58,60-67,87,99H,5-6,17,25,27,30,34-40,43,81H2,1-4H3,(H2,82,103)(H,85,89)(H,88,104)(H,90,105)(H,91,100)(H,92,110)(H,93,109)(H,94,112)(H,95,111)(H,96,107)(H,97,108)(H,98,106)(H,101,102)(H4,83,84,86) AHRZYQWKXXBNHK-UHFFFAOYSA-N 50321606 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxy-2,6-dimethylphenyl)-27-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172253 Mu-type opioid receptor Cavia porcellus 8.3 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321606 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000882&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321606&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933506 104143135 CHEMBL1172253 1 YTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKTVNVCNWI Mu-type opioid receptor OPRM_CAVPO P97266 50914735 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C76H90N16O12/c1-4-5-23-58(68(97)90-64(38-66(94)95)73(102)87-60(67(78)96)32-45-16-7-6-8-17-45)85-71(100)62(34-51-39-83-57-24-14-13-22-54(51)57)89-69(98)59(25-15-28-82-76(79)80)86-70(99)61(33-46-26-27-47-18-9-10-19-48(47)31-46)88-72(101)63(36-52-40-81-42-84-52)91-74(103)65-35-49-20-11-12-21-50(49)41-92(65)75(104)56(77)37-55-43(2)29-53(93)30-44(55)3/h6-14,16-22,24,26-27,29-31,39-40,42,56,58-65,83,93H,4-5,15,23,25,28,32-38,41,77H2,1-3H3,(H2,78,96)(H,81,84)(H,85,100)(H,86,99)(H,87,102)(H,88,101)(H,89,98)(H,90,97)(H,91,103)(H,94,95)(H4,79,80,82) TVINVHGLLFLSBP-UHFFFAOYSA-N 50321596 (3S,6R,9S,12S,15S,18S)-3-((1H-imidazol-5-yl)methyl)-12-((1H-indol-3-yl)methyl)-18-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-1-(2-((R)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-15-butyl-9-(3-guanidinopropyl)-6-(naphthalen-2-ylmethyl)-1,4,7,10,13,16-hexaoxo-2,5,8,11,14,17-hexaazaicosan-20-oic acid::CHEMBL2372623 Delta-type opioid receptor Mus musculus 2.5 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321596 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000865&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321596&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 73354785 104143125 CHEMBL2372623 1 MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA 4EJ4 Delta-type opioid receptor OPRD_MOUSE P32300 50914736 C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(N)=O InChI=1S/C23H29N5O5/c1-14(27-23(33)18(24)11-16-7-9-17(29)10-8-16)22(32)26-13-20(30)28-19(21(25)31)12-15-5-3-2-4-6-15/h2-10,14,18-19,29H,11-13,24H2,1H3,(H2,25,31)(H,26,32)(H,27,33)(H,28,30) RJEUERNNQHNSKG-UHFFFAOYSA-N 21123 Enkephalin Amide::(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]propanamido]acetamido}-3-phenylpropanamide::YDAGF-NH2 Mu-type opioid receptor Cavia porcellus 47 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21123 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000882&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=21123&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 5490373 49689196 1 YTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKTVNVCNWI Mu-type opioid receptor OPRM_CAVPO P97266 50914737 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C76H90N16O12/c1-4-5-23-58(68(97)90-64(38-66(94)95)73(102)87-60(67(78)96)32-45-16-7-6-8-17-45)85-71(100)62(34-51-39-83-57-24-14-13-22-54(51)57)89-69(98)59(25-15-28-82-76(79)80)86-70(99)61(33-46-26-27-47-18-9-10-19-48(47)31-46)88-72(101)63(36-52-40-81-42-84-52)91-74(103)65-35-49-20-11-12-21-50(49)41-92(65)75(104)56(77)37-55-43(2)29-53(93)30-44(55)3/h6-14,16-22,24,26-27,29-31,39-40,42,56,58-65,83,93H,4-5,15,23,25,28,32-38,41,77H2,1-3H3,(H2,78,96)(H,81,84)(H,85,100)(H,86,99)(H,87,102)(H,88,101)(H,89,98)(H,90,97)(H,91,103)(H,94,95)(H4,79,80,82) TVINVHGLLFLSBP-UHFFFAOYSA-N 50321596 (3S,6R,9S,12S,15S,18S)-3-((1H-imidazol-5-yl)methyl)-12-((1H-indol-3-yl)methyl)-18-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-1-(2-((R)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-15-butyl-9-(3-guanidinopropyl)-6-(naphthalen-2-ylmethyl)-1,4,7,10,13,16-hexaoxo-2,5,8,11,14,17-hexaazaicosan-20-oic acid::CHEMBL2372623 Cholecystokinin receptor type A Homo sapiens 15 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321596 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2125&target=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321596&enzyme=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search 73354785 104143125 CHEMBL2372623 1 MDVVDSLLVNGSNITPPCELGLENETLFCLDQPRPSKEWQPAVQILLYSLIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLLKDFIFGSAVCKTTTYFMGTSVSVSTFNLVAISLERYGAICKPLQSRVWQTKSHALKVIAATWCLSFTIMTPYPIYSNLVPFTKNNNQTANMCRFLLPNDVMQQSWHTFLLLILFLIPGIVMMVAYGLISLELYQGIKFEASQKKSAKERKPSTTSSGKYEDSDGCYLQKTRPPRKLELRQLSTGSSSRANRIRSNSSAANLMAKKRVIRMLIVIVVLFFLCWMPIFSANAWRAYDTASAERRLSGTPISFILLLSYTSSCVNPIIYCFMNKRFRLGFMATFPCCPNPGPPGARGEVGEEEEGGTTGASLSRFSYSHMSASVPPQ 7XOV,7XOU,7EZM,7EZK,7EZH,7MBX,7MBY Cholecystokinin receptor type A CCKAR_HUMAN P32238 B2R9Z5 50914738 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C76H90N16O12/c1-4-5-23-58(68(97)90-64(38-66(94)95)73(102)87-60(67(78)96)32-45-16-7-6-8-17-45)85-71(100)62(34-51-39-83-57-24-14-13-22-54(51)57)89-69(98)59(25-15-28-82-76(79)80)86-70(99)61(33-46-26-27-47-18-9-10-19-48(47)31-46)88-72(101)63(36-52-40-81-42-84-52)91-74(103)65-35-49-20-11-12-21-50(49)41-92(65)75(104)56(77)37-55-43(2)29-53(93)30-44(55)3/h6-14,16-22,24,26-27,29-31,39-40,42,56,58-65,83,93H,4-5,15,23,25,28,32-38,41,77H2,1-3H3,(H2,78,96)(H,81,84)(H,85,100)(H,86,99)(H,87,102)(H,88,101)(H,89,98)(H,90,97)(H,91,103)(H,94,95)(H4,79,80,82) TVINVHGLLFLSBP-UHFFFAOYSA-N 50321596 (3S,6R,9S,12S,15S,18S)-3-((1H-imidazol-5-yl)methyl)-12-((1H-indol-3-yl)methyl)-18-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-1-(2-((R)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-15-butyl-9-(3-guanidinopropyl)-6-(naphthalen-2-ylmethyl)-1,4,7,10,13,16-hexaoxo-2,5,8,11,14,17-hexaazaicosan-20-oic acid::CHEMBL2372623 Gastrin/cholecystokinin type B receptor Homo sapiens 200 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321596 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2126&target=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321596&enzyme=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search 73354785 104143125 CHEMBL2372623 1 MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG 8IA7,7XOW Gastrin/cholecystokinin type B receptor GASR_HUMAN P32239 A8K7P9 O75824 Q16144 Q92492 Q96LC6 Q9NYK7 Q9UBV1 50914740 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C74H92N18O14/c1-3-4-24-54(67(100)92-61(38-63(95)96)73(106)88-56(64(76)97)33-44-17-8-5-9-18-44)86-71(104)59(36-48-39-81-53-25-15-14-23-51(48)53)90-68(101)55(26-16-31-80-74(77)78)87-70(103)58(35-46-21-12-7-13-22-46)89-72(105)60(37-49-40-79-42-83-49)91-69(102)57(34-45-19-10-6-11-20-45)85-62(94)41-82-65(98)43(2)84-66(99)52(75)32-47-27-29-50(93)30-28-47/h5-15,17-23,25,27-30,39-40,42-43,52,54-61,81,93H,3-4,16,24,26,31-38,41,75H2,1-2H3,(H2,76,97)(H,79,83)(H,82,98)(H,84,99)(H,85,94)(H,86,104)(H,87,103)(H,88,106)(H,89,105)(H,90,101)(H,91,102)(H,92,100)(H,95,96)(H4,77,78,80) ZUUGDHAKGUQZKD-UHFFFAOYSA-N 50321608 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-15,21-dibenzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxyphenyl)-27-methyl-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172251 Mu-type opioid receptor Rattus norvegicus 14 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321608 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321608&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798111 104143137 CHEMBL1172251 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50914741 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C74H92N18O14/c1-3-4-24-54(67(100)92-61(38-63(95)96)73(106)88-56(64(76)97)33-44-17-8-5-9-18-44)86-71(104)59(36-48-39-81-53-25-15-14-23-51(48)53)90-68(101)55(26-16-31-80-74(77)78)87-70(103)58(35-46-21-12-7-13-22-46)89-72(105)60(37-49-40-79-42-83-49)91-69(102)57(34-45-19-10-6-11-20-45)85-62(94)41-82-65(98)43(2)84-66(99)52(75)32-47-27-29-50(93)30-28-47/h5-15,17-23,25,27-30,39-40,42-43,52,54-61,81,93H,3-4,16,24,26,31-38,41,75H2,1-2H3,(H2,76,97)(H,79,83)(H,82,98)(H,84,99)(H,85,94)(H,86,104)(H,87,103)(H,88,106)(H,89,105)(H,90,101)(H,91,102)(H,92,100)(H,95,96)(H4,77,78,80) ZUUGDHAKGUQZKD-UHFFFAOYSA-N 50321608 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-15,21-dibenzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxyphenyl)-27-methyl-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172251 Cholecystokinin receptor type A Homo sapiens 1400 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321608 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2125&target=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321608&enzyme=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search 49798111 104143137 CHEMBL1172251 1 MDVVDSLLVNGSNITPPCELGLENETLFCLDQPRPSKEWQPAVQILLYSLIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLLKDFIFGSAVCKTTTYFMGTSVSVSTFNLVAISLERYGAICKPLQSRVWQTKSHALKVIAATWCLSFTIMTPYPIYSNLVPFTKNNNQTANMCRFLLPNDVMQQSWHTFLLLILFLIPGIVMMVAYGLISLELYQGIKFEASQKKSAKERKPSTTSSGKYEDSDGCYLQKTRPPRKLELRQLSTGSSSRANRIRSNSSAANLMAKKRVIRMLIVIVVLFFLCWMPIFSANAWRAYDTASAERRLSGTPISFILLLSYTSSCVNPIIYCFMNKRFRLGFMATFPCCPNPGPPGARGEVGEEEEGGTTGASLSRFSYSHMSASVPPQ 7XOV,7XOU,7EZM,7EZK,7EZH,7MBX,7MBY Cholecystokinin receptor type A CCKAR_HUMAN P32238 B2R9Z5 50914742 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C74H92N18O14/c1-3-4-24-54(67(100)92-61(38-63(95)96)73(106)88-56(64(76)97)33-44-17-8-5-9-18-44)86-71(104)59(36-48-39-81-53-25-15-14-23-51(48)53)90-68(101)55(26-16-31-80-74(77)78)87-70(103)58(35-46-21-12-7-13-22-46)89-72(105)60(37-49-40-79-42-83-49)91-69(102)57(34-45-19-10-6-11-20-45)85-62(94)41-82-65(98)43(2)84-66(99)52(75)32-47-27-29-50(93)30-28-47/h5-15,17-23,25,27-30,39-40,42-43,52,54-61,81,93H,3-4,16,24,26,31-38,41,75H2,1-2H3,(H2,76,97)(H,79,83)(H,82,98)(H,84,99)(H,85,94)(H,86,104)(H,87,103)(H,88,106)(H,89,105)(H,90,101)(H,91,102)(H,92,100)(H,95,96)(H4,77,78,80) ZUUGDHAKGUQZKD-UHFFFAOYSA-N 50321608 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-15,21-dibenzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxyphenyl)-27-methyl-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172251 Gastrin/cholecystokinin type B receptor Homo sapiens 18 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321608 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2126&target=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321608&enzyme=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798111 104143137 CHEMBL1172251 1 MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG 8IA7,7XOW Gastrin/cholecystokinin type B receptor GASR_HUMAN P32239 A8K7P9 O75824 Q16144 Q92492 Q96LC6 Q9NYK7 Q9UBV1 50914744 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C78H94N18O14/c1-3-4-23-58(71(104)96-65(40-67(99)100)77(110)92-60(68(80)101)35-46-16-7-5-8-17-46)90-75(108)63(38-52-41-85-57-24-14-13-22-55(52)57)94-72(105)59(25-15-32-84-78(81)82)91-74(107)62(37-49-26-29-50-20-11-12-21-51(50)33-49)93-76(109)64(39-53-42-83-44-87-53)95-73(106)61(36-47-18-9-6-10-19-47)89-66(98)43-86-69(102)45(2)88-70(103)56(79)34-48-27-30-54(97)31-28-48/h5-14,16-22,24,26-31,33,41-42,44-45,56,58-65,85,97H,3-4,15,23,25,32,34-40,43,79H2,1-2H3,(H2,80,101)(H,83,87)(H,86,102)(H,88,103)(H,89,98)(H,90,108)(H,91,107)(H,92,110)(H,93,109)(H,94,105)(H,95,106)(H,96,104)(H,99,100)(H4,81,82,84) ZZVLKHHSRQKCEV-UHFFFAOYSA-N 50321607 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxyphenyl)-27-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172252 Mu-type opioid receptor Rattus norvegicus 0.690000 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321607 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321607&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798112 104143136 CHEMBL1172252 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50914745 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C78H94N18O14/c1-3-4-23-58(71(104)96-65(40-67(99)100)77(110)92-60(68(80)101)35-46-16-7-5-8-17-46)90-75(108)63(38-52-41-85-57-24-14-13-22-55(52)57)94-72(105)59(25-15-32-84-78(81)82)91-74(107)62(37-49-26-29-50-20-11-12-21-51(50)33-49)93-76(109)64(39-53-42-83-44-87-53)95-73(106)61(36-47-18-9-6-10-19-47)89-66(98)43-86-69(102)45(2)88-70(103)56(79)34-48-27-30-54(97)31-28-48/h5-14,16-22,24,26-31,33,41-42,44-45,56,58-65,85,97H,3-4,15,23,25,32,34-40,43,79H2,1-2H3,(H2,80,101)(H,83,87)(H,86,102)(H,88,103)(H,89,98)(H,90,108)(H,91,107)(H,92,110)(H,93,109)(H,94,105)(H,95,106)(H,96,104)(H,99,100)(H4,81,82,84) ZZVLKHHSRQKCEV-UHFFFAOYSA-N 50321607 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxyphenyl)-27-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172252 Cholecystokinin receptor type A Homo sapiens 9 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321607 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2125&target=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321607&enzyme=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search 49798112 104143136 CHEMBL1172252 1 MDVVDSLLVNGSNITPPCELGLENETLFCLDQPRPSKEWQPAVQILLYSLIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLLKDFIFGSAVCKTTTYFMGTSVSVSTFNLVAISLERYGAICKPLQSRVWQTKSHALKVIAATWCLSFTIMTPYPIYSNLVPFTKNNNQTANMCRFLLPNDVMQQSWHTFLLLILFLIPGIVMMVAYGLISLELYQGIKFEASQKKSAKERKPSTTSSGKYEDSDGCYLQKTRPPRKLELRQLSTGSSSRANRIRSNSSAANLMAKKRVIRMLIVIVVLFFLCWMPIFSANAWRAYDTASAERRLSGTPISFILLLSYTSSCVNPIIYCFMNKRFRLGFMATFPCCPNPGPPGARGEVGEEEEGGTTGASLSRFSYSHMSASVPPQ 7XOV,7XOU,7EZM,7EZK,7EZH,7MBX,7MBY Cholecystokinin receptor type A CCKAR_HUMAN P32238 B2R9Z5 50914746 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C78H94N18O14/c1-3-4-23-58(71(104)96-65(40-67(99)100)77(110)92-60(68(80)101)35-46-16-7-5-8-17-46)90-75(108)63(38-52-41-85-57-24-14-13-22-55(52)57)94-72(105)59(25-15-32-84-78(81)82)91-74(107)62(37-49-26-29-50-20-11-12-21-51(50)33-49)93-76(109)64(39-53-42-83-44-87-53)95-73(106)61(36-47-18-9-6-10-19-47)89-66(98)43-86-69(102)45(2)88-70(103)56(79)34-48-27-30-54(97)31-28-48/h5-14,16-22,24,26-31,33,41-42,44-45,56,58-65,85,97H,3-4,15,23,25,32,34-40,43,79H2,1-2H3,(H2,80,101)(H,83,87)(H,86,102)(H,88,103)(H,89,98)(H,90,108)(H,91,107)(H,92,110)(H,93,109)(H,94,105)(H,95,106)(H,96,104)(H,99,100)(H4,81,82,84) ZZVLKHHSRQKCEV-UHFFFAOYSA-N 50321607 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxyphenyl)-27-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172252 Gastrin/cholecystokinin type B receptor Homo sapiens 120 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321607 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2126&target=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321607&enzyme=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798112 104143136 CHEMBL1172252 1 MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG 8IA7,7XOW Gastrin/cholecystokinin type B receptor GASR_HUMAN P32239 A8K7P9 O75824 Q16144 Q92492 Q96LC6 Q9NYK7 Q9UBV1 50914748 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:8.20,58.71,93.99,78.84,wD:73.79,48.59,22.31,33.48,4.4,101.107,(24.59,-5.48,;25.93,-4.72,;25.93,-3.18,;24.59,-2.4,;24.59,-.86,;23.26,-.1,;21.93,-.87,;21.93,-2.41,;20.59,-.11,;20.59,1.44,;22,2.07,;23.25,1.19,;24.48,2.12,;23.98,3.58,;24.73,4.92,;23.94,6.24,;22.4,6.22,;21.65,4.87,;22.44,3.55,;19.25,-.87,;17.91,-.12,;17.91,1.43,;16.57,-.89,;16.57,-2.43,;17.91,-3.2,;17.91,-4.73,;19.24,-5.51,;19.24,-7.05,;17.93,-7.8,;20.61,-7.81,;15.25,-.1,;13.92,-.87,;13.92,-2.41,;12.59,-.1,;12.6,1.44,;13.92,2.21,;15.26,1.44,;16.59,2.21,;16.6,3.75,;17.93,4.53,;17.92,6.07,;16.58,6.84,;15.25,6.06,;15.26,4.52,;13.92,3.75,;11.26,-.86,;9.92,-.1,;9.92,1.45,;8.58,-.87,;8.58,-2.41,;9.92,-3.18,;11.32,-2.55,;12.36,-3.69,;11.59,-5.03,;10.08,-4.71,;7.25,-.09,;5.91,-.85,;5.91,-2.39,;4.58,-.08,;4.58,1.46,;5.91,2.23,;7.25,1.47,;8.58,2.24,;8.58,3.78,;7.24,4.55,;5.91,3.78,;3.25,-.85,;1.92,-.07,;1.92,1.47,;.58,-.85,;-.75,-.07,;-2.08,-.85,;-2.08,-2.38,;-3.41,-.07,;-3.41,1.47,;-4.75,-.84,;-6.09,-.08,;-6.09,1.47,;-7.42,-.86,;-7.4,-2.4,;-8.75,-.1,;-10.08,-.88,;-10.06,-2.42,;-8.72,-3.17,;-11.4,-3.2,;-12.73,-2.44,;-14.07,-3.22,;-12.76,-.9,;-11.41,-.13,;-11.43,1.41,;25.93,-.09,;25.93,1.45,;27.26,-.87,;28.59,-.09,;28.59,1.45,;29.93,2.21,;31.25,1.45,;29.93,3.76,;29.93,-.87,;29.93,-2.4,;31.26,-.1,;32.6,-.87,;32.6,-2.4,;33.93,-3.17,;35.28,-2.4,;36.61,-3.17,;36.61,-4.71,;35.27,-5.48,;33.94,-4.71,;33.93,-.1,;35.27,-.86,;33.93,1.45,)| InChI=1S/C80H98N18O14/c1-5-6-25-60(73(106)98-67(40-69(101)102)79(112)94-62(70(82)103)34-48-18-9-7-10-19-48)92-77(110)65(37-53-41-87-59-26-16-15-24-56(53)59)96-74(107)61(27-17-30-86-80(83)84)93-76(109)64(36-50-28-29-51-22-13-14-23-52(51)33-50)95-78(111)66(38-54-42-85-44-89-54)97-75(108)63(35-49-20-11-8-12-21-49)91-68(100)43-88-71(104)47(4)90-72(105)58(81)39-57-45(2)31-55(99)32-46(57)3/h7-16,18-24,26,28-29,31-33,41-42,44,47,58,60-67,87,99H,5-6,17,25,27,30,34-40,43,81H2,1-4H3,(H2,82,103)(H,85,89)(H,88,104)(H,90,105)(H,91,100)(H,92,110)(H,93,109)(H,94,112)(H,95,111)(H,96,107)(H,97,108)(H,98,106)(H,101,102)(H4,83,84,86) AHRZYQWKXXBNHK-UHFFFAOYSA-N 50321606 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxy-2,6-dimethylphenyl)-27-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172253 Mu-type opioid receptor Rattus norvegicus 0.130000 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321606 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321606&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933506 104143135 CHEMBL1172253 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50914749 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:8.20,58.71,93.99,78.84,wD:73.79,48.59,22.31,33.48,4.4,101.107,(24.59,-5.48,;25.93,-4.72,;25.93,-3.18,;24.59,-2.4,;24.59,-.86,;23.26,-.1,;21.93,-.87,;21.93,-2.41,;20.59,-.11,;20.59,1.44,;22,2.07,;23.25,1.19,;24.48,2.12,;23.98,3.58,;24.73,4.92,;23.94,6.24,;22.4,6.22,;21.65,4.87,;22.44,3.55,;19.25,-.87,;17.91,-.12,;17.91,1.43,;16.57,-.89,;16.57,-2.43,;17.91,-3.2,;17.91,-4.73,;19.24,-5.51,;19.24,-7.05,;17.93,-7.8,;20.61,-7.81,;15.25,-.1,;13.92,-.87,;13.92,-2.41,;12.59,-.1,;12.6,1.44,;13.92,2.21,;15.26,1.44,;16.59,2.21,;16.6,3.75,;17.93,4.53,;17.92,6.07,;16.58,6.84,;15.25,6.06,;15.26,4.52,;13.92,3.75,;11.26,-.86,;9.92,-.1,;9.92,1.45,;8.58,-.87,;8.58,-2.41,;9.92,-3.18,;11.32,-2.55,;12.36,-3.69,;11.59,-5.03,;10.08,-4.71,;7.25,-.09,;5.91,-.85,;5.91,-2.39,;4.58,-.08,;4.58,1.46,;5.91,2.23,;7.25,1.47,;8.58,2.24,;8.58,3.78,;7.24,4.55,;5.91,3.78,;3.25,-.85,;1.92,-.07,;1.92,1.47,;.58,-.85,;-.75,-.07,;-2.08,-.85,;-2.08,-2.38,;-3.41,-.07,;-3.41,1.47,;-4.75,-.84,;-6.09,-.08,;-6.09,1.47,;-7.42,-.86,;-7.4,-2.4,;-8.75,-.1,;-10.08,-.88,;-10.06,-2.42,;-8.72,-3.17,;-11.4,-3.2,;-12.73,-2.44,;-14.07,-3.22,;-12.76,-.9,;-11.41,-.13,;-11.43,1.41,;25.93,-.09,;25.93,1.45,;27.26,-.87,;28.59,-.09,;28.59,1.45,;29.93,2.21,;31.25,1.45,;29.93,3.76,;29.93,-.87,;29.93,-2.4,;31.26,-.1,;32.6,-.87,;32.6,-2.4,;33.93,-3.17,;35.28,-2.4,;36.61,-3.17,;36.61,-4.71,;35.27,-5.48,;33.94,-4.71,;33.93,-.1,;35.27,-.86,;33.93,1.45,)| InChI=1S/C80H98N18O14/c1-5-6-25-60(73(106)98-67(40-69(101)102)79(112)94-62(70(82)103)34-48-18-9-7-10-19-48)92-77(110)65(37-53-41-87-59-26-16-15-24-56(53)59)96-74(107)61(27-17-30-86-80(83)84)93-76(109)64(36-50-28-29-51-22-13-14-23-52(51)33-50)95-78(111)66(38-54-42-85-44-89-54)97-75(108)63(35-49-20-11-8-12-21-49)91-68(100)43-88-71(104)47(4)90-72(105)58(81)39-57-45(2)31-55(99)32-46(57)3/h7-16,18-24,26,28-29,31-33,41-42,44,47,58,60-67,87,99H,5-6,17,25,27,30,34-40,43,81H2,1-4H3,(H2,82,103)(H,85,89)(H,88,104)(H,90,105)(H,91,100)(H,92,110)(H,93,109)(H,94,112)(H,95,111)(H,96,107)(H,97,108)(H,98,106)(H,101,102)(H4,83,84,86) AHRZYQWKXXBNHK-UHFFFAOYSA-N 50321606 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxy-2,6-dimethylphenyl)-27-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172253 Cholecystokinin receptor type A Homo sapiens 18 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321606 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2125&target=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321606&enzyme=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search 91933506 104143135 CHEMBL1172253 1 MDVVDSLLVNGSNITPPCELGLENETLFCLDQPRPSKEWQPAVQILLYSLIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLLKDFIFGSAVCKTTTYFMGTSVSVSTFNLVAISLERYGAICKPLQSRVWQTKSHALKVIAATWCLSFTIMTPYPIYSNLVPFTKNNNQTANMCRFLLPNDVMQQSWHTFLLLILFLIPGIVMMVAYGLISLELYQGIKFEASQKKSAKERKPSTTSSGKYEDSDGCYLQKTRPPRKLELRQLSTGSSSRANRIRSNSSAANLMAKKRVIRMLIVIVVLFFLCWMPIFSANAWRAYDTASAERRLSGTPISFILLLSYTSSCVNPIIYCFMNKRFRLGFMATFPCCPNPGPPGARGEVGEEEEGGTTGASLSRFSYSHMSASVPPQ 7XOV,7XOU,7EZM,7EZK,7EZH,7MBX,7MBY Cholecystokinin receptor type A CCKAR_HUMAN P32238 B2R9Z5 50914750 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:8.20,58.71,93.99,78.84,wD:73.79,48.59,22.31,33.48,4.4,101.107,(24.59,-5.48,;25.93,-4.72,;25.93,-3.18,;24.59,-2.4,;24.59,-.86,;23.26,-.1,;21.93,-.87,;21.93,-2.41,;20.59,-.11,;20.59,1.44,;22,2.07,;23.25,1.19,;24.48,2.12,;23.98,3.58,;24.73,4.92,;23.94,6.24,;22.4,6.22,;21.65,4.87,;22.44,3.55,;19.25,-.87,;17.91,-.12,;17.91,1.43,;16.57,-.89,;16.57,-2.43,;17.91,-3.2,;17.91,-4.73,;19.24,-5.51,;19.24,-7.05,;17.93,-7.8,;20.61,-7.81,;15.25,-.1,;13.92,-.87,;13.92,-2.41,;12.59,-.1,;12.6,1.44,;13.92,2.21,;15.26,1.44,;16.59,2.21,;16.6,3.75,;17.93,4.53,;17.92,6.07,;16.58,6.84,;15.25,6.06,;15.26,4.52,;13.92,3.75,;11.26,-.86,;9.92,-.1,;9.92,1.45,;8.58,-.87,;8.58,-2.41,;9.92,-3.18,;11.32,-2.55,;12.36,-3.69,;11.59,-5.03,;10.08,-4.71,;7.25,-.09,;5.91,-.85,;5.91,-2.39,;4.58,-.08,;4.58,1.46,;5.91,2.23,;7.25,1.47,;8.58,2.24,;8.58,3.78,;7.24,4.55,;5.91,3.78,;3.25,-.85,;1.92,-.07,;1.92,1.47,;.58,-.85,;-.75,-.07,;-2.08,-.85,;-2.08,-2.38,;-3.41,-.07,;-3.41,1.47,;-4.75,-.84,;-6.09,-.08,;-6.09,1.47,;-7.42,-.86,;-7.4,-2.4,;-8.75,-.1,;-10.08,-.88,;-10.06,-2.42,;-8.72,-3.17,;-11.4,-3.2,;-12.73,-2.44,;-14.07,-3.22,;-12.76,-.9,;-11.41,-.13,;-11.43,1.41,;25.93,-.09,;25.93,1.45,;27.26,-.87,;28.59,-.09,;28.59,1.45,;29.93,2.21,;31.25,1.45,;29.93,3.76,;29.93,-.87,;29.93,-2.4,;31.26,-.1,;32.6,-.87,;32.6,-2.4,;33.93,-3.17,;35.28,-2.4,;36.61,-3.17,;36.61,-4.71,;35.27,-5.48,;33.94,-4.71,;33.93,-.1,;35.27,-.86,;33.93,1.45,)| InChI=1S/C80H98N18O14/c1-5-6-25-60(73(106)98-67(40-69(101)102)79(112)94-62(70(82)103)34-48-18-9-7-10-19-48)92-77(110)65(37-53-41-87-59-26-16-15-24-56(53)59)96-74(107)61(27-17-30-86-80(83)84)93-76(109)64(36-50-28-29-51-22-13-14-23-52(51)33-50)95-78(111)66(38-54-42-85-44-89-54)97-75(108)63(35-49-20-11-8-12-21-49)91-68(100)43-88-71(104)47(4)90-72(105)58(81)39-57-45(2)31-55(99)32-46(57)3/h7-16,18-24,26,28-29,31-33,41-42,44,47,58,60-67,87,99H,5-6,17,25,27,30,34-40,43,81H2,1-4H3,(H2,82,103)(H,85,89)(H,88,104)(H,90,105)(H,91,100)(H,92,110)(H,93,109)(H,94,112)(H,95,111)(H,96,107)(H,97,108)(H,98,106)(H,101,102)(H4,83,84,86) AHRZYQWKXXBNHK-UHFFFAOYSA-N 50321606 (3S,6S,9S,12S,15R,18S,21S,27R,30S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-30-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-31-(4-hydroxy-2,6-dimethylphenyl)-27-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26,29-nonaoxo-4,7,10,13,16,19,22,25,28-nonaazahentriacontan-1-oic acid::CHEMBL1172253 Gastrin/cholecystokinin type B receptor Homo sapiens 110 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321606 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2126&target=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321606&enzyme=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933506 104143135 CHEMBL1172253 1 MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG 8IA7,7XOW Gastrin/cholecystokinin type B receptor GASR_HUMAN P32239 A8K7P9 O75824 Q16144 Q92492 Q96LC6 Q9NYK7 Q9UBV1 50914752 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:69.75,8.20,58.71,89.95,wD:48.59,22.31,33.48,4.4,97.103,74.80,(28.82,-7.95,;30.15,-7.19,;30.15,-5.65,;28.82,-4.88,;28.82,-3.34,;27.48,-2.57,;26.15,-3.35,;26.15,-4.89,;24.82,-2.58,;24.82,-1.03,;26.22,-.4,;27.48,-1.28,;28.71,-.35,;28.21,1.11,;28.95,2.45,;28.16,3.77,;26.62,3.74,;25.87,2.4,;26.66,1.08,;23.48,-3.34,;22.13,-2.59,;22.13,-1.04,;20.8,-3.36,;20.8,-4.9,;22.13,-5.67,;22.13,-7.21,;23.47,-7.98,;23.47,-9.52,;22.16,-10.27,;24.84,-10.28,;19.47,-2.57,;18.15,-3.35,;18.15,-4.88,;16.82,-2.57,;16.82,-1.03,;18.15,-.26,;19.48,-1.03,;20.81,-.26,;20.82,1.28,;22.15,2.06,;22.15,3.6,;20.8,4.36,;19.47,3.58,;19.48,2.05,;18.14,1.28,;15.48,-3.33,;14.14,-2.57,;14.14,-1.02,;12.8,-3.34,;12.8,-4.88,;14.14,-5.65,;15.55,-5.02,;16.59,-6.17,;15.81,-7.5,;14.31,-7.18,;11.47,-2.57,;10.13,-3.32,;10.13,-4.86,;8.81,-2.55,;8.81,-1.01,;10.13,-.25,;11.47,-1.01,;12.81,-.24,;12.8,1.31,;11.47,2.07,;10.14,1.3,;7.47,-3.33,;6.13,-2.55,;6.13,-1.01,;4.8,-3.33,;4.8,-4.87,;3.47,-2.56,;2.12,-3.32,;2.13,-4.86,;.8,-2.54,;.81,-1,;-.54,-3.3,;-1.86,-2.52,;-1.85,-.98,;-.51,-.23,;-3.18,-.2,;-4.52,-.96,;-5.84,-.18,;-4.53,-2.49,;-3.2,-3.27,;-3.21,-4.81,;30.15,-2.57,;30.15,-1.03,;31.49,-3.34,;32.82,-2.57,;32.82,-1.02,;34.15,-.26,;35.48,-1.03,;34.15,1.29,;34.15,-3.34,;34.15,-4.88,;35.49,-2.57,;36.82,-3.34,;36.82,-4.88,;38.16,-5.65,;39.5,-4.87,;40.83,-5.65,;40.84,-7.18,;39.5,-7.95,;38.16,-7.19,;38.16,-2.57,;39.49,-3.33,;38.16,-1.02,)| InChI=1S/C78H95N17O13/c1-5-6-25-59(71(102)95-66(40-67(97)98)77(108)90-61(68(80)99)34-47-18-9-7-10-19-47)88-75(106)64(37-52-41-85-58-26-16-15-24-55(52)58)93-72(103)60(27-17-30-84-78(81)82)89-73(104)63(36-49-28-29-50-22-13-14-23-51(50)33-49)92-76(107)65(38-53-42-83-43-86-53)94-74(105)62(35-48-20-11-8-12-21-48)91-69(100)46(4)87-70(101)57(79)39-56-44(2)31-54(96)32-45(56)3/h7-16,18-24,26,28-29,31-33,41-43,46,57,59-66,85,96H,5-6,17,25,27,30,34-40,79H2,1-4H3,(H2,80,99)(H,83,86)(H,87,101)(H,88,106)(H,89,104)(H,90,108)(H,91,100)(H,92,107)(H,93,103)(H,94,105)(H,95,102)(H,97,98)(H4,81,82,84) JMDKMESJXNSGPX-UHFFFAOYSA-N 50321605 (6R,9S,12S,15R,18S,21S,24S,27S)-12-((1H-imidazol-5-yl)methyl)-21-((1H-indol-3-yl)methyl)-27-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-9-benzyl-24-butyl-18-(3-guanidinopropyl)-1-(4-hydroxy-2,6-dimethylphenyl)-6-methyl-15-(naphthalen-2-ylmethyl)-4,7,10,13,16,19,22,25-octaoxo-3,5,8,11,14,17,20,23,26-nonaazanonacosan-29-oic acid::CHEMBL1172428 Mu-type opioid receptor Rattus norvegicus 4.9 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321605 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321605&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933505 104143134 CHEMBL1172428 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50914753 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:69.75,8.20,58.71,89.95,wD:48.59,22.31,33.48,4.4,97.103,74.80,(28.82,-7.95,;30.15,-7.19,;30.15,-5.65,;28.82,-4.88,;28.82,-3.34,;27.48,-2.57,;26.15,-3.35,;26.15,-4.89,;24.82,-2.58,;24.82,-1.03,;26.22,-.4,;27.48,-1.28,;28.71,-.35,;28.21,1.11,;28.95,2.45,;28.16,3.77,;26.62,3.74,;25.87,2.4,;26.66,1.08,;23.48,-3.34,;22.13,-2.59,;22.13,-1.04,;20.8,-3.36,;20.8,-4.9,;22.13,-5.67,;22.13,-7.21,;23.47,-7.98,;23.47,-9.52,;22.16,-10.27,;24.84,-10.28,;19.47,-2.57,;18.15,-3.35,;18.15,-4.88,;16.82,-2.57,;16.82,-1.03,;18.15,-.26,;19.48,-1.03,;20.81,-.26,;20.82,1.28,;22.15,2.06,;22.15,3.6,;20.8,4.36,;19.47,3.58,;19.48,2.05,;18.14,1.28,;15.48,-3.33,;14.14,-2.57,;14.14,-1.02,;12.8,-3.34,;12.8,-4.88,;14.14,-5.65,;15.55,-5.02,;16.59,-6.17,;15.81,-7.5,;14.31,-7.18,;11.47,-2.57,;10.13,-3.32,;10.13,-4.86,;8.81,-2.55,;8.81,-1.01,;10.13,-.25,;11.47,-1.01,;12.81,-.24,;12.8,1.31,;11.47,2.07,;10.14,1.3,;7.47,-3.33,;6.13,-2.55,;6.13,-1.01,;4.8,-3.33,;4.8,-4.87,;3.47,-2.56,;2.12,-3.32,;2.13,-4.86,;.8,-2.54,;.81,-1,;-.54,-3.3,;-1.86,-2.52,;-1.85,-.98,;-.51,-.23,;-3.18,-.2,;-4.52,-.96,;-5.84,-.18,;-4.53,-2.49,;-3.2,-3.27,;-3.21,-4.81,;30.15,-2.57,;30.15,-1.03,;31.49,-3.34,;32.82,-2.57,;32.82,-1.02,;34.15,-.26,;35.48,-1.03,;34.15,1.29,;34.15,-3.34,;34.15,-4.88,;35.49,-2.57,;36.82,-3.34,;36.82,-4.88,;38.16,-5.65,;39.5,-4.87,;40.83,-5.65,;40.84,-7.18,;39.5,-7.95,;38.16,-7.19,;38.16,-2.57,;39.49,-3.33,;38.16,-1.02,)| InChI=1S/C78H95N17O13/c1-5-6-25-59(71(102)95-66(40-67(97)98)77(108)90-61(68(80)99)34-47-18-9-7-10-19-47)88-75(106)64(37-52-41-85-58-26-16-15-24-55(52)58)93-72(103)60(27-17-30-84-78(81)82)89-73(104)63(36-49-28-29-50-22-13-14-23-51(50)33-49)92-76(107)65(38-53-42-83-43-86-53)94-74(105)62(35-48-20-11-8-12-21-48)91-69(100)46(4)87-70(101)57(79)39-56-44(2)31-54(96)32-45(56)3/h7-16,18-24,26,28-29,31-33,41-43,46,57,59-66,85,96H,5-6,17,25,27,30,34-40,79H2,1-4H3,(H2,80,99)(H,83,86)(H,87,101)(H,88,106)(H,89,104)(H,90,108)(H,91,100)(H,92,107)(H,93,103)(H,94,105)(H,95,102)(H,97,98)(H4,81,82,84) JMDKMESJXNSGPX-UHFFFAOYSA-N 50321605 (6R,9S,12S,15R,18S,21S,24S,27S)-12-((1H-imidazol-5-yl)methyl)-21-((1H-indol-3-yl)methyl)-27-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-9-benzyl-24-butyl-18-(3-guanidinopropyl)-1-(4-hydroxy-2,6-dimethylphenyl)-6-methyl-15-(naphthalen-2-ylmethyl)-4,7,10,13,16,19,22,25-octaoxo-3,5,8,11,14,17,20,23,26-nonaazanonacosan-29-oic acid::CHEMBL1172428 Gastrin/cholecystokinin type B receptor Homo sapiens 180 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321605 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2126&target=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321605&enzyme=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933505 104143134 CHEMBL1172428 1 MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG 8IA7,7XOW Gastrin/cholecystokinin type B receptor GASR_HUMAN P32239 A8K7P9 O75824 Q16144 Q92492 Q96LC6 Q9NYK7 Q9UBV1 50914755 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:58.71,74.80,8.20,87.93,69.75,wD:48.59,22.31,4.4,33.48,95.101,(27.14,-11.6,;25.81,-10.83,;25.81,-9.29,;24.47,-8.52,;24.47,-6.97,;23.14,-6.2,;21.8,-6.97,;21.8,-8.5,;20.47,-6.2,;20.47,-4.66,;21.89,-4.07,;23.12,-5,;24.38,-4.1,;23.93,-2.63,;24.71,-1.31,;23.96,.04,;22.43,.05,;21.64,-1.26,;22.38,-2.61,;19.13,-6.97,;17.8,-6.2,;17.8,-4.66,;16.46,-6.97,;16.46,-8.51,;17.8,-9.28,;17.8,-10.82,;19.14,-11.58,;19.13,-13.12,;17.8,-13.89,;20.46,-13.9,;15.12,-6.21,;13.78,-6.97,;13.78,-8.51,;12.45,-6.2,;12.42,-4.66,;13.74,-3.87,;15.09,-4.61,;16.4,-3.81,;16.37,-2.28,;17.69,-1.49,;17.67,.05,;16.32,.8,;15,.01,;15.03,-1.52,;13.71,-2.32,;11.12,-6.97,;9.78,-6.21,;9.78,-4.66,;8.44,-6.98,;8.44,-8.51,;9.78,-9.29,;11.18,-8.65,;12.21,-9.8,;11.45,-11.14,;9.94,-10.82,;7.1,-6.21,;5.76,-6.97,;5.76,-8.5,;4.43,-6.2,;4.43,-4.66,;5.76,-3.89,;7.1,-4.65,;8.42,-3.88,;8.42,-2.34,;7.09,-1.57,;5.75,-2.34,;3.1,-6.99,;1.76,-6.22,;1.76,-4.68,;.42,-6.99,;.42,-8.53,;-.9,-6.21,;-2.25,-6.97,;-2.25,-8.51,;-3.58,-6.2,;-4.91,-6.98,;-3.58,-4.66,;-2.25,-3.89,;-.92,-4.66,;.41,-3.89,;.4,-2.35,;1.77,-1.59,;-.92,-1.58,;-2.25,-2.35,;25.81,-6.21,;25.81,-4.67,;27.15,-6.98,;28.48,-6.21,;28.48,-4.66,;29.82,-3.89,;31.15,-4.66,;29.82,-2.35,;29.82,-6.97,;29.82,-8.51,;31.15,-6.2,;32.49,-6.97,;32.49,-8.5,;33.83,-9.28,;35.16,-8.5,;36.5,-9.28,;36.5,-10.82,;35.16,-11.58,;33.83,-10.81,;33.83,-6.2,;35.15,-6.96,;33.83,-4.65,)| InChI=1S/C76H91N17O13/c1-3-4-23-57(69(100)93-64(40-65(95)96)75(106)88-59(66(78)97)35-45-16-7-5-8-17-45)86-73(104)62(38-51-41-83-56-24-14-13-22-54(51)56)91-70(101)58(25-15-32-82-76(79)80)87-71(102)61(37-48-26-29-49-20-11-12-21-50(49)33-48)90-74(105)63(39-52-42-81-43-84-52)92-72(103)60(36-46-18-9-6-10-19-46)89-67(98)44(2)85-68(99)55(77)34-47-27-30-53(94)31-28-47/h5-14,16-22,24,26-31,33,41-44,55,57-64,83,94H,3-4,15,23,25,32,34-40,77H2,1-2H3,(H2,78,97)(H,81,84)(H,85,99)(H,86,104)(H,87,102)(H,88,106)(H,89,98)(H,90,105)(H,91,101)(H,92,103)(H,93,100)(H,95,96)(H4,79,80,82) NENKRICCIWXRGU-UHFFFAOYSA-N 50321604 (3S,6S,9S,12S,15R,18S,21S,24R,27S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-27-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-28-(4-hydroxyphenyl)-24-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26-octaoxo-4,7,10,13,16,19,22,25-octaazaoctacosan-1-oic acid::CHEMBL1172429 Mu-type opioid receptor Rattus norvegicus 250 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321604 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321604&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933504 104143133 CHEMBL1172429 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50914756 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:58.71,74.80,8.20,87.93,69.75,wD:48.59,22.31,4.4,33.48,95.101,(27.14,-11.6,;25.81,-10.83,;25.81,-9.29,;24.47,-8.52,;24.47,-6.97,;23.14,-6.2,;21.8,-6.97,;21.8,-8.5,;20.47,-6.2,;20.47,-4.66,;21.89,-4.07,;23.12,-5,;24.38,-4.1,;23.93,-2.63,;24.71,-1.31,;23.96,.04,;22.43,.05,;21.64,-1.26,;22.38,-2.61,;19.13,-6.97,;17.8,-6.2,;17.8,-4.66,;16.46,-6.97,;16.46,-8.51,;17.8,-9.28,;17.8,-10.82,;19.14,-11.58,;19.13,-13.12,;17.8,-13.89,;20.46,-13.9,;15.12,-6.21,;13.78,-6.97,;13.78,-8.51,;12.45,-6.2,;12.42,-4.66,;13.74,-3.87,;15.09,-4.61,;16.4,-3.81,;16.37,-2.28,;17.69,-1.49,;17.67,.05,;16.32,.8,;15,.01,;15.03,-1.52,;13.71,-2.32,;11.12,-6.97,;9.78,-6.21,;9.78,-4.66,;8.44,-6.98,;8.44,-8.51,;9.78,-9.29,;11.18,-8.65,;12.21,-9.8,;11.45,-11.14,;9.94,-10.82,;7.1,-6.21,;5.76,-6.97,;5.76,-8.5,;4.43,-6.2,;4.43,-4.66,;5.76,-3.89,;7.1,-4.65,;8.42,-3.88,;8.42,-2.34,;7.09,-1.57,;5.75,-2.34,;3.1,-6.99,;1.76,-6.22,;1.76,-4.68,;.42,-6.99,;.42,-8.53,;-.9,-6.21,;-2.25,-6.97,;-2.25,-8.51,;-3.58,-6.2,;-4.91,-6.98,;-3.58,-4.66,;-2.25,-3.89,;-.92,-4.66,;.41,-3.89,;.4,-2.35,;1.77,-1.59,;-.92,-1.58,;-2.25,-2.35,;25.81,-6.21,;25.81,-4.67,;27.15,-6.98,;28.48,-6.21,;28.48,-4.66,;29.82,-3.89,;31.15,-4.66,;29.82,-2.35,;29.82,-6.97,;29.82,-8.51,;31.15,-6.2,;32.49,-6.97,;32.49,-8.5,;33.83,-9.28,;35.16,-8.5,;36.5,-9.28,;36.5,-10.82,;35.16,-11.58,;33.83,-10.81,;33.83,-6.2,;35.15,-6.96,;33.83,-4.65,)| InChI=1S/C76H91N17O13/c1-3-4-23-57(69(100)93-64(40-65(95)96)75(106)88-59(66(78)97)35-45-16-7-5-8-17-45)86-73(104)62(38-51-41-83-56-24-14-13-22-54(51)56)91-70(101)58(25-15-32-82-76(79)80)87-71(102)61(37-48-26-29-49-20-11-12-21-50(49)33-48)90-74(105)63(39-52-42-81-43-84-52)92-72(103)60(36-46-18-9-6-10-19-46)89-67(98)44(2)85-68(99)55(77)34-47-27-30-53(94)31-28-47/h5-14,16-22,24,26-31,33,41-44,55,57-64,83,94H,3-4,15,23,25,32,34-40,77H2,1-2H3,(H2,78,97)(H,81,84)(H,85,99)(H,86,104)(H,87,102)(H,88,106)(H,89,98)(H,90,105)(H,91,101)(H,92,103)(H,93,100)(H,95,96)(H4,79,80,82) NENKRICCIWXRGU-UHFFFAOYSA-N 50321604 (3S,6S,9S,12S,15R,18S,21S,24R,27S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-27-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-28-(4-hydroxyphenyl)-24-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26-octaoxo-4,7,10,13,16,19,22,25-octaazaoctacosan-1-oic acid::CHEMBL1172429 Cholecystokinin receptor type A Homo sapiens 1.6 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321604 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2125&target=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321604&enzyme=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search 91933504 104143133 CHEMBL1172429 1 MDVVDSLLVNGSNITPPCELGLENETLFCLDQPRPSKEWQPAVQILLYSLIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLLKDFIFGSAVCKTTTYFMGTSVSVSTFNLVAISLERYGAICKPLQSRVWQTKSHALKVIAATWCLSFTIMTPYPIYSNLVPFTKNNNQTANMCRFLLPNDVMQQSWHTFLLLILFLIPGIVMMVAYGLISLELYQGIKFEASQKKSAKERKPSTTSSGKYEDSDGCYLQKTRPPRKLELRQLSTGSSSRANRIRSNSSAANLMAKKRVIRMLIVIVVLFFLCWMPIFSANAWRAYDTASAERRLSGTPISFILLLSYTSSCVNPIIYCFMNKRFRLGFMATFPCCPNPGPPGARGEVGEEEEGGTTGASLSRFSYSHMSASVPPQ 7XOV,7XOU,7EZM,7EZK,7EZH,7MBX,7MBY Cholecystokinin receptor type A CCKAR_HUMAN P32238 B2R9Z5 50914757 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:58.71,74.80,8.20,87.93,69.75,wD:48.59,22.31,4.4,33.48,95.101,(27.14,-11.6,;25.81,-10.83,;25.81,-9.29,;24.47,-8.52,;24.47,-6.97,;23.14,-6.2,;21.8,-6.97,;21.8,-8.5,;20.47,-6.2,;20.47,-4.66,;21.89,-4.07,;23.12,-5,;24.38,-4.1,;23.93,-2.63,;24.71,-1.31,;23.96,.04,;22.43,.05,;21.64,-1.26,;22.38,-2.61,;19.13,-6.97,;17.8,-6.2,;17.8,-4.66,;16.46,-6.97,;16.46,-8.51,;17.8,-9.28,;17.8,-10.82,;19.14,-11.58,;19.13,-13.12,;17.8,-13.89,;20.46,-13.9,;15.12,-6.21,;13.78,-6.97,;13.78,-8.51,;12.45,-6.2,;12.42,-4.66,;13.74,-3.87,;15.09,-4.61,;16.4,-3.81,;16.37,-2.28,;17.69,-1.49,;17.67,.05,;16.32,.8,;15,.01,;15.03,-1.52,;13.71,-2.32,;11.12,-6.97,;9.78,-6.21,;9.78,-4.66,;8.44,-6.98,;8.44,-8.51,;9.78,-9.29,;11.18,-8.65,;12.21,-9.8,;11.45,-11.14,;9.94,-10.82,;7.1,-6.21,;5.76,-6.97,;5.76,-8.5,;4.43,-6.2,;4.43,-4.66,;5.76,-3.89,;7.1,-4.65,;8.42,-3.88,;8.42,-2.34,;7.09,-1.57,;5.75,-2.34,;3.1,-6.99,;1.76,-6.22,;1.76,-4.68,;.42,-6.99,;.42,-8.53,;-.9,-6.21,;-2.25,-6.97,;-2.25,-8.51,;-3.58,-6.2,;-4.91,-6.98,;-3.58,-4.66,;-2.25,-3.89,;-.92,-4.66,;.41,-3.89,;.4,-2.35,;1.77,-1.59,;-.92,-1.58,;-2.25,-2.35,;25.81,-6.21,;25.81,-4.67,;27.15,-6.98,;28.48,-6.21,;28.48,-4.66,;29.82,-3.89,;31.15,-4.66,;29.82,-2.35,;29.82,-6.97,;29.82,-8.51,;31.15,-6.2,;32.49,-6.97,;32.49,-8.5,;33.83,-9.28,;35.16,-8.5,;36.5,-9.28,;36.5,-10.82,;35.16,-11.58,;33.83,-10.81,;33.83,-6.2,;35.15,-6.96,;33.83,-4.65,)| InChI=1S/C76H91N17O13/c1-3-4-23-57(69(100)93-64(40-65(95)96)75(106)88-59(66(78)97)35-45-16-7-5-8-17-45)86-73(104)62(38-51-41-83-56-24-14-13-22-54(51)56)91-70(101)58(25-15-32-82-76(79)80)87-71(102)61(37-48-26-29-49-20-11-12-21-50(49)33-48)90-74(105)63(39-52-42-81-43-84-52)92-72(103)60(36-46-18-9-6-10-19-46)89-67(98)44(2)85-68(99)55(77)34-47-27-30-53(94)31-28-47/h5-14,16-22,24,26-31,33,41-44,55,57-64,83,94H,3-4,15,23,25,32,34-40,77H2,1-2H3,(H2,78,97)(H,81,84)(H,85,99)(H,86,104)(H,87,102)(H,88,106)(H,89,98)(H,90,105)(H,91,101)(H,92,103)(H,93,100)(H,95,96)(H4,79,80,82) NENKRICCIWXRGU-UHFFFAOYSA-N 50321604 (3S,6S,9S,12S,15R,18S,21S,24R,27S)-18-((1H-imidazol-5-yl)methyl)-9-((1H-indol-3-yl)methyl)-27-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-21-benzyl-6-butyl-12-(3-guanidinopropyl)-28-(4-hydroxyphenyl)-24-methyl-15-(naphthalen-2-ylmethyl)-5,8,11,14,17,20,23,26-octaoxo-4,7,10,13,16,19,22,25-octaazaoctacosan-1-oic acid::CHEMBL1172429 Gastrin/cholecystokinin type B receptor Homo sapiens 190 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321604 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2126&target=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321604&enzyme=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933504 104143133 CHEMBL1172429 1 MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG 8IA7,7XOW Gastrin/cholecystokinin type B receptor GASR_HUMAN P32239 A8K7P9 O75824 Q16144 Q92492 Q96LC6 Q9NYK7 Q9UBV1 50914759 C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(N)=O InChI=1S/C23H29N5O5/c1-14(27-23(33)18(24)11-16-7-9-17(29)10-8-16)22(32)26-13-20(30)28-19(21(25)31)12-15-5-3-2-4-6-15/h2-10,14,18-19,29H,11-13,24H2,1H3,(H2,25,31)(H,26,32)(H,27,33)(H,28,30) RJEUERNNQHNSKG-UHFFFAOYSA-N 21123 Enkephalin Amide::(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]propanamido]acetamido}-3-phenylpropanamide::YDAGF-NH2 Mu-type opioid receptor Rattus norvegicus 2.8 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21123 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=21123&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 5490373 49689196 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50914760 CCCC[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C28H37N5O7/c1-2-3-9-21(31-26(38)20(29)14-18-10-12-19(34)13-11-18)27(39)33-23(16-24(35)36)28(40)32-22(25(30)37)15-17-7-5-4-6-8-17/h4-8,10-13,20-23,34H,2-3,9,14-16,29H2,1H3,(H2,30,37)(H,31,38)(H,32,40)(H,33,39)(H,35,36) WQLXJYHQHWSRFL-UHFFFAOYSA-N 50321609 (S)-4-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-3-((S)-2-((S)-2-amino-3-(4-hydroxyphenyl)propanamido)hexanamido)-4-oxobutanoic acid::CHEMBL1171596 Gastrin/cholecystokinin type B receptor Homo sapiens 61 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321609 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2126&target=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321609&enzyme=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798148 104143138 CHEMBL1171596 1 MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG 8IA7,7XOW Gastrin/cholecystokinin type B receptor GASR_HUMAN P32239 A8K7P9 O75824 Q16144 Q92492 Q96LC6 Q9NYK7 Q9UBV1 50914761 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C76H90N16O12/c1-4-5-23-58(68(97)90-64(38-66(94)95)73(102)87-60(67(78)96)32-45-16-7-6-8-17-45)85-71(100)62(34-51-39-83-57-24-14-13-22-54(51)57)89-69(98)59(25-15-28-82-76(79)80)86-70(99)61(33-46-26-27-47-18-9-10-19-48(47)31-46)88-72(101)63(36-52-40-81-42-84-52)91-74(103)65-35-49-20-11-12-21-50(49)41-92(65)75(104)56(77)37-55-43(2)29-53(93)30-44(55)3/h6-14,16-22,24,26-27,29-31,39-40,42,56,58-65,83,93H,4-5,15,23,25,28,32-38,41,77H2,1-3H3,(H2,78,96)(H,81,84)(H,85,100)(H,86,99)(H,87,102)(H,88,101)(H,89,98)(H,90,97)(H,91,103)(H,94,95)(H4,79,80,82) TVINVHGLLFLSBP-UHFFFAOYSA-N 50321596 (3S,6R,9S,12S,15S,18S)-3-((1H-imidazol-5-yl)methyl)-12-((1H-indol-3-yl)methyl)-18-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-1-(2-((R)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-15-butyl-9-(3-guanidinopropyl)-6-(naphthalen-2-ylmethyl)-1,4,7,10,13,16-hexaoxo-2,5,8,11,14,17-hexaazaicosan-20-oic acid::CHEMBL2372623 Mu-type opioid receptor Rattus norvegicus 47 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321596 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321596&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 73354785 104143125 CHEMBL2372623 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50914763 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:33.48,22.31,4.4,48.59,93.100,wD:70.77,58.62,8.20,85.92,(16.65,-3.98,;15.32,-4.75,;15.32,-6.29,;13.98,-7.06,;13.98,-8.6,;12.65,-9.36,;11.32,-8.59,;11.32,-7.05,;9.99,-9.35,;9.99,-10.9,;11.32,-11.67,;12.72,-11.05,;13.76,-12.19,;12.98,-13.52,;13.46,-14.99,;12.42,-16.14,;10.92,-15.81,;10.44,-14.35,;11.48,-13.21,;8.66,-8.59,;7.33,-9.38,;7.33,-10.92,;6,-8.61,;6,-7.07,;7.33,-6.3,;7.33,-4.76,;8.66,-3.97,;8.68,-2.43,;7.33,-1.66,;10,-1.66,;4.65,-9.35,;3.32,-8.59,;3.32,-7.05,;1.99,-9.36,;1.76,-10.89,;2.96,-11.84,;2.73,-13.37,;3.92,-14.33,;5.36,-13.77,;6.57,-14.74,;8.01,-14.17,;8.23,-12.64,;7.03,-11.68,;5.59,-12.24,;4.39,-11.29,;.66,-8.58,;-.66,-9.38,;-.66,-10.92,;-2,-8.61,;-2,-7.07,;-.66,-6.29,;.75,-6.93,;1.79,-5.78,;1.01,-4.45,;-.5,-4.76,;-3.33,-9.38,;-4.67,-8.61,;-4.67,-7.07,;-6,-9.38,;-7.33,-8.62,;-8.66,-9.39,;-9.99,-8.62,;-11.33,-9.39,;-11.33,-10.93,;-9.99,-11.69,;-8.66,-10.92,;-7.33,-11.7,;-6,-10.91,;-4.66,-11.68,;-3.33,-10.91,;-4.66,-13.22,;-5.99,-13.99,;-3.32,-13.99,;-3.32,-15.53,;-4.65,-16.3,;-5.98,-15.53,;-4.65,-17.84,;-3.31,-18.61,;-3.31,-20.15,;-1.98,-17.84,;-1.98,-16.29,;-.65,-15.52,;15.32,-9.37,;15.32,-10.91,;16.65,-8.59,;17.98,-9.36,;17.98,-10.91,;19.32,-11.67,;20.64,-10.9,;19.32,-13.21,;19.32,-8.59,;19.32,-7.05,;20.65,-9.36,;21.98,-8.59,;21.98,-7.05,;23.31,-6.28,;24.65,-7.06,;25.98,-6.29,;25.99,-4.75,;24.65,-3.98,;23.32,-4.75,;23.31,-9.36,;24.65,-8.59,;23.31,-10.91,)| InChI=1S/C76H90N16O12/c1-4-5-23-58(68(97)90-64(38-66(94)95)73(102)87-60(67(78)96)32-45-16-7-6-8-17-45)85-71(100)62(34-51-39-83-57-24-14-13-22-54(51)57)89-69(98)59(25-15-28-82-76(79)80)86-70(99)61(33-46-26-27-47-18-9-10-19-48(47)31-46)88-72(101)63(36-52-40-81-42-84-52)91-74(103)65-35-49-20-11-12-21-50(49)41-92(65)75(104)56(77)37-55-43(2)29-53(93)30-44(55)3/h6-14,16-22,24,26-27,29-31,39-40,42,56,58-65,83,93H,4-5,15,23,25,28,32-38,41,77H2,1-3H3,(H2,78,96)(H,81,84)(H,85,100)(H,86,99)(H,87,102)(H,88,101)(H,89,98)(H,90,97)(H,91,103)(H,94,95)(H4,79,80,82) TVINVHGLLFLSBP-UHFFFAOYSA-N 50321597 (3S,6R,9S,12S,15S,18S)-3-((1H-imidazol-5-yl)methyl)-12-((1H-indol-3-yl)methyl)-18-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-1-((R)-2-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-15-butyl-9-(3-guanidinopropyl)-6-(naphthalen-2-ylmethyl)-1,4,7,10,13,16-hexaoxo-2,5,8,11,14,17-hexaazaicosan-20-oic acid::CHEMBL1172249 Gastrin/cholecystokinin type B receptor Homo sapiens 100 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321597 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2126&target=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321597&enzyme=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933500 104143126 CHEMBL1172249 1 MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG 8IA7,7XOW Gastrin/cholecystokinin type B receptor GASR_HUMAN P32239 A8K7P9 O75824 Q16144 Q92492 Q96LC6 Q9NYK7 Q9UBV1 50914764 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:33.48,22.31,4.4,48.59,93.100,wD:70.77,58.62,8.20,85.92,(16.65,-3.98,;15.32,-4.75,;15.32,-6.29,;13.98,-7.06,;13.98,-8.6,;12.65,-9.36,;11.32,-8.59,;11.32,-7.05,;9.99,-9.35,;9.99,-10.9,;11.32,-11.67,;12.72,-11.05,;13.76,-12.19,;12.98,-13.52,;13.46,-14.99,;12.42,-16.14,;10.92,-15.81,;10.44,-14.35,;11.48,-13.21,;8.66,-8.59,;7.33,-9.38,;7.33,-10.92,;6,-8.61,;6,-7.07,;7.33,-6.3,;7.33,-4.76,;8.66,-3.97,;8.68,-2.43,;7.33,-1.66,;10,-1.66,;4.65,-9.35,;3.32,-8.59,;3.32,-7.05,;1.99,-9.36,;1.76,-10.89,;2.96,-11.84,;2.73,-13.37,;3.92,-14.33,;5.36,-13.77,;6.57,-14.74,;8.01,-14.17,;8.23,-12.64,;7.03,-11.68,;5.59,-12.24,;4.39,-11.29,;.66,-8.58,;-.66,-9.38,;-.66,-10.92,;-2,-8.61,;-2,-7.07,;-.66,-6.29,;.75,-6.93,;1.79,-5.78,;1.01,-4.45,;-.5,-4.76,;-3.33,-9.38,;-4.67,-8.61,;-4.67,-7.07,;-6,-9.38,;-7.33,-8.62,;-8.66,-9.39,;-9.99,-8.62,;-11.33,-9.39,;-11.33,-10.93,;-9.99,-11.69,;-8.66,-10.92,;-7.33,-11.7,;-6,-10.91,;-4.66,-11.68,;-3.33,-10.91,;-4.66,-13.22,;-5.99,-13.99,;-3.32,-13.99,;-3.32,-15.53,;-4.65,-16.3,;-5.98,-15.53,;-4.65,-17.84,;-3.31,-18.61,;-3.31,-20.15,;-1.98,-17.84,;-1.98,-16.29,;-.65,-15.52,;15.32,-9.37,;15.32,-10.91,;16.65,-8.59,;17.98,-9.36,;17.98,-10.91,;19.32,-11.67,;20.64,-10.9,;19.32,-13.21,;19.32,-8.59,;19.32,-7.05,;20.65,-9.36,;21.98,-8.59,;21.98,-7.05,;23.31,-6.28,;24.65,-7.06,;25.98,-6.29,;25.99,-4.75,;24.65,-3.98,;23.32,-4.75,;23.31,-9.36,;24.65,-8.59,;23.31,-10.91,)| InChI=1S/C76H90N16O12/c1-4-5-23-58(68(97)90-64(38-66(94)95)73(102)87-60(67(78)96)32-45-16-7-6-8-17-45)85-71(100)62(34-51-39-83-57-24-14-13-22-54(51)57)89-69(98)59(25-15-28-82-76(79)80)86-70(99)61(33-46-26-27-47-18-9-10-19-48(47)31-46)88-72(101)63(36-52-40-81-42-84-52)91-74(103)65-35-49-20-11-12-21-50(49)41-92(65)75(104)56(77)37-55-43(2)29-53(93)30-44(55)3/h6-14,16-22,24,26-27,29-31,39-40,42,56,58-65,83,93H,4-5,15,23,25,28,32-38,41,77H2,1-3H3,(H2,78,96)(H,81,84)(H,85,100)(H,86,99)(H,87,102)(H,88,101)(H,89,98)(H,90,97)(H,91,103)(H,94,95)(H4,79,80,82) TVINVHGLLFLSBP-UHFFFAOYSA-N 50321597 (3S,6R,9S,12S,15S,18S)-3-((1H-imidazol-5-yl)methyl)-12-((1H-indol-3-yl)methyl)-18-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-1-((R)-2-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-15-butyl-9-(3-guanidinopropyl)-6-(naphthalen-2-ylmethyl)-1,4,7,10,13,16-hexaoxo-2,5,8,11,14,17-hexaazaicosan-20-oic acid::CHEMBL1172249 Cholecystokinin receptor type A Homo sapiens 32 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321597 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2125&target=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321597&enzyme=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search 91933500 104143126 CHEMBL1172249 1 MDVVDSLLVNGSNITPPCELGLENETLFCLDQPRPSKEWQPAVQILLYSLIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLLKDFIFGSAVCKTTTYFMGTSVSVSTFNLVAISLERYGAICKPLQSRVWQTKSHALKVIAATWCLSFTIMTPYPIYSNLVPFTKNNNQTANMCRFLLPNDVMQQSWHTFLLLILFLIPGIVMMVAYGLISLELYQGIKFEASQKKSAKERKPSTTSSGKYEDSDGCYLQKTRPPRKLELRQLSTGSSSRANRIRSNSSAANLMAKKRVIRMLIVIVVLFFLCWMPIFSANAWRAYDTASAERRLSGTPISFILLLSYTSSCVNPIIYCFMNKRFRLGFMATFPCCPNPGPPGARGEVGEEEEGGTTGASLSRFSYSHMSASVPPQ 7XOV,7XOU,7EZM,7EZK,7EZH,7MBX,7MBY Cholecystokinin receptor type A CCKAR_HUMAN P32238 B2R9Z5 50914765 CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:33.48,22.31,4.4,48.59,93.100,wD:70.77,58.62,8.20,85.92,(16.65,-3.98,;15.32,-4.75,;15.32,-6.29,;13.98,-7.06,;13.98,-8.6,;12.65,-9.36,;11.32,-8.59,;11.32,-7.05,;9.99,-9.35,;9.99,-10.9,;11.32,-11.67,;12.72,-11.05,;13.76,-12.19,;12.98,-13.52,;13.46,-14.99,;12.42,-16.14,;10.92,-15.81,;10.44,-14.35,;11.48,-13.21,;8.66,-8.59,;7.33,-9.38,;7.33,-10.92,;6,-8.61,;6,-7.07,;7.33,-6.3,;7.33,-4.76,;8.66,-3.97,;8.68,-2.43,;7.33,-1.66,;10,-1.66,;4.65,-9.35,;3.32,-8.59,;3.32,-7.05,;1.99,-9.36,;1.76,-10.89,;2.96,-11.84,;2.73,-13.37,;3.92,-14.33,;5.36,-13.77,;6.57,-14.74,;8.01,-14.17,;8.23,-12.64,;7.03,-11.68,;5.59,-12.24,;4.39,-11.29,;.66,-8.58,;-.66,-9.38,;-.66,-10.92,;-2,-8.61,;-2,-7.07,;-.66,-6.29,;.75,-6.93,;1.79,-5.78,;1.01,-4.45,;-.5,-4.76,;-3.33,-9.38,;-4.67,-8.61,;-4.67,-7.07,;-6,-9.38,;-7.33,-8.62,;-8.66,-9.39,;-9.99,-8.62,;-11.33,-9.39,;-11.33,-10.93,;-9.99,-11.69,;-8.66,-10.92,;-7.33,-11.7,;-6,-10.91,;-4.66,-11.68,;-3.33,-10.91,;-4.66,-13.22,;-5.99,-13.99,;-3.32,-13.99,;-3.32,-15.53,;-4.65,-16.3,;-5.98,-15.53,;-4.65,-17.84,;-3.31,-18.61,;-3.31,-20.15,;-1.98,-17.84,;-1.98,-16.29,;-.65,-15.52,;15.32,-9.37,;15.32,-10.91,;16.65,-8.59,;17.98,-9.36,;17.98,-10.91,;19.32,-11.67,;20.64,-10.9,;19.32,-13.21,;19.32,-8.59,;19.32,-7.05,;20.65,-9.36,;21.98,-8.59,;21.98,-7.05,;23.31,-6.28,;24.65,-7.06,;25.98,-6.29,;25.99,-4.75,;24.65,-3.98,;23.32,-4.75,;23.31,-9.36,;24.65,-8.59,;23.31,-10.91,)| InChI=1S/C76H90N16O12/c1-4-5-23-58(68(97)90-64(38-66(94)95)73(102)87-60(67(78)96)32-45-16-7-6-8-17-45)85-71(100)62(34-51-39-83-57-24-14-13-22-54(51)57)89-69(98)59(25-15-28-82-76(79)80)86-70(99)61(33-46-26-27-47-18-9-10-19-48(47)31-46)88-72(101)63(36-52-40-81-42-84-52)91-74(103)65-35-49-20-11-12-21-50(49)41-92(65)75(104)56(77)37-55-43(2)29-53(93)30-44(55)3/h6-14,16-22,24,26-27,29-31,39-40,42,56,58-65,83,93H,4-5,15,23,25,28,32-38,41,77H2,1-3H3,(H2,78,96)(H,81,84)(H,85,100)(H,86,99)(H,87,102)(H,88,101)(H,89,98)(H,90,97)(H,91,103)(H,94,95)(H4,79,80,82) TVINVHGLLFLSBP-UHFFFAOYSA-N 50321597 (3S,6R,9S,12S,15S,18S)-3-((1H-imidazol-5-yl)methyl)-12-((1H-indol-3-yl)methyl)-18-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-1-((R)-2-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-15-butyl-9-(3-guanidinopropyl)-6-(naphthalen-2-ylmethyl)-1,4,7,10,13,16-hexaoxo-2,5,8,11,14,17-hexaazaicosan-20-oic acid::CHEMBL1172249 Mu-type opioid receptor Rattus norvegicus 18 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321597 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321597&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933500 104143126 CHEMBL1172249 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50914767 Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N1CC(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@H](Cc2ccc3ccccc3c2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CSSC[C@@H](N)C1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:69.84,89.95,29.31,10.11,wD:44.48,74.80,19.20,81.87,55.59,(1.42,-5.48,;.09,-4.71,;-1.25,-5.49,;-2.59,-4.72,;-3.92,-5.48,;-2.59,-3.17,;-1.25,-2.41,;-1.25,-.87,;.08,-3.17,;1.41,-2.4,;2.75,-3.17,;2.75,-4.71,;4.08,-2.39,;4.08,-.85,;5.42,-3.16,;6.02,-4.57,;5.09,-5.8,;3.56,-5.61,;5.68,-7.22,;4.75,-8.45,;3.42,-7.68,;2.08,-8.45,;.68,-7.83,;-.35,-8.98,;.42,-10.31,;1.93,-9.98,;4.75,-9.99,;3.42,-10.76,;6.09,-10.76,;6.09,-12.3,;4.75,-13.07,;4.75,-14.61,;6.08,-15.37,;6.09,-16.91,;4.75,-17.69,;4.75,-19.22,;3.42,-19.99,;2.08,-19.22,;2.09,-17.68,;3.42,-16.92,;3.42,-15.39,;7.42,-13.07,;7.42,-14.61,;8.75,-12.3,;10.09,-13.07,;10.09,-14.61,;8.75,-15.38,;8.75,-16.92,;7.42,-17.69,;7.42,-19.23,;6.09,-20,;8.75,-20,;11.42,-12.3,;12.75,-13.07,;11.42,-10.76,;12.75,-9.99,;14.09,-10.76,;15.42,-9.99,;15.57,-8.48,;17.08,-8.15,;17.86,-9.48,;19.37,-9.79,;19.85,-11.26,;18.82,-12.42,;17.3,-12.1,;16.82,-10.63,;12.75,-8.45,;11.42,-7.68,;14.09,-7.68,;14.09,-6.14,;12.75,-5.37,;12.75,-3.83,;10,-3.73,;8.47,-3.54,;7.88,-2.12,;8.81,-.89,;6.35,-1.93,;5.75,-.51,;15.42,-5.37,;16.75,-6.14,;15.42,-3.83,;16.75,-3.06,;18.09,-3.83,;19.42,-3.06,;19.42,-1.52,;20.76,-3.83,;16.75,-1.52,;15.42,-.75,;18.09,-.75,;18.09,.78,;16.75,1.55,;16.75,3.09,;18.09,3.85,;18.09,5.39,;16.76,6.16,;15.42,5.39,;15.43,3.86,;19.42,1.55,;19.42,3.09,;20.76,.78,)| InChI=1S/C68H81N17O13S2/c1-36-21-44(86)22-37(2)46(36)28-47(69)66(97)85-32-57(87)78-54(27-43-31-74-35-77-43)63(94)81-52(25-39-18-19-40-13-6-7-14-41(40)23-39)61(92)79-50(17-10-20-75-68(72)73)60(91)82-53(26-42-30-76-49-16-9-8-15-45(42)49)62(93)84-56(34-100-99-33-48(70)67(85)98)65(96)83-55(29-58(88)89)64(95)80-51(59(71)90)24-38-11-4-3-5-12-38/h3-9,11-16,18-19,21-23,30-31,35,47-48,50-56,76,86H,10,17,20,24-29,32-34,69-70H2,1-2H3,(H2,71,90)(H,74,77)(H,78,87)(H,79,92)(H,80,95)(H,81,94)(H,82,91)(H,83,96)(H,84,93)(H,88,89)(H4,72,73,75) YDLLMSIGAKQIBS-UHFFFAOYSA-N 50321598 (S)-3-((4R,7S,10S,13R,16S,22S)-16-((1H-imidazol-5-yl)methyl)-7-((1H-indol-3-yl)methyl)-22-amino-20-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-10-(3-guanidinopropyl)-13-(naphthalen-2-ylmethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexaazacyclotricosane-4-carboxamido)-4-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid::CHEMBL1172248 Mu-type opioid receptor Rattus norvegicus 5.9 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321598 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321598&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933501 104143127 CHEMBL1172248 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50914769 Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N1CC(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@H](Cc2ccccc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CSSC[C@@H](N)C1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:10.11,65.79,85.90,29.31,wD:19.20,70.75,40.43,77.82,51.54,(-6.99,1.44,;-8.33,2.2,;-9.67,1.43,;-11.01,2.2,;-12.34,1.43,;-11,3.74,;-9.66,4.51,;-9.66,6.05,;-8.33,3.74,;-7,4.51,;-5.67,3.75,;-5.66,2.21,;-4.33,4.52,;-4.34,6.06,;-3,3.75,;-2.4,2.34,;-3.33,1.11,;-4.86,1.3,;-2.73,-.31,;-3.66,-1.53,;-5,-.77,;-6.33,-1.54,;-7.73,-.92,;-8.76,-2.06,;-7.99,-3.4,;-6.48,-3.07,;-3.66,-3.08,;-5,-3.85,;-2.33,-3.85,;-2.33,-5.39,;-3.66,-6.16,;-3.66,-7.7,;-5,-8.46,;-5,-10,;-3.67,-10.77,;-2.33,-10,;-2.34,-8.46,;-1,-6.16,;-1,-7.7,;.34,-5.39,;1.67,-6.16,;1.67,-7.7,;.34,-8.47,;.34,-10.01,;-1,-10.78,;-1,-12.32,;-2.33,-13.09,;.34,-13.09,;3,-5.39,;4.34,-6.16,;3,-3.85,;4.34,-3.08,;5.67,-3.85,;7.01,-3.08,;7.16,-1.56,;8.67,-1.24,;9.44,-2.57,;10.95,-2.88,;11.43,-4.34,;10.4,-5.5,;8.89,-5.18,;8.41,-3.71,;4.34,-1.54,;3,-.77,;5.67,-.77,;5.67,.77,;4.34,1.54,;4.34,3.08,;1.59,3.18,;.06,3.38,;-.54,4.79,;.39,6.02,;-2.07,4.99,;-2.66,6.41,;7.01,1.54,;8.34,.77,;7.01,3.08,;8.34,3.85,;9.67,3.08,;11.01,3.85,;11.01,5.39,;12.34,3.08,;8.34,5.39,;7.01,6.16,;9.67,6.16,;9.67,7.7,;8.34,8.47,;8.34,10.01,;9.68,10.78,;9.68,12.32,;8.34,13.09,;7.01,12.31,;7.01,10.77,;11.01,8.47,;11.01,10.01,;12.34,7.7,)| InChI=1S/C64H79N17O13S2/c1-34-20-40(82)21-35(2)42(34)26-43(65)62(93)81-30-53(83)74-50(25-39-29-70-33-73-39)59(90)77-48(23-37-14-7-4-8-15-37)57(88)75-46(18-11-19-71-64(68)69)56(87)78-49(24-38-28-72-45-17-10-9-16-41(38)45)58(89)80-52(32-96-95-31-44(66)63(81)94)61(92)79-51(27-54(84)85)60(91)76-47(55(67)86)22-36-12-5-3-6-13-36/h3-10,12-17,20-21,28-29,33,43-44,46-52,72,82H,11,18-19,22-27,30-32,65-66H2,1-2H3,(H2,67,86)(H,70,73)(H,74,83)(H,75,88)(H,76,91)(H,77,90)(H,78,87)(H,79,92)(H,80,89)(H,84,85)(H4,68,69,71) OYHTUAKSBPLZSH-UHFFFAOYSA-N 50321599 (S)-3-((4R,7S,10S,13R,16S,22S)-16-((1H-imidazol-5-yl)methyl)-7-((1H-indol-3-yl)methyl)-22-amino-20-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-13-benzyl-10-(3-guanidinopropyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexaazacyclotricosane-4-carboxamido)-4-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid::CHEMBL1172247 Cholecystokinin receptor type A Homo sapiens >10000 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321599 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2125&target=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321599&enzyme=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search 91933502 104143128 CHEMBL1172247 1 MDVVDSLLVNGSNITPPCELGLENETLFCLDQPRPSKEWQPAVQILLYSLIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLLKDFIFGSAVCKTTTYFMGTSVSVSTFNLVAISLERYGAICKPLQSRVWQTKSHALKVIAATWCLSFTIMTPYPIYSNLVPFTKNNNQTANMCRFLLPNDVMQQSWHTFLLLILFLIPGIVMMVAYGLISLELYQGIKFEASQKKSAKERKPSTTSSGKYEDSDGCYLQKTRPPRKLELRQLSTGSSSRANRIRSNSSAANLMAKKRVIRMLIVIVVLFFLCWMPIFSANAWRAYDTASAERRLSGTPISFILLLSYTSSCVNPIIYCFMNKRFRLGFMATFPCCPNPGPPGARGEVGEEEEGGTTGASLSRFSYSHMSASVPPQ 7XOV,7XOU,7EZM,7EZK,7EZH,7MBX,7MBY Cholecystokinin receptor type A CCKAR_HUMAN P32238 B2R9Z5 50914770 Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N1CC(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@H](Cc2ccccc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CSSC[C@@H](N)C1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:10.11,65.79,85.90,29.31,wD:19.20,70.75,40.43,77.82,51.54,(-6.99,1.44,;-8.33,2.2,;-9.67,1.43,;-11.01,2.2,;-12.34,1.43,;-11,3.74,;-9.66,4.51,;-9.66,6.05,;-8.33,3.74,;-7,4.51,;-5.67,3.75,;-5.66,2.21,;-4.33,4.52,;-4.34,6.06,;-3,3.75,;-2.4,2.34,;-3.33,1.11,;-4.86,1.3,;-2.73,-.31,;-3.66,-1.53,;-5,-.77,;-6.33,-1.54,;-7.73,-.92,;-8.76,-2.06,;-7.99,-3.4,;-6.48,-3.07,;-3.66,-3.08,;-5,-3.85,;-2.33,-3.85,;-2.33,-5.39,;-3.66,-6.16,;-3.66,-7.7,;-5,-8.46,;-5,-10,;-3.67,-10.77,;-2.33,-10,;-2.34,-8.46,;-1,-6.16,;-1,-7.7,;.34,-5.39,;1.67,-6.16,;1.67,-7.7,;.34,-8.47,;.34,-10.01,;-1,-10.78,;-1,-12.32,;-2.33,-13.09,;.34,-13.09,;3,-5.39,;4.34,-6.16,;3,-3.85,;4.34,-3.08,;5.67,-3.85,;7.01,-3.08,;7.16,-1.56,;8.67,-1.24,;9.44,-2.57,;10.95,-2.88,;11.43,-4.34,;10.4,-5.5,;8.89,-5.18,;8.41,-3.71,;4.34,-1.54,;3,-.77,;5.67,-.77,;5.67,.77,;4.34,1.54,;4.34,3.08,;1.59,3.18,;.06,3.38,;-.54,4.79,;.39,6.02,;-2.07,4.99,;-2.66,6.41,;7.01,1.54,;8.34,.77,;7.01,3.08,;8.34,3.85,;9.67,3.08,;11.01,3.85,;11.01,5.39,;12.34,3.08,;8.34,5.39,;7.01,6.16,;9.67,6.16,;9.67,7.7,;8.34,8.47,;8.34,10.01,;9.68,10.78,;9.68,12.32,;8.34,13.09,;7.01,12.31,;7.01,10.77,;11.01,8.47,;11.01,10.01,;12.34,7.7,)| InChI=1S/C64H79N17O13S2/c1-34-20-40(82)21-35(2)42(34)26-43(65)62(93)81-30-53(83)74-50(25-39-29-70-33-73-39)59(90)77-48(23-37-14-7-4-8-15-37)57(88)75-46(18-11-19-71-64(68)69)56(87)78-49(24-38-28-72-45-17-10-9-16-41(38)45)58(89)80-52(32-96-95-31-44(66)63(81)94)61(92)79-51(27-54(84)85)60(91)76-47(55(67)86)22-36-12-5-3-6-13-36/h3-10,12-17,20-21,28-29,33,43-44,46-52,72,82H,11,18-19,22-27,30-32,65-66H2,1-2H3,(H2,67,86)(H,70,73)(H,74,83)(H,75,88)(H,76,91)(H,77,90)(H,78,87)(H,79,92)(H,80,89)(H,84,85)(H4,68,69,71) OYHTUAKSBPLZSH-UHFFFAOYSA-N 50321599 (S)-3-((4R,7S,10S,13R,16S,22S)-16-((1H-imidazol-5-yl)methyl)-7-((1H-indol-3-yl)methyl)-22-amino-20-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl)-13-benzyl-10-(3-guanidinopropyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexaazacyclotricosane-4-carboxamido)-4-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid::CHEMBL1172247 Mu-type opioid receptor Rattus norvegicus 8.6 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321599 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321599&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933502 104143128 CHEMBL1172247 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50914772 N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C66H81ClN18O14/c67-40-19-15-38(16-20-40)27-49-62(96)80-47(14-8-24-74-66(70)71)61(95)84-51(29-41-28-39-11-4-5-12-45(39)77-41)64(98)79-46(60(94)85-53(32-56(89)90)65(99)81-48(57(69)91)26-36-9-2-1-3-10-36)13-6-7-23-73-54(87)31-52(82-58(92)44(68)25-37-17-21-43(86)22-18-37)59(93)75-34-55(88)78-50(63(97)83-49)30-42-33-72-35-76-42/h1-5,9-12,15-22,28,33,35,44,46-53,77,86H,6-8,13-14,23-27,29-32,34,68H2,(H2,69,91)(H,72,76)(H,73,87)(H,75,93)(H,78,88)(H,79,98)(H,80,96)(H,81,99)(H,82,92)(H,83,97)(H,84,95)(H,85,94)(H,89,90)(H4,70,71,74) YCEIOOXEUSAMIZ-UHFFFAOYSA-N 50321600 (S)-3-((3S,6S,9S,12S,18R,26S)-12-((1H-imidazol-5-yl)methyl)-3-((1H-indol-2-yl)methyl)-18-((S)-2-amino-3-(4-hydroxyphenyl)propanamido)-9-(4-chlorobenzyl)-6-(3-guanidinopropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,21-heptaazacyclohexacosane-26-carboxamido)-4-((R)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid::CHEMBL1172246 Gastrin/cholecystokinin type B receptor Homo sapiens 930 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321600 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2126&target=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321600&enzyme=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798106 104143129 CHEMBL1172246 1 MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG 8IA7,7XOW Gastrin/cholecystokinin type B receptor GASR_HUMAN P32239 A8K7P9 O75824 Q16144 Q92492 Q96LC6 Q9NYK7 Q9UBV1 50914773 N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C66H81ClN18O14/c67-40-19-15-38(16-20-40)27-49-62(96)80-47(14-8-24-74-66(70)71)61(95)84-51(29-41-28-39-11-4-5-12-45(39)77-41)64(98)79-46(60(94)85-53(32-56(89)90)65(99)81-48(57(69)91)26-36-9-2-1-3-10-36)13-6-7-23-73-54(87)31-52(82-58(92)44(68)25-37-17-21-43(86)22-18-37)59(93)75-34-55(88)78-50(63(97)83-49)30-42-33-72-35-76-42/h1-5,9-12,15-22,28,33,35,44,46-53,77,86H,6-8,13-14,23-27,29-32,34,68H2,(H2,69,91)(H,72,76)(H,73,87)(H,75,93)(H,78,88)(H,79,98)(H,80,96)(H,81,99)(H,82,92)(H,83,97)(H,84,95)(H,85,94)(H,89,90)(H4,70,71,74) YCEIOOXEUSAMIZ-UHFFFAOYSA-N 50321600 (S)-3-((3S,6S,9S,12S,18R,26S)-12-((1H-imidazol-5-yl)methyl)-3-((1H-indol-2-yl)methyl)-18-((S)-2-amino-3-(4-hydroxyphenyl)propanamido)-9-(4-chlorobenzyl)-6-(3-guanidinopropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,21-heptaazacyclohexacosane-26-carboxamido)-4-((R)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid::CHEMBL1172246 Cholecystokinin receptor type A Homo sapiens 560 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321600 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2125&target=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321600&enzyme=Cholecystokinin+receptor+type+A&column=ki&startPg=0&Increment=50&submit=Search 49798106 104143129 CHEMBL1172246 1 MDVVDSLLVNGSNITPPCELGLENETLFCLDQPRPSKEWQPAVQILLYSLIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLLKDFIFGSAVCKTTTYFMGTSVSVSTFNLVAISLERYGAICKPLQSRVWQTKSHALKVIAATWCLSFTIMTPYPIYSNLVPFTKNNNQTANMCRFLLPNDVMQQSWHTFLLLILFLIPGIVMMVAYGLISLELYQGIKFEASQKKSAKERKPSTTSSGKYEDSDGCYLQKTRPPRKLELRQLSTGSSSRANRIRSNSSAANLMAKKRVIRMLIVIVVLFFLCWMPIFSANAWRAYDTASAERRLSGTPISFILLLSYTSSCVNPIIYCFMNKRFRLGFMATFPCCPNPGPPGARGEVGEEEEGGTTGASLSRFSYSHMSASVPPQ 7XOV,7XOU,7EZM,7EZK,7EZH,7MBX,7MBY Cholecystokinin receptor type A CCKAR_HUMAN P32238 B2R9Z5 50914774 N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](Cc1ccccc1)C(N)=O |r| InChI=1S/C66H81ClN18O14/c67-40-19-15-38(16-20-40)27-49-62(96)80-47(14-8-24-74-66(70)71)61(95)84-51(29-41-28-39-11-4-5-12-45(39)77-41)64(98)79-46(60(94)85-53(32-56(89)90)65(99)81-48(57(69)91)26-36-9-2-1-3-10-36)13-6-7-23-73-54(87)31-52(82-58(92)44(68)25-37-17-21-43(86)22-18-37)59(93)75-34-55(88)78-50(63(97)83-49)30-42-33-72-35-76-42/h1-5,9-12,15-22,28,33,35,44,46-53,77,86H,6-8,13-14,23-27,29-32,34,68H2,(H2,69,91)(H,72,76)(H,73,87)(H,75,93)(H,78,88)(H,79,98)(H,80,96)(H,81,99)(H,82,92)(H,83,97)(H,84,95)(H,85,94)(H,89,90)(H4,70,71,74) YCEIOOXEUSAMIZ-UHFFFAOYSA-N 50321600 (S)-3-((3S,6S,9S,12S,18R,26S)-12-((1H-imidazol-5-yl)methyl)-3-((1H-indol-2-yl)methyl)-18-((S)-2-amino-3-(4-hydroxyphenyl)propanamido)-9-(4-chlorobenzyl)-6-(3-guanidinopropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,21-heptaazacyclohexacosane-26-carboxamido)-4-((R)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid::CHEMBL1172246 Mu-type opioid receptor Rattus norvegicus 2100 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321600 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321600&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 49798106 104143129 CHEMBL1172246 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 50914776 C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:5.5,1.0,78.83,66.79,55.66,37.39,97.102,wD:22.22,41.55,89.94,(17.54,.39,;18.85,-.37,;20.18,.39,;20.18,1.92,;18.85,2.7,;21.5,2.69,;21.5,4.24,;22.81,1.93,;22.81,.41,;21.51,-.37,;21.53,-1.91,;22.87,-2.67,;22.87,-4.2,;24.18,-1.88,;24.18,-.35,;18.85,-1.92,;20.2,-2.69,;17.54,-2.68,;17.54,-4.23,;16.23,-4.98,;14.91,-4.23,;16.23,-6.53,;14.91,-7.3,;13.6,-6.53,;12.26,-7.31,;12.29,-8.88,;10.96,-9.65,;9.62,-8.89,;9.61,-7.35,;10.94,-6.57,;14.91,-8.85,;16.26,-9.62,;13.6,-9.6,;13.6,-11.15,;12.3,-11.91,;12.3,-13.47,;10.99,-14.22,;10.99,-15.77,;9.67,-16.53,;8.36,-15.77,;8.36,-14.26,;7.02,-16.55,;7.02,-18.1,;8.36,-18.88,;9.61,-17.94,;10.87,-18.83,;10.39,-20.31,;11.18,-21.63,;10.42,-22.98,;8.88,-22.99,;8.1,-21.66,;8.85,-20.32,;5.7,-15.79,;4.36,-16.57,;4.36,-18.12,;3.05,-15.81,;3.05,-14.3,;4.36,-13.54,;4.36,-11.99,;5.67,-11.23,;5.67,-9.68,;4.33,-8.91,;6.98,-8.93,;1.71,-16.59,;.4,-15.83,;.4,-14.32,;-.95,-16.61,;-.95,-18.16,;.4,-18.93,;1.74,-18.14,;3.07,-18.9,;3.08,-20.45,;4.42,-21.21,;1.76,-21.23,;.42,-20.46,;-2.26,-15.85,;-3.61,-16.63,;-3.61,-18.18,;-4.92,-15.87,;-6.26,-16.65,;-4.92,-14.35,;-3.61,-13.6,;-2.21,-14.2,;-1.18,-13.04,;-1.97,-11.71,;-3.47,-12.05,;12.33,-16.55,;12.33,-18.07,;13.67,-15.77,;14.98,-16.53,;14.98,-18.05,;16.33,-18.82,;17.67,-18.05,;16.33,-20.33,;16.33,-15.75,;16.33,-14.2,;17.64,-16.51,;18.98,-15.73,;18.98,-14.18,;20.3,-13.43,;21.63,-14.17,;22.95,-13.39,;22.94,-11.85,;21.61,-11.09,;20.27,-11.87,;20.3,-16.49,;21.64,-15.71,;20.3,-18.01,)| InChI=1S/C74H92ClN19O14/c1-42(87-66(101)52(76)31-45-23-27-50(95)28-24-45)65(100)85-40-62(96)88-58(33-44-15-6-3-7-16-44)68(103)82-29-11-10-19-55(69(104)94-61(37-63(97)98)73(108)91-57(64(78)99)32-43-13-4-2-5-14-43)89-72(107)60(35-47-38-84-54-18-9-8-17-51(47)54)93-70(105)56(20-12-30-83-74(79)80)90-71(106)59(34-46-21-25-48(75)26-22-46)92-67(102)53(77)36-49-39-81-41-86-49/h2-9,13-18,21-28,38-39,41-42,52-53,55-61,84,95H,10-12,19-20,29-37,40,76-77H2,1H3,(H2,78,99)(H,81,86)(H,82,103)(H,85,100)(H,87,101)(H,88,96)(H,89,107)(H,90,106)(H,91,108)(H,92,102)(H,93,105)(H,94,104)(H,97,98)(H4,79,80,83) VEMKPSHWNYIGPG-UHFFFAOYSA-N 50321601 (2S,5R,11S,18S,21S)-2-amino-21-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-18-((S)-2-((S)-2-((R)-2-((S)-2-amino-3-(1H-imidazol-5-yl)propanamido)-3-(4-chlorophenyl)propanamido)-5-guanidinopentanamido)-3-(1H-indol-3-yl)propanamido)-11-benzyl-1-(4-hydroxyphenyl)-5-methyl-3,6,9,12,19-pentaoxo-4,7,10,13,20-pentaazatricosan-23-oic acid::CHEMBL1172245 Mu-type opioid receptor Rattus norvegicus 7.4 ChEMBL 10.1016/j.bmcl.2010.05.078 10.7270/Q2D79CCN 20547453 Lee, YS; Fernandes, S; Kulkarani, V; Mayorov, A; Davis, P; Ma, SW; Brown, K; Gillies, RJ; Lai, J; Porreca, F; Hruby, VJ 7/8/2010 12/31/2012 University of Arizona http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50321601 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50321601&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91933503 104143130 CHEMBL1172245 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120